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Chapter 1
Introduction
Part of this chapter has been adapted from: Heerschap A, Kan HE, Nabuurs CI, Renema WK, Isbrandt D, 
Wieringa B. Subcell Biochem. 2007;46:119-48. Review.
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1  Introduction
Nuclear magnetic resonance (NMR) is a technique widely known for its imaging 
applications (MRI). Less well-known are its spectroscopic applications, which are 
frequently used in biochem istry and biophysics to determ ine concentrations and 
structural details of bio-compounds. Every compound that contains nuclei with magnetic 
properties (e.g. 1H, 31P or 13C atoms) is potentially detectable with MR spectroscopy 
(MRS). As a num ber of biochemical compounds tha t are involved in energy metabolism 
are p resen t in sufficiently high concentrations, MRS is a very suitable tool to study energy 
m etabolism in vivo . The non-invasive character of MRS has been very valuable for 
investigating the biology, physiology and diagnostic medicine in living organisms.
In this chapter, a short introduction of the energy metabolism  in vertebrates will be given 
first, in order to explain basic biology expressions and processes th a t will be used in the 
rem aining chapters. We will zoom in on brain and skeletal muscle, as these are the organs 
tha t have been the focus of this thesis. Secondly, a brief introduction on the basic 
principles of in v ivo  MRS is given, followed by a short overview of some previous MRS 
studies in knockout mouse models with deficiencies of enzymes involved in creatine 
related  m etabolic pathways. This chapter is not m eant to provide a full overview of the 
field, bu t is restricted  to the topics tha t are essential as background inform ation for the 
studies described in this thesis.
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1.1 ENERGY METABOLISM IN VERTEBRATES
ATP, th e  u ltim a te  h ig h -en erg y  p h o sp h a te  co m p o u n d— For every healthy cell a complex 
system of energy generating pathways ensures that the energy demand is met for a large 
variation of circumstances. Every cell-type has its own regulatory pathways for maintaining 
energy homeostasis, adjusted for its specific requirements and function. This is why, for 
example, muscle cells are capable of both extensive long-duration and short-term high-intensity 
exercise.
Central in energy generation are phosphagens; molecules containing the trivalent ion PO43-. In 
vertebrates, phosphagens are used as the principal reservoirs of biochemical energy in the form 
of adenosine triphosphate (ATP) and creatine phosphate (PCr) amongst other high-energy- 
phosphates (HEP). In virtually every living cell, adenosine triphosphate (ATP) plays the central 
role in energy metabolism. Mediated by various cellular ATPases, hydrolysis of ATP splits off the 
terminal phosphate, thereby generating one adenosine diphosphate (ADP) and a free phosphate, 
i.e. inorganic phosphate (Pi).
A T P  ATPases > A D P  + P i + H  + + Energy [1.1]
During this process free energy is released, which can be used for energy requiring processes to 
achieve complex tasks including cell division and growth, active transport of ions, generation of 
heat, neurotransmission, and active sliding of microtubuli for cell motility or muscle contraction. 
The negative charge of ATP at physiological pH levels is thought to be one of the important 
reasons why phosphates are suited for functions that are vital in energy metabolism in many 
organisms. The repulsive force between the negative charged phosphate-groups is responsible 
for the generation of energy upon hydrolyzation. Additionally, being ionized enables the 
retention of HEP like ATP within lipophylic membranes (1). The negative charge also facilitates 
binding with metal ions and positively charged moieties of proteins (i.e. enzymes). In addition, it 
makes high energy phosphates kinetically prone to hydrolysis. The combination of 
thermodynamic instability and the solubility in an aqueous medium is essential for the role of 
ATP in bioenergetic pathways (2).
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A ero b ic  p ro d u c tio n  o f  ATP— ATP is produced, stored, and distributed by many ATPases and 
other ATP-binding receptors involved in metabolic pathways, see fig. 1.1. The synthesis of ATP 
essentially occurs via two metabolic pathways; aerobic and anaerobic combustion. The former is 
the predominant and most efficient pathway of ATP production It involves the chemical 
conversion of carbohydrates, lipids and (to a smaller extent) proteins into carbon dioxide and 
water and requires sufficient supply of oxygen to generate ATP from ADP and Pi. Use of the 
different substrates depends on substrate availability, physiological conditions and tissue type.
glucose Fatty acids (FA)
Figure 1.1: Schematic overview  o f basic energy m etabolism  in the cytosol and mitochondrium.
Glucose and free fa tty acids (FA) can be taken up and converted into CO2 and water to produce ATP. For 
glucose this process involves subsequently glycolysis, the tricarboxylic acid cycle (TCA) cycle and oxidative 
phosphorylation. FA in the mitochondrial matrix are first converted to Acetyl-CoA by the ß-oxidation and 
then enter the TCA cycle for aerobic combustion. NADH and FADH2 are donating electrons in the electron 
transport chain, which drives the production o f ATP by FF0-ATPase. The produced ATP, which is indirectly 
shuttled to the cytosol using creatine (Cr) as a phosphate carrier, can then be used for energy consumption 
facilitated by ATPase-mediated hydrolysis of ATP in the cytosol.
Carbohydrates are taken up in the form of glucose from the blood into the cytosol via tissue- 
specific glucose transporters (e.g. GLUT1 for endothelial tissues such as the blood-brain-barrier,
8T
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GLUT3 for neurons and GLUT4 for muscle). In muscle and liver tissue and to a minor extent 
also in brain tissue glucose is included in glycogen as an efficient storage molecule to supply 
glucose when needed. Via a chain of successive reactions in the glycolytic pathway -occurring in 
the cytosol- glucose is converted into pyruvate that, in case of sufficient oxygen supply, enters 
the mitochondria. These organelles consist of an inner space (matrix) surrounded by two bi­
layer membranes; the inner mitochondrial membrane and the outer mitochondrial membrane. 
Decarboxylation of the mitochondrial pyruvate yields acetyl-CoA which enters the tricarboxylic 
acid cycle (TCA cycle). This cycle enables the actual conversion of carbons into CO2 and H2O and 
additionally leads to the reduction of three molecules of nicotinamide adenine dinucleotide 
(NAD+) and one molecule of flavine adenine dinucleotide (FAD) generating three NADH and one 
FADH2. These TCA cycle products subsequently donate their electrons to an electron transport 
system that extracts the energy (as electrons) from NADH and FADH2, oxidizing them to NAD+ 
and FAD, respectively. The electron flow through the chain results in the pumping of proton ions 
(H+) out of the mitochondrial matrix. The proton pumping is accomplished by three different 
respiratory enzymes; Complex I, Complex III and Complex IV, all localized in the inner 
mitochondrial membrane.. The resulting membrane potential drives the synthesis of ATP by 
F1F0-ATPase, see fig. 1.1. The produced ATP is transported from the mitochondrial matrix 
towards the inner membrane space by adenosine nucleotide transporters (ANT) in order to be 
exported to the rest of the cell. The enzyme activities of ANT and F-type ATPase are normally 
tightly coupled (3).
Although the TCA cycle itself is not directly dependent on oxygen supply, the cycle depends on 
oxydative phosphorylation to refurnish the supply of NAD+ and FAD. The total energy gained 
from the complete breakdown of one molecule of glucose by glycolysis, the TCA cycle and 
oxidative phosphorylation equals 30 ATP molecules, in eukaryotes.
For several tissues (e.g skeletal muscle and especially heart), lipids can be used as an alternative 
substrate for aerobic combustion. Circulating free fatty acids (4) from the blood are taken up and 
stored as triglycerides (5) in the cytosol of muscle fibers. Catabolism of this pool starts with the 
hydrolysis of TG to FFA and glycerol. The glycerol molecules enter glycolysis to generate 
pyruvate and subsequently follow the same pathway as glucose combustion. The FFAs are 
catabolised by a process called ß-oxidation in order to yield acetyl-CoA, which is used in the 
citric acid cycle, followed by oxidative phosphorylation.
T 9
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The cytosolic phosphorylation potential:
P  = — ------ —
[ A D P  ][ P i]
[ A T P  ]
[1 .2]
is proportional to the free energy of hydrolysis of ATP and thus provides information about the 
amount of energy that mitochondria are able to “store” in ATP and the ability of cells to perform 
work. This ratio is believed to play a role in the control of mitochondrial respiration.
A n a ero b ic  ATP p ro d u c tio n : G lycolysis— Under circumstances in which aerobic ATP production 
is insufficient to meet the energy demand (i.e. strenuous exercise) or in total absence of oxygen 
supply (ischemia) non-oxygen requiring ATP generating pathways have to take over the 
production of ATP. In these cases an access of cytosolic pyruvate formed by glycolysis is 
converted into lactate (and alanine). In this way, the glycolytic pathway is capable of ATP 
production without any oxygen. However, the formation of lactic acid leads to acidification if 
sustained for prolonged periods. Compared to aerobic combustion of carbohydrates. ATP 
production by the glycolytic pathway is rather insufficient: the net yield is only 2 ATP molecules 
per glucose molecule. These are synthesized by two subsequent reactions catalyzed by the 
enzymes glyceraldehyde-d-phosphate dehydrogenase (GAPDH) and phosphoglycerate kinase
where GAP stands for glyceraldehyde-3-phosphate; 1,3DPG is 1,3-diphosphoglyceric acid and 
3PGA is 3-phosphoglyceric acid (6). The other two ATP molecules, generated in the last step of 
the glycolysis (pyruvate kinase reaction), are considered as a pay-off for the required hydrolyses 
of two ATP molecules to drive the hexokinase/glucokinase reaction.
The cre a tin e  k in a se  (CK) s y s te m — In addition to the two main ATP producing pathways 
presented above, several tissues with high and rapidly fluctuating energy demands require an 
additional energy buffer for the replenishment of ATP levels. For example, skeletal muscle, heart 
and brain are frequently subjected or very vulnerable to situations in which energy production
(PGK):
G A P  +  N A D + + P i < GAPDH >1,3DPG + N A D H  + H + [1.3]
1,3D P G  +  A D P < PGK >3 P G A + A T P [1.4]
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is not able to follow fast increases in consumption. Although glycolytic ATP production can 
eventually be enhanced in most tissues, the activation of this pathway is not rapid enough to 
maintain ATP levels at the early onset of rapid fluctuations in energy demand or oxygen 
deprivation. In order to cope with this situation, the PCr-CK system can ensure rapid energy 
supply. In this system, PCr serves as an important energy reservoir, which can be used to rapidly 
re-phosphorylate ADP into ATP when ATP demand exceeds ATP supply (7):
P C r 2~ +  M g A D P  +  H + + < cp  >C r + M g A T P 2-  [1.5]
This reaction was discovered by Lohmann in 1934 (8). The intracellular free Mg2+ 
concentrations are relevant in this equation, since only the magnesium bound adenine 
nucleotides are substrates for CK.
Although it is commonly accepted that PCr serves an important role as a very fast “temporal 
energy buffer”, there is still an ongoing debate on a possible role as a spatial energy buffer 
within the muscle cells as well (9-10). Another important function of the CK system is its proton 
buffering capacity: protons produced by ATP hydrolysis are re-used in the CK reaction.
Five isoenzymes of CK are expressed in different tissues, they are composed of four different 
subunits: M-CK, B-CK, Sc-CKmit and UbCKmit (11). Hetero- or homodimeric isoenzymes 
composed of M-CK and B-CK units are found in the cytosol. MM-CK is predominantly found in 
differentiated striated muscle and in the heart, which also contains small amounts of MB-CK and 
BB-CK. High amounts of BB-CK can be found in brain photoreceptor cells of the retina, epithelial 
cells of kidney and intestine, osteoclasts, uterus, spermatozoa and in smooth muscle (for review 
see (12)).
The other two isoenzymes of CK are mitochondrial isoforms, which are located in the 
innermembrane space of mitochondria (for review, see (13)). Typically, the sarcomeric 
mitochondrial CK (ScCKmit) is co-expressed with the cytosolic M-CK, whereas the ubiquitous 
mitochondrial CK (UbCKmit) seems to be active in cells where B-CK is expressed. The 
contribution of mitochondrial CK activity to the total CK activity is about 8% (14) in skeletal 
muscle and 0.5-15% in brain (15-16).
The a d e n y la te  k in a se  (AK) s y s te m — Under conditions where ATP demand does not match its 
synthesis, e.g. under PCr depletion, the AK reaction becomes important to prevent ADP 
accumulation (17). Tight control of the ADP concentration in skeletal muscles is essential as it
11
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plays an important role in the regulation of the local phosphorylation potential (14, 18-20). The 
exchange catalyzed by AK occurs between different high energy phosphate groups:
The net reaction that is catalyzed by AK is represented by:
2A D P  < p  > A M P  + A T P  [18 ]
where AMP and ADP respectively stand for adenosine mono- and diphosphate. Five different 
isoforms of the AK enzymes are known AK1-AK5, of which AK1 is the most import in skeletal 
muscle, representing approximately 99% of all AK activity (21). The AK and CK systems are 
working in concert. For example, an increased AK-mediated phosphotransfer compensates for 
the loss of CK-activity in case CK is pharmacologically inhibited (22) or decreased by a mutation 
in the M-CK gene or (14 ,23).
E n ergy m e ta b o lism  in m u sc le— Muscle contraction is accomplished by action potentials; 
electrical signals that induce a combination of electrophysiological, biochemical and mechanical 
processes resulting in a net force generation. When an action potential arrives at a motor unit in 
contact with a muscle fiber, it propagates along the fiber and results in the release of large 
amounts of stored calcium (Ca2+) into the cytoplasm. This is the onset for a cascade of processes 
that eventually pull the actin and myosin filaments in opposite directions by conformational 
changes in the myosin head. This process is called the cross-bridge cycle and requires hydrolysis 
of ATP (24). The displacement of actin and myosin structures lead to shortening of the fiber: the 
contraction. If several action potentials are applied in a short time period, sequential 
contractions can fuse and add up.
During the first minutes of moderate exercise, ATP is produced predominantly by oxidative 
phosphorylation using muscle glycogen as the major fuel. During prolonged metabolic demand, 
glucose and free fatty acids from the blood serve as energy substrates for generating ATP. In the 
case of strenuous exercise (for instance power exercise or sprinting) or a lack of oxygen, muscle 
switches to anaerobic glycolysis using both glycogen and glucose from the blood as fuel. In 
addition, PCr can be used as a fast buffer in case the ATP production cannot follow the rate of
AMP o  oADP o  aATP [1.6]
[1.7]ßA T P  o  ß A D P  o y A T P
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utilization. For example, contractile experiments unequivocally demonstrated an important role 
for CK in burst activity (25).
Skeletal muscle fibers are roughly divided into two groups depending on their color: (i) red 
fibers, containing high levels of myoglobin and oxygen storing proteins have a red appearance. 
Red muscle fibers tend to have more mitochondria and blood vessels in comparison to the (ii) 
white fibers, which have a low content of myoglobin and a white appearance.
Skeletal muscle fibers are also classified based on their twitch capabilities: Slow twitch fibers 
(oxidative, type 1) are adapted for long term exercise with oxidative phosphorylation as its 
major energy producing pathway, see table 1.1. They tend to have a low activity level of ATPase, 
a slower speed of contraction with a less well-developed glycolytic capacity. They contain large 
and numerous mitochondria and with high levels of myoglobin that gives them a red 
pigmentation and they have been demonstrated to have high concentration of mitochondrial 
enzymes, which makes them fatigue resistant.
Fast twitch fibers (type 2) are more suited for short term work with high energy demand. Fast 
twitch muscles often defined as the type in which the myosin can split ATP very quickly. 
However, fast twitch fibers also demonstrate a higher capability for electrochemical 
transmission of action potentials and a rapid level of calcium release and uptake by the 
sarcoplasmic reticulum. The fast twitch fibers rely on a well-developed, short term, glycolytic 
system for energy transfer and can contract and develop tension at 2-3 times the rate of slow 
twitch fibers. Two subtypes have been distinguished: type 2b fibers rely mostly on glycolysis 
and PCr buffering for fast availability of energy, so do type 2a fibers, but in addition they rely on 
oxidative processes.
Individual muscles are a mixture of the three 3 types of muscle fibers (type 1 and type 2a and 
2b), but their proportions vary depending on the function of a particular muscle. However, they 
can only have one type of muscle fiber within a motor unit. This is demonstrated if we look at 
contractions: if a weak contraction is needed only the type 1 motor units will be activated. These 
fibers are used mainly for endurance activities. If a stronger contraction is required the type 2 a 
fibers will be activated or used to assist the type 1 fibers. Maximal contractions facilitate the use 
of type 2b fibers which are always activated last. These fibers are used during ballistic activities 
but tire easily. Metabolite and enzyme levels differ significantly between the three muscle types 
(26).
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T able 1.1: C lassification  o f  f ib e r  ty p e s
Type 1 Type 2a, Type 2b
Red, oxidative Red, Fast oxidative White, fast glycolytic
Slow twitch, Fast twitch Fast twitch
Large amounts of myoglobin. Large amounts of myoglobin. Low myoglobin content.
Many mitochondria. Many mitochondria. Few mitochondria.
Many blood capillaries. Many blood capillaries. Few blood capillaries.
Generate ATP by the aerobic 
system,
High capacity for generating ATP 
by oxidation
Large amount of glycogen. and 
rely on PCr buffering
Split ATP at a slow rate. 
Slow contraction velocity.
Split ATP at a very rapid rate 
high contraction velocity.
Split ATP very quickly.
Resistant to fatigue. Resistant to fatigue but not as 
much as slow oxidative fibers.
Fatigue easily.
Needed for aerobic activities like 
long distance running.
Needed for sports such as middle 
distance running and swimming.
Needed for sports like sprinting.
http://www.isokinetics.net/advanced/musclefibertypes.htm
E n ergy  m e ta b o lism  in b ra in — Compared to muscle, brain tissue is highly heterogeneous. Not 
only functions are spatially distributed, also the distribution of different cell-types in distinct 
areas hampers one coherent interpretation of metabolism and function brain tissue in general. 
Furthermore, functional and spatial organization of the central nervous system (CNS) is rather 
different between species. For instance, white and gray matter is clearly distinguishable in 
human brain, whereas this is not the case in rodents. Some functional areas, such as the olfactory 
bulb, are relatively much larger in rodents.
In general, neurons and glial cells are the most abundant cell types in brain tissue. Most neurons 
use action potentials, brief and uniform pulses of electrical activity, to transmit information. 
Action potentials are generated when the membrane potential of a neuron reaches a threshold 
value. They travel down the axon toward synapses terminating at postsynaptic neurons, Upon
14|
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arrival of an action potential at the synaps, the presynaptic neuron releases neurotransmitters, 
such as glutamate (Glu, excitatory) or y-aminobutyric acid (GABA, inhibitory). Binding of the 
released neurotransmitter molecules to specific receptors on the cell membrane of the post- 
synaptic neuron induce small changes to the membrane potential. Temporal and spatial 
summation of those changes in the membrane potential, determine whether the second neuron 
will be excited.
Although glial cells have for a long time been regarded as supportive or isolating cells between 
the neurons, more functions essential to brain have been found recently for these type of cells, 
including cellular support during CNS development, ion homeostasis, uptake of neurotransmitters, 
contribution to the CNS immune system, neuromodulation and preservation tissue integrity following 
injury. Different subtypes of glial cells are distinguished, of which astrocytes are the most 
abundant. These cells are often located between capillaries and neurons and play an important 
role in clearing the major excitatory neurotransmitter molecule glutamate from the synaptic 
cleft. Following uptake, astrocytes convert glutamate into glutamine, which is shuttled back to 
the neuronal cells in order to be re-used for neurotransmission. This efficient recycling process 
of neurotransmitters between the neuronal and glial compartments is referred to as the 
neurotransmitter cycling (27).
Astrocytes and neurons are not only cooperating in neurotransmission, they are also working in 
close collaboration when it comes to energy metabolism, see fig. 1.2. Under normoxic conditions, 
brain tissue almost exclusively relies on mitochondrial oxidative phosphorylation of 
carbohydrate for ATP synthesis. Glucose is the predominant substrate, although acetate, lactate 
and keton bodies are also metabolized, depending on cell-type and availability of the various 
substrates. In the early 90's, Pellerin and Magistretti introduced the so-called astrocyte-neuron 
lactate shuttle theory (ANLS) (28-30), which proposes a model for the tight metabolic link 
between the two cell types. In this model the majority of glucose that crosses the blood brain 
barrier (BBB) is taken up by the astrocytes, which are in close vicinity to the blood vessels. The 
glucose is converted to lactate by glycolysis, which is assumed to be transferred to neurons, 
which prefer the use of lactate over glucose. In the neurons, lactate is converted into pyruvate 
and subsequently fed to the TCA cycle for oxidative phosphorylation.
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Figure 1.2: Schematic view  o f m etabolic link between astrocytes and neurons. The bold arrows indicate 
the main flux of substrates when glucose enters the astrocyte-neuron system. Glucose is mainly taken up by 
the asctrucytes where it is converted into lactate (by the glycolytic pathway). According to the ANLS model, 
lactate is subsequently transported from the astrocyte to the neuron, where it is oxidatively catabolized. 
Neurotransmission causes cycling of glutamate and glutamine between the two compartments. Glutamate is 
mainly present in the neurons, while the main pool of glutamine is located in the actrocytes. The link between 
neurotransmission and metabolism is presented by the arrow between the TCA cycle and the glutamate pool 
in both compartments.
A tight coupling between neurotransmitter cycling and brain activity has been shown by 
combining 13C MRS data of rodents measured by different research groups. The electric activity 
in brain ranged from isoelectric activity (when no signals are detected in the EEG) to enhanced 
brain activity during electric seizures, which was accomplished by the use of different 
anesthetics at different doses. This indicated a relation between glucose uptake and 
neurotransmitter cycling, see (31-35). At the iso-electric state, there was no neurotransmitter 
cycling. The remaining cerebral metabolic rate of oxidative glucose combustion (CMRglc), < 10% 
of the CMRglc at normal brain activity, was totally ascribed to energy supporting house-keeping 
activities in cells (for example, cell motility and neurogenesis).
We mention in passing that, unlike muscle, brain tissue is always “at work”, since even upon no 
specific task-induced activation neurons are firing at a base-level frequency. Hence, there is no
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real “resting” state in brain, unless activation is suppressed biochemically. Task or stimulus 
induced activation of a certain brain area induces alterations in local neuronal electro- 
physiological activity. In the recent years, functional MRI, 13C MRS, positron emission 
tomography (PET) and electrophysiology experiments have been performed in order to relate 
brain activity to glucose oxidation. Brain energy production was measured in the form of glucose 
oxidation (cerebral rate of oxidative glucose consumption: CMRglc(ox) ) in the resting awake 
state and the anesthetized state and have followed regional changes during simulation from 
these states. The most striking result is that the total energy consumption needed for neuronal 
firing in the conscious awake baseline state is orders of magnitude larger than the energy 
changes during specific stimulation (31-35).
However, at the cellular or sub-cellular level the fluctuations in energy demand upon increases 
of neuronal firing can be very rapid and large. This is where the PCr-CK system might come into 
play, although its role in brain is not completely understood. The mitochondrial content and 
fractional contribution of mitochondrial CK activity (~ 30% of total CK activity) is much higher 
in brain than in muscle tissue. The distribution and co-expression of B-CK and Ub-CKmit 
isoforms in glial and neuronal cells appears to be rather variable and does not seem to support 
the co-existence of cytosolic and mitochondrial endpoints of the CK circuit in various brain 
regions ((36) and references therein). The close metabolic collaboration between glial and 
neuronal cells for brain energetic (30, 37) makes it difficult to investigate how the CK system 
plays a role in this. Recently an additional function of PCr-CK system the neurotransmission has 
been suggested (38-39).
Thus, although a lot of knowledge on cerebral function and metabolism has been gained over the 
last few decades, the coupling between electrophysiological activity, energy metabolism and 
hemodynamics is still far from total elucidation. In 2002, Aubert et al. (4) introduced a 
mathematical model that combines these responses in brain, based on experimental data from 
various methods. This model was extended by implementing compartmentalization and 
introducing new experimental data (40) and provides a good basis to verify our present 
knowledge with new experiments. Such a model acquires proper understanding of the included 
results determined by various experimental methods.
C reatine b io sy n th e sis  a n d  Cr d efic ien cy— The PCr-CK system requires sufficiently high Cr 
concentrations in tissues like muscle and brain in order to function as a HEP buffer. A constant 
fraction of the Cr and PCr pool is catabolised non-enzymatically to creatinine (Crn), which is
17
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excreted in the urine (41-42). The total body Cr content is maintained by dietary intake and 
endogenous Cr production.
The first step in the synthetic route of Cr, catalyzed by L-arginin:glycine amidinotransferase 
(AGAT), transfers the amidino group from argining to glycine, to yield ornithine and guanidino 
acetate (43); a process that occurs mainly in the kidneys and pancreas (see fig. 4.1). GAA is 
transported to the liver, where it is methylated to form Cr. This reaction is mediated by 
guanidine acetate methyl transferase (GAMT) (44). Circulating Cr, either originating from 
nutritional intake or biosynthesis, is taken up by tissues of usage (mainly muscle and brain) 
mediated by Na+- and Cl- dependent creatine transporters (SLC6A8), situated in the cellular and 
mitochondrial membranes (13, 44).
Biosynthesis and uptake of Cr is essential for normal brain function in humans, as shown by the 
clinical symptoms reported in patients with different inborn errors of Cr metabolism or Cr 
transporters. The first report was on an infant with extrapyramidal movement disorder (45), 
which had low Cr and Crn and elevated GAA in serum and urine, XH MRS revealed low Cr signals 
in brain (46-47). The absence of Cr and elevation in GAA pointed toward a deficiency of GAMT. 
The clinical presentation of this disorder, now reported in ~ 30 patients world wide, includes 
mild to severe mental retardation, expressive speech and language delay, autistic-like behaviour 
and occasional to drug-resistant seizures (48).
More recently, decreased cerebral and circulating Cr levels were also observed in patients with a 
deficiency of AGAT (49). GAA levels were depleted in body fluids of AGATV- patients. They 
showed similar clinical aspects as the GAMT patients although epileptic seizures were less 
profound.
Treatment with Cr monohydrate in patients with biosynthesis defects consistently has yielded 
improvement in epilepsy and movement disorder. However, severe mental retardation 
remained. The optimal dosage and treatment strategies for recovery and maintenance of Cr still 
has to be established, for review see (50-51).
1.2 BASIC PRINCIPLES OF IN VIVO MAGNETIC RESONANCE SPECTROSCOPY
When present in an external magnetic field, specific atomic nuclei are able to absorb and 
transmit electromagnetic energy in so-called Nuclear Magnetic Resonance (NMR) experiments. 
This phenomenon was first observed independently in 1946 by E. Purcell (52) and F. Bloch (53) 
and coworkers, who both received the Nobel Prize for Physics (1952) for their discovery. Later it
18 I
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was recognized that the chemical environment influences the frequency of the resonance signal 
of a nucleus, leading to the so-called chemical shift, in addition to the applied magnetic field. This 
made NMR an attractive method to study structure and environment of different compounds. It 
was not until the mid 70’s that the first in vivo MR images (Lauterbur 1973(54)) and NMR 
spectra were recorded of suspensions of intact red blood cells (Moon and Richards, 1973 (55)) 
and of freshly excised rat muscle (Hoult et al., 1974 (56)). The introduction of larger horizontal, 
superconducting magnets and extensive new designs of radio frequency (57) coils has enabled 
non-invasive examination of bioenergetic processes in localized regions of tissues in intact 
animals and humans. After the successful introduction of 31P MR spectroscopy (MRS), methods 
for 1H-NMR and 13C-NMR were developed and MRS was extended to studies of several tissues. 
Over the last decades, MRS became a widely used tool in biology and medicine for its ability to 
analyze tissue composition or the time-resolved detection of metabolic processes at the level of 
tissues in the live animal or human being.
In this section, we provide a brief semi-classical description of NMR in order to explain basic 
principles of MR spectroscopy methods that we apply in the following chapters.
S em i-qu an tu m  m ech a n ica l d esc r ip tio n  o f  NMR— NMR can only be performed on nuclei that 
carry a magnetic moment generated by its spin. According to quantum mechanics a nuclear spin 
quantum number I = y  • n, can be assigned to these nuclei, where n is an integer. Isotopes with 
even numbers of protons and neutrons have a nuclear spin quantum number I = 0, i.e. they do 
not have a nuclear spin and consequently do not exhibit magnetic phenomena. The most 
abundant and frequently used isotopes for in vivo NMR are listed in table 1.2.
Table 1.2: Properties of atomic nuclei that are frequently used in biological NMR.
nucleus I Y
(107 ra d /s /T )
NA
(%)
Sensitivity
(*Y3)
&o/2 n
(MHz/T)
1H y 26.75 99.9 1.00 42.58
2H i 4.11 0.015 1.45 -10-6 6.53
13C y 6.73 1.108 1.76 -10-4 10.71
3lp y 10.84 100 6.65 -10-2 17.25
I: spin quantum number, y: gyromagnetic ratio, NA: natural abundance, œ0: Larmorfrequency, Sensitivity = 
relative sensitivity normalized to that of 1H spins.
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The nucleus of an atom with 1 1  0 is rotating with a constant velocity around its own axis (fig. 
1.3). This “spinning” motion is described by the spin angular momentum, L*. The spinning 
nucleus carries an electrical charge, q, which generates a current loop. According to classical 
physics this current generates a magnetic field, which is characterized by the magnetic dipole 
moment
L ß
Figure 1.3: A schem atic representation o f a spinning nucleus with angular and dipolar moments.
Left: spinning of a sphere with mass (m) and angular frequency (Ms). Right: same nucleus now with charge 
(q) spinning with an angular frequency Ms. The rotation of the charge gives the nucleus a magnetic moment 
y  while the rotation of the mass produces an angular momentum L
The relation between the magnetic moment and the angular moment is given by:
ß  = Y L  [1.9]
Where y is the gyromagnetic ratio, which is a characteristic property of each isotope 
determinant for its relative sensitivity to the applied magnetic field.
In the absence of an external magnetic field, the orientation of dipole moments of an ensemble of 
spins is random. Hence, there is no net magnetization. However, by placing spinning nuclei in an 
external magnetic field B0 (fig. 1.4) they start to perform a precession motion about the direction 
of this field. The time-dependent change of the dipolar moment is described by equation [1.10]:
d ß  r  r
- ^ - = Y ß X  B0 [1.10]
d t
* Vectors are presented in bold and underlined in the text, in figures and formulae with an arrow as a hat.
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This equation implies that the change in orientation of ^  is always perpendicular to both and 
Bn. and proportional to y  and the magnitude of Bn see fig 1.4. The induced circular motion, 
precession, takes place at the so-called Larmor angular frequency, Wn, which depends on both y  
and Bn:
4  = 1B 0 [1.11]
The magnetic energy of in an external magnetic field is given by:
E  = —ß  • B 0 =  —ßB0 cos($) [1.12]
where 0 is the angle between ^  and Bn According to classical mechanics, magnetic energy can 
have any value between the two energy limits (corresponding with 0 = 0° or 180°). However, the 
quantum mechanical theory predicts that only two states are possible for nuclei with spin I = %: 
(i) ^  is parallel to Bn (0 = 0°), in which case the magnetic energy is minimized. Or (ii) ^  and Bû 
are anti-parallel (0 =180°), which corresponds with a maximum of magnetic energy. The 
restriction to two energy states for nuclei with spin I = % is described by the second quantum 
number m, which can only possess certain discrete numbers. For a nucleus with spin I = %, the 
two allowed energy levels, characterized by m = +% and m = correspond with orientations 
parallel and anti-parallel to the imposed field (fig 1.5).
Figure 1.4: Precession o f a nucleus with a m agnetic dipole moment, y . The torque induced by the 
external field causes the magnetic dipole moment to undergo a circular motion around an axis parallel to
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m Eß = +% yfyBo a n ti-p a ra lle l
Bn
Ea = -%  yfyBo p a ra lle l
Fig. 1.5: The energy scheme o f spins with I = Y2. The lower energy level, Ea corresponds to magnetic 
moments parallel to Bo, while spins in the higher energy leve l, Eß, are anti-parallel to Bo In thermal 
equilibrium, the occupancy o f the energy level corresponding to the anti-parallel orientation (Nß) is smaller 
than that of parallel orientation (Na).
The energy difference between those states is given by:
where fy is Planck's constant divided by 2n. Combining eq [1.11] and [1.13], yielding AE = fy^o, 
shows us that the energy difference between the two levels is related with the Larmor 
frequency of the precessing spins. The ratio of the populations of nuclear spins in the two energy 
states is given by the Boltzmann distribution:
magnetic field; k is the Boltzmann constant (1.38 1 0-23 J/K) and T the absolute temperature in 
Kelvin. Thus, in thermal equilibrium the population of spins in the a-state is always larger than
AE = y&B0 [1.13]
[1.14]
where Nß is the number of spins anti-parallel and Na the number of spins parallel to the external
the population of spins in the ß-state (see fig. 1.5). The surplus of parallel oriented magnetic 
dipoles, due to the presence of a magnetic field, results in a net magnetization vector:
[1.15]
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In equilibrium the z component of M is constant, having a size Mo (equilibrium magnetization) 
and is aligned parallel to Bn Eqs [1.14] and [1.15] show that Mo is not only dependent on the 
nucleus to be measured as determined by y, but can be enhanced by increasing the field strength 
or lowering the temperature T. For conventional reasons we assume that Bû is oriented in z- 
direction. The x and y  components of all individual magnetic dipoles have random orientations 
(no phase coherence, thus the phase is randomly distributed). So there is no net magnetization 
in the transverse plane, M = [o, o, Mo].
E xcita tion— The direction and phase of the magnetic dipoles, and thus the net magnetization of 
an ensemble of spins can change when subjected to electromagnetic irradiation with a frequency 
that exactly corresponds with AE (= hœo). Hence, the frequency of the irradiated signal should 
equal the Larmor frequency œo. Most often this frequency is within the radiofrequency (57) 
bandwidth, thus one speaks of RF irradiation. This is mostly applied in the form of pulses. 
Although most pulse sequences used in MRI and MRS consist of more than only one RF pulse, 
this chapter only describes the effect of single pulse excitation to explain the basic principle of an 
NMR experiment.
The RF pulse is usually applied to the sample by a coil that is part of a resonant LC circuit The 
coil is oriented in such a way that the generated RF field is perpendicular to Bû.To facilitate the 
description of the time dependent changes in M as a result of the applied RF-pulses usually a 
rotating frame of reference [x' y ’, z'] is introduced, which is rotating with a frequency œo. In the 
rotating frame, a magnetization vector precessing with a frequency œo appears to be static. In the 
laboratory frame [x, y , z], it performs a spiral motion along the surface of a sphere. In the 
rotating frame the applied RF field can be represented by a vector, B1  directed along the x’-axis. 
In the presence of this field M precesses about B1  with an angular frequency œi = yBi, where Bi is 
the amplitude of the applied RF field. When the RF field is applied in the form of a pulse of a 
particular duration, it rotates M from the z-direction [Ü, o, Mo] into the transversal plain in the 
direction of y ’ [Ü, Mo, o] (fig. 1.6). This is a so-called 900 pulse. In general the angle of rotation is 
proportional to the duration of the applied RF pulse and the strength of the Bi field. Since all 
individual spins are given the same phase during the RF pulse, one speaks of phase coherence.
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Figure 1.6: Effect o f  a second oscillating m agnetic field. When an extra (oscillating) magnetic field Bi is 
added along the x' axis in a rotating frame, the net magnetization vector (M) starts to precess in the y ’,z ’- 
plane. In this example the pulse length is chosen such that the flip angle, a, is 9Ü°. At the end of the RF pulse 
there is complete phase-coherence, in our case the net magnetization vector is in the direction of y ’.
R e la x a tio n — After excitation by the RF pulse, the spins will return to thermal equilibrium. This 
process is called relaxation. The transversal and longitudinal component of M may have 
different relaxation time constants, although they occur simultaneously.
The energy absorbed from the RF pulse is lost over time by interactions of the spins with the 
surrounding ‘lattice’. This leads to a restoration of the magnetization along the z-axis; the z- 
component of M will grow from zero towards the initial equilibrium magnetization [o, o, Mo] 
with a characteristic time Ti, called the spin-lattice or longitudinal relaxation time constant.
The transverse magnetization component will disappear with a characteristic time T2, also 
known as the transverse relaxation or spin-spin relaxation time constant This relaxation 
process occurs because interactions between spins undergoing Brownian motion lead to a loss 
of phase coherence of the precessing spins. This leads to a mono-exponential decay, the free 
induction decay, FID.
The time dependent motion of the components of M is described by the so-called Bloch 
equations (58). The solution of these equations in the period after the 900 pulse is given by:
M x = M 0e t 'T2 cos(Æ»0t) 
M y =  M 0e - 'T2 sm(ao0t )
[1.16]
[1.17]
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D etec tio n — After the application of a 900 pulse the precession of M around the z-axis at the 
Larmor frequency induces an oscillating electric current in a receiving coil positioned in the 
transverse plane. The acquired signal in the time domain (NMR signal) is the free induction 
decay (FID):
of the relaxation time constant T2. By Fourier transformation of the FID one obtains the desired 
spectral information in the frequency domain: the NMR spectrum. The magnitude of the 
absorption peaks or resonances in the NMR spectrum are directly proportional to the number of 
spins in a sample. Spectra of homogeneous media (liquids) contain signals with Lorentzian line 
shapes with intrinsic line widths defined by the distribution of the phases in the ensemble of 
spins (full width at half height = 1 /(nTV) ). Spectra of inhomogeneous media often encountered 
in in vivo give rise to line shapes approaching a more Gaussian curvature.
C hem ical sh if t— The practical application of MRS is essentially possible because of the 
existence of the so-called chemical shift: the resonance frequency of a particular spin system 
depends on the chemical environment of the constituent spins. This enables a distinction 
between nuclei in different molecules or different nuclei in the same molecule. The electronic 
surroundings of the nuclei cause a small shielding of the externally applied magnetic field, Bo 
This phenomenon leads to a small decrease of Bo at the position of the observed spin, which 
reduces its resonance frequency:
Where o  is the chemical shift term and Bloc is the magnetic field at the site of the spin. Not only 
the direct electronic environment if the considered spin but also surrounding groups and 
molecules may influence the effective field strength (Biocai). Certain conditions like pH and 
temperature can affect the electron density in a molecule and thus the chemical shift of its NMR 
signals.
M y  = M 0 [cos(®0t) + i sin(®0t)] e t / Tl = M 0e —i <^01 / T2 [1.19]
Thus the FID contains information on the number of spins (proportional to Mo) and on the value
® = f i l o c a l  = Y(1 — ° ) B 0 [1.20]
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Because the resonance frequency and also the frequency difference between different 
resonances depend on the magnetic field strength the chemical shift is commonly expressed in 
the dimensionless unit:
£  =  ®sample ®ref _ 106 [1 2 1 ]
a ref '
in which œsample and œref represent the resonance frequencies of the compound of interest and a 
reference compound, respectively. In this way the chemical shift is expressed in parts per million 
(ppm) and is independent of the applied magnetic field. Ideally the reference compound is 
chemically inert, has a strong and separate resonance signal and its chemical shift should be 
independent of external variables.
D a ta  p ro c e ss in g — The most straight forward way to quantify a signal is by simply integrating 
the signal area. However, low SNR, overlapping signals, and baseline distortions may hamper 
accurate quantification. This can, to a great extent, be circumvented by introducing prior 
knowledge, i.e. by fitting a Lorentzian, Gausian or mixed line shape or fixing line widths (59). We 
note in passing that in addition, effects of Ti saturation have to be taken into account For some 
multi pulse experiments (with echo acquisitions), corrections for T2 decay are required as well.
L o ca liza tio n — The determination of metabolite concentrations in an a priori defined region of 
interest (ROI), for instance in a specific tissue, requires special localization techniques. One way 
to perform a localized MRS measurement is to use a dedicated surface coil for signal reception. 
This coil should be positioned as close as possible to the volume of interest. More flexible ROI 
selection is accomplished by Bo gradient-based pulse sequences. These techniques combine 
specific RF pulses with slice selective gradients. Slice selective RF pulses in three directions 
enables the excitation of spins in a so-called voxel, see fig. 1.7. The most commonly used single 
voxel localization RF pulse sequences are image selected in vivo spectroscopy (ISIS (6o)), point 
resolved spectroscopy (PRESS, (61-62)), and stimulated echo acquisition mode (STEAM, (63)). 
ISIS is based on a pattern of addition and subtraction of eight subsequent acquisitions, whereas 
the other two are single-shot localization techniques, which largely circumvent the occurrence 
of motion artefacts, but are less suitable for the detection of isotopes with short T2 relaxation 
times (e.g. some 31P containing metabolites).
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Figure 1.7: MRS voxel postion gu ided  by  grad ien t echo MR im ages o f the mouse hind leg in vivo. A
voxel (2 x 2 x 4 mm3)  is positioned in the triceps surae muscles of the hind leg, guided by gradient echo MR 
images acquired in three oblique, perpendicular directions (TE = 5 ms, TR _=25o ms for coronal (A)and 
sagittal(C) slices, TR _ 3oo ms for transversal slices(B), slice thickness o.5 mm, bandwidth io o  kHz, matrix 
size 256 x 256).The location of this voxel, meant for 1H MRS, is shown by the white box. This picture was 
previously published by HE Kan et al. in (64)
1H MRS in b ra in  a n d  m u sc le  tis su e— 1H is the most sensitive isotope in NMR experiments and 
has a natural abundance of almost 100%. In fact, the large signal intensity of 1H in water in most 
tissues enabled the use NMR for imaging (MRI) in living organisms. The sensitivity of NMR, 
however, restricts the detection of other metabolites mostly to small and mobile molecules (M < 
500 Dalton) at relatively high concentrations (> 0.1 mM). Nevertheless, the relative sensitivity of 
1H compared to other nuclei allows for the detection of spectra of small voxel sizes within a 
reasonable scan time. The signal to noise ratio (SNR) may be improved by repeating the process 
of excitation and acquisition several times. In mouse brain a 1H MR spectrum of sufficient SNR to 
analyze some major metabolites in a 1-2mm3 voxel can be acquired at 7T within 20 minutes. 
Absolute quantification of 1H MR spectra is commonly performed by taking the water signal (~ 
50M) as an internal reference. However, the signal of water in tissues (>1000 fold larger than 
most metabolites) hampers accurate detection of the small metabolite resonances. Therefore, 
often two measurements are performed: one in which the water signal is determined to be used 
as a stable reference signal, and a second spectrum in which the water signal is suppressed to 
allow better detection of the metabolite signals. Water suppression is accomplished with pulse 
sequences as VAPOR (65) or CHESS (66), it requires optimal shimming of the Bo field.
In brain up to 30 metabolite signals can be detected by in vivo 1H MRS of which the dominating 
ones are from N-aspartyl aspartate (NAA), creatine (Cr), choline (Cho), taurine (Tau) and myo­
inositol (Ins). As discussed before Cr is involved in HEP buffering, although its function in brain 
is not completely elucidated yet. NAA is considered an important neuronal marker and is often 
decreased in neurodegenerative diseases. Choline compounds reflect cell proliferation and are 
generally increased in tumor tissue. Ins and Tau function as osmolites (amongst other
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functions). An example of a XH MR spectrum acquired in mouse brain is shown in fig. 1.8A. As 
shown in this spectrum, the large amount of signals and low spectral resolution make accurate 
quantification of overlapping signals challenging.
The 1H MR spectra of skeletal muscle are dominated by signals of total Cr (tCr) and Tau (fig. 
1.8B). In order to reduce dipolar interactions that split up the tCr signals, the muscle fibers are 
preferentially positioned at an angle of 55° with respect to Bo (67).
(A)
tCr
Cho NAA
ppm
(B) tCr
Tau
ppm
Figure 1 .8 :1H MR spectra o f mouse muscle and brain. (A) Typical MR spectra o f a striatal-hippocampal 
region in brain and (B) of the triceps surae region in hindleg skeletal muscle. Abbreviations: Glu: glutamate, 
Gln: glutamine, Ins: myo-inositol. NAA: N-aspartyl aspartate, Tau: taurine, tCr: total creatine (= PCr + 
Cr).Both spectra are recorded at 7T.
31P  MRS in b ra in  a n d  m u sc le— 31P spins have a natural abundance of 100%, although they have 
a lower sensitivity (~ 7%) compared to that of 1H nuclei. Nevertheless, 31P MRS is a valuable 
method to study energy metabolism in vivo, since important high-energy phosphates are clearly 
detectible with this method (fig. 1.9). Muscle and brain phosphorous MR spectra normally 
contain five major peaks: ATP gives rise to three signals originating from the individual 
phosphates of the ATP molecule (a, ß and y). Phosphocreatine (PCr) has a resonance defined at 
0.0 ppm. The large PCr resonance is characteristic of muscle and brain tissue, where it is present 
in high concentrations. These tissues also show a resonance of inorganic phosphates (Pi) around
5 ppm. This signal contains the average of cellular HPO42- and H2PO4 signal intensities. Since the 
protonation/deprotonation reaction is extremely fast on the NMR time scale, their individual 
peaks are not separated. The resulting single peak moves in position between the two extremes
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depending on the relative concentrations of the acidic and alkaline forms. As the pK of Pi is in the 
physiological pH range, tissue pH can be obtained from the chemical shift difference between Pi 
and PCr (55). The vast majority of the Pi ( > 90%) is intracellular, therefore the chemical shift of 
the Pi mainly reports on intracellular pH levels (68-69). Two additional peaks most clearly 
detected in brain tissue, represent phosphomonesters (PME, ~ 7.5 ppm ) and phophodiesters 
(PDE, ~ 2.5 ppm).
ppm
Figure 1 .9:31P MR spectrum  o f skeletal muscle. The spectrum shown here is a typical 31P MR spectrum of 
mouse hind limb muscle at rest using a dedicated solenoid coil for localization. As indicated by the grey 
arrow the chemical shift difference between Pi and PCr can be used to calculate tissue pH. Peak assignments: 
Pi: inorganic phosphate, PCr: phosphocreatine, a - , ß- and y-ATP: the three individual phosphates o f ATP
It is common to express the levels of PCr, Pi, PME and PDE as a ratio over one of or the sum of 
the ATP signal intensities. When assuming typical tissue specific ATP levels, one can obtain a 
measure for absolute concentrations. However, when ATP levels are expected to be abnormal, 
phantom replacement studies are required in order to measure actual absolute concentrations 
of all phosphate compounds. Chemically determined PCr/ATP ratios are often somewhat lower 
than PCr/ATP ratios determined by in vivo MRS in WT mice (70). This discrepancy between 
methods can be ascribed to the hydrolysis of PCr during the isolation and freezing of tissues 
and/or tissue extraction (26, 71-72). This illustrates the value of non-invasive assessment by 
MRS of metabolites involved in rapid biochemical conversions.
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At physiological conditions, the 31P resonances of ADP are below the detection level, although 
the extractable amount of ADP in m ost tissues is about 1 mM. The major part of ADP is 
commonly thought to be invisible by NMR methods because of line-broadening effects due to its 
binding to larger structures such as proteins and actin (73), see also Chapter 4. Despite its NMR- 
invisibility, the free cytosolic [ADP] is often calculated from measured 31P spectra: PCr, ATP and 
pH are directly obtained from 31P spectra, total creatine content can be determined from 1H MR 
spectra and the equilibrium constant has been determined previously in vitro by Veech et al. 
(74). These calculations yield [ADP]free ranging from 20-80 [J.M in muscle (74).
Many in vivo MRS studies are performed to study energy metabolism in muscle during resting 
conditions, or under anaesthesia. However, differential effects of pathophysiological conditions 
are likely to become more apparent in response to a metabolic challenge. As a single 31P 
spectrum can be obtained with a reasonable time-resolution (~  1 min in mouse muscle), this 
method is also very suitable for monitoring changes in phosphate levels and pH following 
metabolic perturbations such as intended ischemia and muscle contraction.
Another valuable application of NMR is the measurement of enzyme-catalyzed reactions in a 
stationary situation (concentrations are maintained), using magnetization transfer (MT) 
techniques. This method is very powerful as it obtains information on phosphoryl conversions 
between two metabolites that are in exchange. The relatively fast fluxes between metabolites 
can be detected even though measurements are performed on a much slower time-scale. MT 
experiments do not disturb the stationary status of the tissue, only the distribution of the spins 
over the energy states, thus spin system s are labelled magnetically. Different versions of MT 
techniques have been developed (inversion transfer, saturation transfer and 2-D exchange 
spectroscopy). In Chapter 2, a detailed description is given on saturation transfer 
measurements.
The m ost widely studied enzymatic reaction of which the flux has been studied by in vivo MRS is 
the creatine kinase (CK) reaction. Both in muscle and brain this reaction has been examined 
under different steady-state conditions. In m ost studies, the forward flux (PCr/ATP) is studied 
through those so-called magnetisation transfer MRS experiments. The determination of the 
reverse CK flux (ATP^ PCr) by this technique can be complicated by contributions of different 
exchange reactions. Ugurbil introduced a multi-site exchange model (75), which is used in 
studies on brain and heart tissue. However, in skeletal muscle at resting conditions the forward 
and reverse fluxes were equal at resting conditions, meaning that the reverse flux can be directly 
determined from changes in y-ATP upon PCr saturation for this tissue.
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13C M RS in brain— 13C nuclei have a low sensitivity and in contrast to the nuclei discussed  
above it has a natural abundance of only 1.1%. Consequently, only a few carbon-containing 
metabolites, present at very high concentrations, demonstrate a natural abundance signal in in 
vivo 13C NMR spectra, for example, glycogen and long chain fatty acids in muscle. The low natural 
abundance, however, has turned out to be an advantage as 13C-labelled compounds can be used  
to monitor label transfer along metabolic pathways. The incorporation of 13C isotopes into 
downstream carbon-compounds in various tissues after systemic administration of 13C labelled 
glucose, acetate or lactate allows for a quantitative determination of substrate uptake and fluxes 
through metabolic pathways such as the tricarboxylic acid (TCA) cycle, glycogen turnover and 
neurotransmitter cycling in brain using metabolic models (27, 34, 76-77).
Fig. 1.10 shows the 13C label incorporation at specific carbon positions of the cerebral glutamate 
(Glu) and glutamine (Gln) pools after infusion of 1,6-13C labelled glucose infusion. Circulating 13C 
labeled glucose crosses the blood-brain barrier and is taken up predominantly by astrocytic 
cells. Subsequent labelling of TCA cycle intermediates and the exchange of a-ketoglutarate (a- 
KG) yields incorporation of 13C isotopes at the C4, C3 and C2 positions of Glu, depending on the 
number of times that the label has cycled through the TCA cycle. Neurotransmitter cycling 
between neurons and astrocytes results in 13C labelling of the Gln pool.
Figure 1.10: Label incorporation in brain tissue following 1,6-13C labelled glucose infusion. Glucose 
taken up by brain is converted into pyruvate, in which the 13C ends up at the C3 postion. Pyruvate enters the 
TCA cycle, where a part of the label leaves the TCA cycle due to the conversion of a-ketoglutarate (aKG) into 
glutamate, thereby labelling the C4 position. Neurotransmitter cycling subsequently labels C4-glutamine as 
well. Label that has not left the TCA cycle ends up in Alanine (C2) or at the C3 and C2 positions of glutamate 
and glutamine after a second and third turn through the TCA cycle.
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The low  sensitivity of 13C MRS limits the spatial resolution to large volumes (~  50-150 mL in 
human brain) to gain a reasonable time resolution. One can imagine that especially in the small 
mouse brain, 13C MR detection requires sensitivity enhanced methods, as shown in chapter 7.
A first gain in SNR can be made by the design of dedicated coils: homogeneous volume coils for 
RF transmission and small surface coils positioned as close as possible to the tissue of interest. A 
further increase in SNR can be accomplished by proton decoupling during 13C signal acquisition. 
Adjacent 1H nuclei (often the case in organic metabolites) induce a splitting of the 13C signals 
thereby lowering SNR. 1H decoupling equals the distribution of the 1H spins over their two 
energy levels, thereby modifying the shape of a multiplet 13C signals into a singlet.
Further signal enhancement requires a dedicated pulse sequence design that use spin 
manipulating techniques like polarization transfer or the nuclear Overhauser effect (NOE) (78), 
direct 13C acquisition by cross polarization (79). 13C detection yields a large chemical shift 
dispersion, which allows distinction of Glu and Gln at both the C2 and C3 position. Distortionless 
enhanced polarization transfer (DEPT) (80) maximally yields a ~  fourfold increase (yih/Yi3c) in 
SNR and requires adaptations in the sequence depending on the signals to be measured. For 
example different delays are required for CH, CH2 or CH3 groups (81-83).
(A)
Glc
[ppm]
Figure 1.11: Detection of 13C labeled metabolites in the mouse brain by DEPT and POCE. (A): 13C 
spectrum from mouse brain acquired with ISIS localized distortionless enhanced polarization transfer 
(DEPT) spectroscopy. Measured at 7T with WALTZ-16 1H decoupling, 100 /xL voxel and 512 averages. (B): 
Proton observed carbon edited (POCE) spectra acquired in mouse brain. Upper spectrum represents a 
normal 1H spectrum. In the lower spectrum an extra editing pulse enables detection of only the 1H which 
have a neighboring 13C nucleus. PRESS localized 100 jxL voxel, 512 averages TR = 3 sec. VAPOR water 
suppression.
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The highest sensitivity to detect 13C labeled compounds can be achieved by indirect proton 
observed carbon edited (POCE) spectroscopy (84). This technique has the advantage that not 
only the concentration of 13C labeled compounds can be measured. Also the fractional 
enrichment is determined by interleaved detection of spectra with (yielding only signals from 
the labeled fraction) and without editing pulse (labeled and unlabeled pools). POCE allows for 
smaller voxel sizes or higher temporal resolution at the expense of spectral resolution. The 
choice of method depends on the purpose of the experiment. Fig.1.11 shows examples of a DEPT 
and a POCE spectrum recorded in mouse brain.
1.3 MRS TO STUDY ENERGY METABOLISM IN TRANSGENIC MOUSE MODELS
As transgenic mouse models with deficiencies in creatine metabolism play a key role in the 
studies described in this thesis, we provide a brief description of the MRS work already 
performed on such models.
The ability to generate and use genetically altered mice has provided new possibilities for 
studying the biological role of specific enzymes or complete pathways involved in cell signaling, 
metabolism, morphology and function. Many transgenic mouse models have been developed  
since the introduction of transgenic modification. The non-invasive in vivo MRS measurements 
have played an important role in the phenotyping of those mice. Mice with an under- or 
overexpression of enzymes involved in high-energy phosphoryl transfer are particularly 
attractive for in vivo MRS studies as the substrates of these enzymes are metabolites that are 
visible in MR spectra, see section 1.2.
Dedicated equipment for M RS of mice— For MRS of small animals, optimal sensitivity and field 
homogeneity are of primary interest. Therefore, much of the MR hardware and software used in 
mouse studies are especially designed for this purpose. Proportional spatial downscaling from 
rat to mice requires approximately a tenfold increase in sensitivity. To a large extent this can be 
achieved by the use of smaller radiofrequency coils, which requires skills in miniaturization of 
probe building. In general, a probe will contain a 1H coil for shimming, imaging and 1H MRS. For 
the detection of other nuclei a second coil can be employed orthogonal to the 1H coil, to prevent 
interaction between both coils. For 13C MR measurements of the mouse brain, the 13C MR signal 
is acquired with a surface coil, while for imaging, shimming and decoupling a homogenous
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birdcage 1H coil is used. Sensitivity can also be improved by increasing the magnetic field 
strength. Common field strengths for MRS studies of mice range from 4.7 up to 16 T.
Proper MR imaging and spatially localized spectroscopy requires sufficiently strong magnetic 
field gradients. Especially in the mouse, field inhomogeneities may be relatively severe since 
m ost tissues are in close vicinity to air due the small size of the animal. Thus for high spectral 
resolution, optimization of the field homogeneity is needed by shim coils of sufficient strength
(85-86).
For reliable measurements of anatomical structures, mice have to be “immobilized” without 
suppressing respiratory motion or other basal physiological functions. Commonly, the animal is 
kept under anaesthesia using inhalation or injection anaesthetics. For investigations of limb 
skeletal muscle positioning in the RF probe holder is usually sufficient For brain studies a 
possible way of securing the mouse head is the use of stereotactic ear and teeth bars and tight 
attachment of a surface coil on top of the head. As mice under anaesthesia are not able to 
maintain body temperature a warming device is commonly applied. Furthermore, continuous 
basic physiological monitoring (e.g. temperature and breathing frequency) is required, to adjust 
the depth of the anaesthesia as this may affect the MR results. Monitoring of further specific 
physiological parameters may be needed in the MR magnet for certain experiments, but this may 
pose additional problems in mice, due to their small size and blood and breathing volume.
In data acquisition for localized MRS of tissues in mice, RF and gradient pulse sequences 
generally are not different from other in vivo MR applications, except that smaller spatial 
localization and imaging scales have to be taken into account. Even with optimal RF coils, due to 
smaller tissue dimensions, much longer acquisition times may be needed in MRS of tissue in 
mice than in rats to acquire spectra with sufficient signal-to-noise ratios, which is important to 
obtain reproducible results.
M RS on mice transgenic for muscle-specific CK iso-enzymes— Much of the current knowledge 
about the role and importance of CK in tissues has been gained from the generation of mice with 
complete or partial deletions or overexpression of CK-isoforms. Research on high-energy 
phosphoryl transfer in skeletal muscle benefited enormously from the availability of mice with 
null mutations in the M-CK gene (M-CKV-) (70), ScCKmit gene (ScCKmitV-) (87), both CK genes 
(M-CK/ScCKmit=/=) (88) and animals with a leaky mutation in the M-CK gene (and graded levels 
of MM-CK activity) (25). In vivo MRS measurements on the various knockout mice have been 
essential in those studies as levels of key substrates in the CK reaction (PCr, ATP, H+) can be
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derived non-invasively from 31P MR spectra of living tissue. In addition, the kinetics of the CK 
reaction can be determined from magnetization transfer experiments.
In mice with null mutations in the M-CK gene, initially one was surprised to see normal levels of 
PCr, Pi and ATP and pH values (25, 70). Inversion transfer (70) and saturation transfer (89) MRS 
on skeletal muscle of M-CKV- knockout mice showed an impairment of the CK reaction at rest 
These studies revealed that rapid phosphoryl transfer between PCr and ATP in M-CKV- mice 
with less than 34% of normal wild type MM-CK activity was below the detection level of the MRS 
experiment (25). Interestingly, the fact that reciprocal PCr to Cr conversion does occur in M-CK 
mutants indicated that ScCKmit is able to catalyze the CK reaction bi-directionally in vivo.
A lack of burst activity was demonstrated in this knockout model during contraction induced by 
electrical stimulation (70). MRS during ischemia-reperfusion experiments, by inducing oxidative 
stress during 20 min (90), showed similar breakdown of PCr and accumulation of Pi in WT and 
M-CK muscle, while decreases in pH were more pronounced in M-CKV- muscle. This elevated  
acidification was attributed to diminished proton buffering (90).
Mice with a null deletion in the ScCkmit gene revealed normal PCr, Pi and pH levels in muscle at 
rest. The absence of mitochondrial CK in muscle did not affect the CK flux in muscle at resting 
conditions as was assessed by both inversion and saturation transfer experiments (91-92). And 
upon ischemic conditions only small differences were observed; recovery of PCr and Pi appeared 
to be faster than in WT (90).
Mice lacking both M-CK and ScCKmit were generated by inbreeding of the single knockout mice 
(88). These double knockout mice were expected to have virtually no CK activity in skeletal 
muscle (88). However, the MRS studies of In 't Zandt et al. (93) showed that the postnatal 
increase in PCr levels in the double knockout mice was the same as in wild type animals, which 
was attributed to the presence of residual BB-CK activity during the first postnatal weeks. Later 
on in muscle of mature M-CK/ScCKmit=/= mice the PCr levels decreased with age, possibly 
reflecting decreasing deposition of CK from fusing satellite cells. When the M-CK/ScCKmit=/= 
mice were three weeks old, they were still able to fully hydrolyze PCr (93). Only at older age, this 
CK activity decreased to an undetectably low  level and as a consequence, conversion through the 
CK reaction gradually decreased until in adult mice the MRS detectable flux through the CK 
reaction was fully absent (88, 91). The silencing of the CK reaction in adult animals was reflected 
by a decrease in ATP levels and an immediate decline of tissue pH during 20 minutes of ischemia 
(90). By application of 13C MRS on mice supplemented with 4-13C labeled Cr, simultaneous 
observation of Cr and PCr and thus the assessm ent of PCr/Cr ratios became possible. Cr uptake
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and phosphorylation was observed in CK=/= muscle demonstrating that very low  CK activity is 
sufficient for this process (93).
In summary, MRS studies on skeletal muscle of transgenic mice lacking one or more CK 
isoenzymes have provided the m ost direct evidence for the role of CK in buffering ATP levels, in 
maintaining tissue pH and in the “liberation” of Pi. The CK is essential for burst activity of 
skeletal muscle. CK has little effect on cellular uptake of Cr and its physiological state in the 
muscle cell. The existence of other possible functions for Cr in muscle than only being a global 
phosphate buffer for ATP maintenance remained to be investigated.
Transgenic for brain-specific CK isoenzymes— The role of the PCr/CK circuit in the brain is far 
less understood than in muscle. Mice lacking either the cytosolic B-CK (B-CK-/- mice) (94), the 
mitochondrial ubiquitous isoenzyme (UbCKmit-/- mice) (95) or both enzymes (B-CK/UbCKmit=/= 
mice) (96) have been generated to study the role of the CK reaction in other tissues than muscle, 
notably in brain.
Transgenic mice without the cytosolic B-CK isofirm showed normal PCr, Pi and ATP levels and 
pH values. The flux of phosphoryl transfer through the CK reaction in these mice was 
dramatically lowered, but still measurable with ST experiments (94). This remaining CK activity 
was attributed to the high mitochondrial CK content and contribution (~30% ) to the total CK 
activity brain.
As all the other knockout mice with a single knockout model investigated so far, mice with a 
null-mutation in the gene for UbCKmit also appeared to have normal basal HEP and pH in brain 
(97), although a significantly lower PCr/ATP ratio was also reported in one study (95). Seizure 
induction by PTZ in B-CK/UbCKmit-=/= double knockout mice showed a more pronounced 
decrease in PCr and ß-ATP MR signals while the PCr/ß-ATP ratio remained lower than in WT 
mice (95).
PCr levels in brains of B-CK/UbCKmit=/= mice appeared to be fully depleted, while Pi and ATP 
levels and pH were virtually normal (97). tCr levels were decreased by 30% and NAA levels 
demonstrated an increase, which could point to an osmolar redistribution or other adaptation 
mechanisms (97). The double mutants, appeared viable, but their development was affected, 
resulting in an overall smaller body posture (36). The complete lack of CK in brain in these 
animals had a severe impact on spatial learning and was coupled to abnormal startle responses 
and hearing problems (98). Other functions such as the visual and motor functions, exploration 
behavior and anxiety-related responses were not changed, suggesting no global deficit in 
sensorimotor function or motivation. Various effects on behavior were consistent with
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underlying anatomical changes in the hippocampus or loss of functional integrity that may occur 
in the development. Additionally B-CK/UbCKmit-=/= mice had problems with thermoregulation, 
presumably due to an altered hypothalamic thermostat and their response to chemical seizure 
induction appeared suppressed (99-100).
Apparently, the system is not vital to basic brain physiology, but behavioral studies have 
demonstrated structural, sensory and cognitive deficiencies in brain CK mutants. Testing brain 
function and metabolism under energy stress condition in these mice is warranted to uncover 
more specific function of the circuit such as, for instance, in metabolic coupling between  
neuroactivation and hemodynamic response (40 ).
M RS of transgenic mice lacking guanidinoacetate methyltransferase (GAMT) — Recently, 
mice lacking the GAMT enzyme were generated (101) as a model for human Cr deficiency (102). 
As these animals are not able to synthesize their own Cr, they were completely deprived of Cr 
unless Cr was orally ingested.
Localized 1H MRS of GAMT-/- mice showed reduced levels of Cr in muscle and brain although 
residual Cr may still be present due to oral intake (103). In 1H MR spectra of skeletal muscle, a 
broad signal of GAA is present. In skeletal muscle this immediate precursor of Cr in the 
biosynthesis, is phosphorylated (PGAA) and metabolically active (103). In ischemia-reperfusion 
experiments monitored by 31P MRS, the PGAA signal decreased similar to the PCr signal. The 
recovery of the PGAA signal, however, was significantly delayed (104). As the recovery rate of 
PGAA did not change upon Cr feeding in GAMT-/- mice, it was concluded that the slowed recovery 
is caused by the lower affinity for CK to GAA (104). Accordingly, saturation transfer experiments 
showed negligible transfer of ATP to PGAA indicating slower enzymatic kinetics (104).
Another interesting phenotype of GAMT-/- mice was an increased inorganic phosphate (Pi) signal 
in skeletal muscle during basal conditions which was similar as observed in CK=/= mice (104). 
This increased Pi was only detected when PCr was fully absent for a longer time period. Upon 
(intentional) Cr feeding the Pi signal normalized, the PGAA signal decreased and a PCr signal 
appeared, quickly exceeding the PGAA signal in skeletal muscle (104).
Also in MR spectra of the heart a signal for PGAA was observed and as for skeletal muscle, 
fluctuations in the oral Cr ingestion seem ed to play a role in the fluctuations of the PGAA signal 
in heart (101, 105-106). These differences in the measured (P)Cr concentrations between the 
three studies are mostly likely caused by coprophagia (104, 106). Another parallel between
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skeletal muscle and heart is the response in ischemia-reperfusion experiments, where a delayed 
recovery of PGua compared to PCr control animals is observed in both tissues (104).
Also in 31P MR spectra of the brain a PGAA signal could be observed in GAMT lacking mice (101, 
103). This signal had much lower intensities than in skeletal muscle and large fluctuations of the 
PGAA signal were not observed in the brain of different animals, in contrast to skeletal muscle. 
Limited permeability of the blood brain barrier (BBB) for Cr (107) could explain these 
observations. This limited permeability was already suspected from the slow recovery of the Cr 
signal after long term feeding of high amounts of Cr to GAMT deficient patients (107-108).
In general, MRS experiments on GAMT-/- mice showed that despite the lower affinity of CK for 
PGAA, this compound functions surprisingly well in vivo to match moderate energy demands. 
Only small amounts of PCr were necessary to prevent elevated levels of Pi in skeletal muscle, 
and increased levels of Pi itself may be a adaptation to stimulate glycolysis, yet another pathway 
for relatively fast energy production. Cr ingestion had differential effects on (skeletal) muscle 
and brain, and feeding of Cr to GAMT-/- mice could in the future elucidate the extent of 
permeability of the BBB for Cr.
Direct effects or adaptations in transgenic models— Many knockout mice show a remarkable 
plasticity in coping with the effects of gene deficiency. Unexpected secondary adaptations may 
occur, which may have wider metabolic consequences than the direct effect of gene deletion. For 
example, muscle of CK double knock-out mice showed a shift in fiber type characteristics, an 
upregulation of glycolytic and oxidative potential (109) and lowered mitochondrial affinity for 
ADP (110). Capecchi’s initial statem ent “if you give me a gene, I could knock it out and tell you 
what its function is” (111), turned out to be correct in some cases, but in general appeared to be 
overly optimistic, since in a complex biological system the functions of one protein may be 
multipotent, and interpretation not straightforward (112), due to partial redundancy or overlap 
with functions of other proteins. However, although numerous adaptations can occur that may 
obscure the identification of the primary function of a (deleted) enzyme, the adaptations itself 
provide extremely valuable information on the flexibility of the cellular network in which the 
enzyme is involved. For CK, which was long considered as an irreplaceable elem ent in tissues 
with high-energy demand, a more subtle and dynamic picture of the protein within such a 
network has emerged due to studies with genetic manipulation. Further work under different
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challenging conditions is needed to uncover more specific functions of phosphoryl transferring 
enzymes in vivo, in particular in the brain.
1.4 OUTLINE OF THIS THESIS
The starting point of this thesis is the production of cellular ATP, which is required to sustain 
adequate energy levels in skeletal muscle and brain. ATP production is the result of a complex 
dynamic metabolic network of which many aspects are not well understood. To uncover the true 
biological meaning of (parts of) this network, studies in humans or intact animals with selective 
metabolic perturbations are needed and require a non-invasive monitoring technique. To meet 
the first requirement we have chosen to examine some dedicated transgenic mouse models and 
for the second we have selected MR spectroscopy. A further focus of this thesis concerns the 
role of creatine (Cr) in metabolic pathways, which are ideally suited for MR spectroscopy as 
many of their substrates are directly visible by MR spectroscopy.
The following specific questions are addressed in this thesis:
(i) Can we understand the biophysical state of ATP and ADP in skeletal muscle of the living 
animal with specific 31P MR spectroscopy methods? (Chapter 2-3);
It is well known that ATP and ADP in the cell occur in a free and a bound state. 
However, it is not very well known which fraction of these molecules is bound and 
which macromolecular structures are involved in this interaction. Currently it is 
assumed that ATP occurs mostly in a free state and that ADP primarily is bound, with a 
small free fraction, which plays an important regulatory role. It is possible to address 
these assumptions employing MR spectroscopy, but it requires that other important 
reactions in which they are involved, in particular the creatine kinase (CK) reaction are 
excluded, which is possible with transgenic animals.
(ii) What are the consequences for energy metabolism by obliterating arginine:glycine amidino 
transferase, an essential enzyme in the biosynthesis of creatine? (Chapters 4-6);
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Numerous studies have been devoted to understand the role of the Cr-CK system in 
maintaining ATP levels. However, none have been able to study the effects of a pure 
creatine free condition and thus to assess the ultimate role of creatine in the body and 
in specific CK dependent organs.
(iii) Can we optimize 13C MRS to assess energy metabolism in mouse brain? (Chapter 7).
Many of the animal models, predominantly mice, in which the PCr-CK system  is 
perturbed show alterations in the use of metabolic pathways such as glycolysis. An 
ideal tool to study fluxes through metabolic pathways is 13C MR spectroscopy. However, 
because of the low  sensitivity of this tool and the small size of the mouse it may be 
questioned if 13C MRS can be realized in this animal.
An overview of the work described in Chapters 2 -  7 is given below.
In Chapter 2 a theoretical exposition of transfer of magnetisation between spin systems is given. 
This chapter first describes magnetisation transfer (MT) mediated by different relaxation 
mechanisms in a homonuclear 31P-31P two-spin system, taking ATP as an example. Effects of 
mobility and field strength are considered for a quantitative assessm ent of the size of MT effects 
occurring between 31P nuclei within ATP. Secondly, MT effects mediated by chemical exchange 
reactions involving phosphoryl conversions of ATP are described in a quantitative way. The 
choice for ATP is not arbitrary, as some of the results of this chapter are necessary to explain the 
experimental results in Chapter 3.
In Chapter 3, we report on studies on MT-effects on resonances of ATP in 31P MR spectroscopy 
of skeletal muscle. In particular, the effect on the ß-ATP resonance during saturation of the y- 
ATP resonance is examined. This MT effect has frequently been detected in various tissues by 31P 
saturation transfer MRS measurements, however, the underlying mechanism of this effect has 
thus far not been investigated properly, although phosphoryl conversions between ATP and ADP 
or relaxation effects between neighbouring 31P nuclei in ATP have been suggested as potential 
causes. Saturation transfer measurements on skeletal muscle of wild type and double knockout 
mice with deficiencies in muscle-specific cytosolic isoforms of M-CK and AK1 (MAK=/=) were 
essential in order to exclude the contribution of CK and AK mediated chemical exchange to the
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MT effect on the ß-ATP, while saturating the y-ATP. Additionally, MT effects between different 
31P nuclei within ATP molecules are determined and analysed using the theoretical description 
developed in Chapter 2. The combination of experimental results and a theoretical model leads 
to a new understanding of the dynamic state in which ATP and ADP are present in cells of living 
tissues.
In Chapters 4-6  describe an investigation of the consequences of Cr depletion in a knockout 
mouse model for Arginine:glycine amidino transferase deficiency (AGAT-/-). Creatine has a major 
role in energy metabolism, being a substrate for the CK system, which provides an important 
high energy phosphate reservoir in muscle, brain and heart in order to cope with rapid and large 
fluctuations in energy demand. However, little is known about circumstances in which Cr is 
completely absent and also not replaced by an alternative molecule that can be uses as high 
energy phosphoryl acceptor. A few patients have been reported with AGAT-/-, showing severe 
mental retardation and problems with speech. Thus far, consequences of AGAT-/- deficiency on 
muscle tissue have not been studied in patients. Also tissue specific uptake and turnover of Cr 
are not completely known or a matter of debate.
The recent generation of a mouse model for AGAT deficiency enables in dept studies of this 
particular deficiency and might provide new clues on potential functions of Cr that are not 
directly related to its role in global energy provision.
In Chapter 4, we report first on an examination of the effects of AGAT deficiency on whole body 
metabolism, while the mice are kept on a Cr free diet. Body weight and composition, food intake, 
hormone levels, guanidine compounds in pasma and urine, glucose tolerance and de novo 
lipogenesis in liver are all measured in order to study the AGAT-/- phenotype. The measurements 
are repeated on AGAT-/- mice treated with Cr, to validate if Cr depletion and alterations in whole 
body energy hom eostasis in this mouse model are directly linked. Additionally, we investigated 
the effects of increasing energy intake on the phenotype by feeding the mice a high fat diet.
Chapter 5 describes the investigation of metabolic, morphological and functional consequences 
of Cr deficiency on skeletal muscle of AGAT-/- mice. The uptake and breakdown of Cr in muscle 
were assessed by a longitudinal 1H MRS measurements. In addition ischemia was applied to 
record the consequences of a metabolic by 31P MRS.
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In Chapter 6, we report on studies of the metabolic effects of Cr deficiency on brain tissue by 1H 
and 31P MRS measurements in order to validate that AGAT deficiency in this mouse model has 
similar metabolic consequences for brain tissue as reported for AGAT-deficient patients. Cr 
levels are monitored during depletion and oral Cr supplementation by a longitudinal in vivo 1H 
MRS study and test the susceptibility of these knockout mice to cerebral ischemia.
The application of in vivo 13C MR spectroscopy to mouse brain can be of great value to study the 
dynamics of cerebral carbohydrate metabolism and glutamergic neurotransmission. This 
method is especially valuable in transgenic mice models for neurophatological diseases, in 
particular the models with deficiencies in the Cr-CK system. However, the low  sensitivity of 13C 
nuclei and contaminating signals of lipids in the relatively small mouse brain make this 
application rather challenging. In Chapter 7, we describe how we can m eet these technical 
challenges, by implementing localized semi-adiabatic distortionless enhanced polarization 
transfer (DEPT) MR spectroscopy. Validation of the method is performed by experiments in 
isoflurane-anesthetized mice at 7T after a continuous intravenous [1,6-13C2] glucose infusion.
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A unique feature of NMR is the p ossib ility  to label a sp in  system  m agnetically  by applying  
frequency se lective  p u lses that introduce a non-equilibrium  m agnetization  for th is 
system  and su b seq u en tly  observe the transfer of th is non-equilibrium  m agnetization  to 
one or m ultip le other spin  system s. This so-called  m agnetization  transfer (M T) can be a 
con seq u en ce of either chem ical exchange reactions or relaxation p rocesses. For chem ical 
exchange, the nuclei o f the perturbed spin  system  and therefore a lso  its m agnetization  
are physically  transferred to another com pound, w h ere the sp ins exp erien ce a d ifferent 
sh ield ing  and thus reson ate  at a d ifferent frequency. Secondly, the perturbed spin  system  
m ay return to its equilibrium  state by transfer of its m agnetization  to nearby spin  
system s, generally  indicated  as the environm ent or lattice, through relaxation  p rocesses. 
T hese p rocesses are therefore referred to as the sp in-lattice relaxation. The dynam ics of 
the observable transfer of m agnetization  can y ield  very  useful inform ation about the rate  
of specific  exchange reactions or the p resen ce of neighboring spin  system s.
This chapter contains a m odel-based  descrip tion  concerning the MT b etw een  tw o spin  
system s caused by the application  of frequency-selective saturation pulses. More 
specifically, w e w ill in vestigate  p ossib le  MT effects occurring in  in vivo saturation transfer  
experim ents conducted at 7T for the phosp hate reson an ces of ATP. R elevant chem ical 
exchange reactions and sp in-lattice relaxation m echanism s are included in  the m odel, as 
w ell as the influence on M T-effects o f ATP binding to larger structures. The conclusions of 
th is chapter w ill be used to in terp ret the resu lts o f the in vivo 31P saturation-transfer MRS 
m easu rem en ts on sk eleta l m uscle in Chapter 3.
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2.1 RELAXATION PROCESSES OF 31P IN ATP
Spin-lattice relaxation— In MR experiments the equilibrium distribution of the spin 
populations can be perturbed by RF pulses that induce transitions between different spin states. 
However, fluctuating magnetic fields oscillating at or near the Larmor frequency will also induce 
transitions between the spin states. Such fluctuating magnetic fields originating from the 
environment or loosely called the lattice (for instance fields induced by other spins, electron 
currents or J-coupling), can exchange energy with the perturbed spin systems yielding a re­
establishment of the (thermal) equilibrium. This process is called spin-lattice relaxation (or 
longitudinal or T1 relaxation). For 31P spins, direct the dipole-dipole coupling and chemical shift 
anisotropy are the predominant relaxation mechanisms, vide infra.
Dipole-dipole coupling— Direct dipole-dipole interactions become manifest when adjacent 
spins generate a small local magnetic field (Bloc) at each other's position, i.e. one spin experiences 
a small dipolar field as a consequence of the presence of another spin (fig. 2.1). The dipole-dipole 
coupling may be either intra or inter-molecular. As the magnitude of Bloc decays rapidly with the 
distance between the spins, nearby intra-molecular contributions of the dipole-dipole coupling 
are most often the predominant contribution to T1 relaxation. The Brownian motion and 
rotational movements (tumbling) of molecules in solution, and therefore of the individual spins, 
will result in fluctuations of the magnitude and direction of the local fields.
Figure 2.1 Dipole-dipole interactions. Neighboring spin system, A and B, "notice" each other's presence. 
The size of the dipole moment of ^  is indicated by the size of the arrows In this case spin A has a smaller 
dipole moment than spin B. r is the distance between the two nuclei, and 9 represents the angle between the 
direction of the dipole moment and the direction of r.
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In order to describe the influence of the fluctuating local fields on the time dependence of the z- 
magnetizations we consider a two-spin (AX) system of which the two spins have a spin angular 
momentum I = %. When placed in a magnetic field, the system  can be characterized by the 
energy scheme shown in figure 2.2. The spin populations of the energy levels (i.e. the four 
possible energy states for a two-spin system) are designated Ni, N2, N3 and N 4 (fig. 2.2, left). 
There are six possible transitions between them (see fig. 2.2 right). Transitions between level Ni 
and N 3 and between level N 2 and N 4 are transitions of the A-nucleus. The transitions between  
level Ni and N 2 and between level N 3 and N 4 are those of the X-nucleus. The energy difference 
between the two states corresponds to the resonance frequencies of spin A  and X  respectively.
N l A X
Figure 2.2 The energy scheme of a two-spin system (I = Y2). (left) The four levels correspond with the four 
possible energy states of this spin system. The lowest level corresponds with the state in which both spins are 
parallel to the applied magnet field (aa orff); in the highest level the spins are anti-parallel with respect to 
the field (ßß or-If). The middle levels correspond with the states (aß orf)) and (ßa or)f). The spin 
populations of the levels are designated Ni, N2, N3 and N4. The A and X labels indicate a transition of the A or 
X spin, respectively. (right): The transition probabilities between the levels are represented by the W's. The 
numbers attached to the W's indicate the zero, single or double quantum transition induced by the 
relaxation.
The random fluctuations of the local fields, which are related to the rate of rotational movements 
(tumbling) of the molecule, may give rise to transitions between all energy levels (fig. 2.2, right). 
The probability for spins to undergo a transition from one energy state to another state per unit 
time (i.e. transition probability Wi) as a consequence of Bloc fluctuations, requires that the 
frequency of these fluctuations matches the energy differences between these levels. Figure 2.2 
(right) shows all the possible and theoretically allowed relaxation processes, with their 
transition probabilities W. The four probabilities Wii correspond to the single quantum 
transitions of either spin A  (aa ^ ß a  and a ß ^ ß ß ) or spin X  (a a ^ a ß  and ß a ^ ß ß  ). For like spins 
these transition probabilities are given by (i):
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-
n 1,i ™  , _ . 620 4nr
T C
1 + ®o2tc 2
[2.1]
where ßo is the magnetic permeability of vacuum, h the Planck constant divided by 2n, y the 
gyromagnetic ratio of the concerned nuclei, and r the distance between the two nuclei carrying 
magnetic dipole moment. t  represents the rotational correlation time that characterizes the 
molecular tumbling motion and thus the rate of the local field fluctuations. Hence, Tc is closely 
connected with the rotational mobility of the molecule and dependent on its size, but also on 
temperature and viscosity. In general, small molecules in solution have a short Tc’s ( 1 0 12 - 1 0 10 
s), whereas large molecules have a longer Tc’s (10 8- 10 6 s).
W 2 denotes the probability for relaxation of the spin system via double quantum transitions, 
transitions between N 1-N4, i.e. simultaneous spin flip of both spins in the same direction (e.g. aa  
^  ßß) and is given by:
TJ. 3 /j.q Y Ah 2 tc
W 2 —  ------------ [2.2]5 4nr 1 +  4 o 0 tc
The transition probability for relaxation of the spin system via zero quantum transitions, Wo, 
corresponding with the transitions N3-N2 and vice versa, is caused by simultaneous spin flip a  ^  
ß for one spin and ß ^  a  for the other (hence ßa ^ a ß ). For like-spins this transition probability 
is given by:
W  - ±  r jh _  TC
0 10 4 nr C
Having available expressions for the transition probabilities, we can now write down the 
equations of motion describing the time dependence of the z-magnetization of the A  and Z-spins 
after a perturbation of the spin system  (1).
— P  dip, A ( M zA -  M Za  ) - ° A X  ( M  zX  -  M Zx  ) [2.4]
dt 
d M zX
dt
— - a AX ( M zA -  M °A ) -  P d ip ,X  ( M zX -  M °X ) [2.5]
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These expressions are known as the Solomon equations (1), in which M za and Mzx are the z- 
magnetization of the A  and X-spins respectively and M a0 and Mx0 their equilibrium  
magnetizations. The p  and a  symbols, representing the so called auto and cross-relaxation 
constants, are linear combinations of the transition probabilities:
P dip,A  -  W 0 +  2 W 1A +  W 2 [2.6]
P  d ip ,X - W n +  2 W 1X +  W
For two spins within one molecule (i.e. at a fixed inter-spin distance r) the auto relaxation rate 
constants for either spin A or X can be rewritten as:
P dip,i - V 4 n j 1 r 6 T C +
3t c
+
6 t c
2 2 2 2 1 + 0 O Tc 1 + 4 ^ 0 Tc [2.7]
In equations [2.4] and [2.5], the symbol a  represents the cross-relaxation rate constant, which is 
a linear combination of the zero and double quantum transition probabilities, W 2 and Wo, see fig. 
2.2.
a  -  W  - Wu AX 2 "0 [2.8]
Thus the cross-relaxation rate constant is described by:
V  4 n J 1 O r6
6 t c
------------- -------------- T
1 / 1  2 2 L C
1 +  4 ^  T C
[2.9]
Equations 2.7 and 2.9 demonstrate that the relaxation rate constants are highly dependent on 
the inter-spin distance and the rotational mobility of the spin systems. Note that both relaxation 
rate constants, p  dip and a, are generally also strongly dependent on the NMR frequency and so 
may vary considerably with the magnetic field strength, Bo.
Relaxation owing to chemical shift anisotropy— Another important spin-lattice relaxation 
process to consider is caused by the chemical shift anisotropy (CSA), which is also a source of
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fluctuating local magnetic fields. In contrast to dipole-dipole relaxation, which originates from 
interaction between two spins, CSA relaxation is characterized by fluctuating local fields at the 
site of the considered spin that originate from surrounding molecular electron currents induced 
by the external magnetic field. The relaxation rate constant due to CSA is described by the Wi- 
term:
- 2 2^ 2 
P CSA - 15 ®0 ° [2.10]
TC
Where ô = Aa(1-n/3)^, in which A a  is the chemical shift anisotropy term and n the asymmetry 
term. As shown in eq. [2.10], the CSA relaxation is directly proportional to the square of the 
magnetic field strength and therefore becomes increasingly important at higher magnetic fields. 
At suitable conditions the contribution of the CSA relaxation to the auto-relaxation term may 
exceed the contribution of the dipole-dipole relaxation. Certainly for 31P experiments at higher 
field strengths, CSA relaxation substantially contributes to the spin-lattice relaxation in ATP (2), 
as we will see later in this section. In case the CSA relaxation is not negligible the Solomon 
equations have to account for this effect.
(P  dip, A + P CSA,A )(M  zA ~ M Za ) ~ G (M  X  ~ M ZX ) [2.11]
dt
d M
dt
Z  - - a ( M A -  M<A ) -  (P dip ,X + P  CSA,X )(M X  -  M Zx ) [2.12]
In these two equations, we neglected the cross-correlation (or relaxation interference) term that 
may be present when the dipole-dipole relaxation and the CSA relaxation are governed by the 
same rotational correlation time (i.e. fluctuations in Bloc) (3). However, it can be shown that this 
term can be disregarded for the saturation transfer experiments used in the MT-studies 
described in this thesis. The solutions to eqs. [2.11] and [2.12] are:
M a (t) -  cueAt + C12^21 + C1 [2.13]
M X  (t) -  c21e v  + c2 2 + C 2 [2.14]
in which the relaxation rate constants, Ai and fa, are represented by
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[2.15]
In eq. 2.15 we introduced the auto-relaxation constant: pi = pdip,i + pcsA,i , which we will 
henceforth use in all following equations. Ci and C2 are the values of MzA(t^-w) and Mzx(t^w), 
respectively. The constants cij depend on the type of MT experiment. Note that the general 
solutions for the eqs. ([2.11] and [2.12]) are bi-exponential. Relaxation mechanisms resulting 
from through-bond coupling (J-coupling) and spin rotation are not expected to be important for 
ATP. Quadrupole relaxation is not relevant for spin-% systems, thus can be disregarded for the 
31P-spins considered in this chapter.
M T  in saturation transfer experiments— Although both saturation transfer and selective 
inversion recovery are widely used MT methods for their ability to reveal MT phenomena, we 
here restrict ourselves to saturation transfer experiments.
For simplicity we consider a 2-spin AX  system for like-spins, with one of the two spins (spin X) 
being selectively saturated for a time t (henceforth in this chapter, t presents the duration of the 
saturation pulse). The selective saturation pulse causes the spin system  to equalize the X spins 
over its two corresponding energy levels: i.e. N 1=N2 and N3=N4. For complete saturation of the 
magnetization of spin X  (Mzx(t)= O), eq. [2.11] becomes decoupled from eq. [2.12]:
We solve eq. [2.16] and in accord with normal conventions, we find an expression for the 
normalized signal “enhancement", commonly referred to as the nuclear Overhauser 
enhancement factor n (t):
having equal equilibrium magnetizations, i.e. M za0 = Mzx0, as they are equally abundant. In 
contrast to the ^/-exponential solutions given in eqs. [2.13] and [2.14], the saturation of one of
[2.16]
[2.17]
In the derivation use has been made of the fact that in this thesis we only consider spin systems
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the two spin systems decouples eqs. [2.11] and [2.12], which results in a mono-exponential 
function for the time-dependency of the NOE. The presence of cross-relaxation leads to either 
positive or negative NOEs, depending on the values of Wo and W 2 (and thus o, see eq. [2.8]). For 
short correlation times, Tc, i.e. for small molecules, o > 0 and the signal intensity of spins A  will be 
enhanced. For long correlation times, i.e. for large molecules, o < 0 and Mza becomes negative. 
Application of a saturating RF-field, resonating at the Larmor frequency of the X  spins for a 
sufficiently long time (i.e. for t > 5/p), drives the MT effect to the so-called steady-state NOE 
enhancement, nss:
M a  “ -  M j  a  x
Vss - „ 0  - —  [2.18]
M a  P a
Accordingly, eqs. [2.17]-[2.18] demonstrate that nss is not determined by the cross-relaxation 
alone. It is the balance between cross-relaxation and auto-relaxation which is important, 
although the sign is solely determined by g. For like-spins, the nss ranges from -1 to 0.5 
depending on the rotational correlation time, see fig. 2.3A. For nss = 0, no net magnetization is 
transferred from spin X  to spin A  (i.e. MzA(t) = Mza0). Figure 2.3B demonstrates the NOE factor as 
a function of t, the saturation time.
31P  Saturation transfer experiments on ATP— In the remaining part of this chapter we 
concentrate on MT effects that are observed in in vivo 31P saturation transfer experiments on 
ATP. In order to evaluate the possibilities to detect NOEs in ATP by 31P saturation transfer 
experiments, we have to consider the individual relaxation rate constants of 31P spins in eqs. 
[2.7]-[2.10] and the constants given in Table 2.1. In the case of ATP we are considering intra­
molecular homo-nuclear dipole-dipole and CSA relaxation rates. It should be mentioned that the 
rotational correlation time we used to calculate the relaxation rate constants is based on ATP 
freely moving in an aqueous solution (Tc = 0.3 ns (4)).
The field-dependence of the different relaxation rate constants and the steady state nuclear 
Overhauser effects between nearest neighbor 3iP-3iP spins of ATP is presented in figure 2.4. 
This figure shows that the dipole-dipole relaxation, i.e. dipolar auto and cross-relaxation are 
much smaller than the CSA relaxation at the field strengths commonly used for in vivo 
measurements (1-7 T). Note the scales on the y-axes. pdip and Oax decrease mildly with 
increasing field strength, in contrast to the CSA relaxation rate constant, which is very large and
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even becomes increasingly important at higher field strengths. Consequently at higher fields nss ( 
= o/p ) approaches zero, whereas at field strengths below 2T, where the CSA contribution is not 
completely dominating over the auto-relaxation, a positive steady state NOE enhancement can 
be obtained (fig. 2.4D).
Table 2.1: Constants used for the calculation of 31P relaxation in ATP
Gyromagnetic ratio 31P Y = 108.39-106 rad-s^ -T-1
Planck constant divided by 2n h = 1.055-10-34 J-s
Distance 31P-31P r = 3.0 -10-10 m
Rotation correlation time Tc = 0.3 -10-9 s
Permeability in vacuum P0 = 4-pi-10-7 m-kg-s~2-A-2
Chemical shift anisotropy s =■180-10-6 -
Larmor frequence at 7T M0 = 2-pi* 121.53-106 rad-s-1
For r and S we used values for ATP derived in (5).
(A)
Vs
Tc (S)
(B)
Figure 2.3: Steady state NOE and time dependent M T effect on the resonance of the A-spins upon 
saturation of the X  spins. (A) Steady state NOE as a function of Tc for a two-spin system with like-spins 
without CSA. (B) The signal intensity of spins system A (Mza) demonstrates a mono-exponential reduction 
upon irradiation of the X-spins for a time t (eq. [2.17]). NB: figure B was obtained using o = -0.21s-1 and p = 
0.21 s-1 as an example, i.e.for a long rotational correlation time. (no CSA). Note that in the case of a positive o, 
the function exhibits s a mono-exponential increase.
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The field-dependence of the different relaxation rate constants and the steady state nuclear 
Overhauser effects between nearest neighbor 3ip-3ip spins of ATP is presented in figure 2.4. 
This figure shows that the dipole-dipole relaxation, i.e. dipolar auto and cross-relaxation are 
much smaller than the CSA relaxation at the field strengths commonly used for in vivo 
measurements (1-7 T). Note the scales on the y-axes. pdip and Oax decrease mildly with 
increasing field strength, in contrast to the CSA relaxation rate constant, which is very large and 
even becomes increasingly important at higher field strengths. Consequently at higher fields nss ( 
= o/p  ) approaches zero, whereas at field strengths below 2T, where the CSA contribution is not 
completely dominating over the auto-relaxation, a positive steady state NOE enhancement can 
be obtained (fig. 2.4D).
Fig. 2.4D shows that at lower field strengths, B 0 < 2 T, steady state NOE effects are large enough 
to be detected for freely moving ATP. However, steady state conditions are not reached until 
saturation pulses last in the order of several times 1 / |g |,  which implies that the duration of the 
saturation pulse has to be longer than 15 min to reach steady state.
For the specific case that saturation transfer experiments on ATP are performed at 7T, as will be 
the case in Chapter 3, the CSA relaxation rate constant (pcsA = 0.718 s 1) dominates over the 
dipolar-relaxation constant (pdip = 0.006 s 1), yielding an overall auto-relaxation constant which 
equals the sum of both (i.e. p = 0.724 s 1). The large contribution of the CSA relaxation, combined 
with the very small cross-relaxation rate constant (o = 0.003 s 1) at 7T, results in a negligible 
positive NOE for the steady state (nss = +0.004). In practice this means that, when a frequency 
selective saturation pulse is applied at the y-phosphate resonance (-2.5 ppm), a negligible 
positive steady state NOE effect is present at the ß-ATP signal. This is in accord with the absence 
of NOE effects in ATP in vitro, as was previously observed by Le Rumeur et al. (6). We note in 
passing that without the large pcsA contribution top, there would be a prominent NOE buildup 
even at higher field strengths, nss = o/p »  0.5. However, then again long saturation times are 
required to buildup the full enhancement, i.e. 1 / |g | = 323 s.
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Figure 2.4: Relaxation rate constants as a function of field strength. Relaxation rate constants and 
steady state NOEs were calculated for a 31P-31P spin system using eqs. [2.7], [2.9],[2.10] and [2.18]. In the 
calculations we used the parameters listed in Table 2.1. From top to bottom: (A) auto-relaxation due to 
dipole-dipole interactions (pdip), (B) cross-relaxation (o), (C) auto-relaxation due to CSA ( pc sa) ,  and (D) the 
steady state NOE (nss).
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Having calculated the relaxation rate constants and NOEs at different field strengths, we now  
make an estimate as to what extent the relaxation processes may contribute to 31P MT effects 
measured at 7T for ATP in vivo. In Chapter 3 this theoretical outcome will be related to 
experimental results.
First, the calculated value for the auto-relaxation rate constant at higher field strengths is in 
agreement with experimentally determined values for T1 relaxation for the 31P spins of ATP in 
vitro, i.e. 0.5-1.1 s at 4 °C and 109 MHz (2), and in vivo, i.e. 1.5 s in mouse skeletal muscle at 121 
MHz (7). The similarity between calculated and experimental values suggests that the rotational 
mobility of ATP in the cytosol is comparable to that of ATP in solution. However, this 
interpretation should be considered with some caution as follows from an examination of fig. 2.7 
later on.
Second, even if we assume a Tc of 0.3 ns for cytosolic ATP, then the relatively large contribution 
of the CSA relaxation to the auto-relaxation at high fields impairs the detection of direct 3iP-3iP 
NOE effects. In other words the MT on neighboring phosphates of ATP (4 %%  at 7T) will be far 
below  the detection limits of the method, certainly with the relatively low  SNR of in vivo MRS.
2.2 EXCHANGE REACTIONS INVOLVING PHOSPHATES OF ATP
Not only relaxation mechanisms can induce transfer of magnetization, MT can also occur due to 
chemical exchange reactions. In general, saturation transfer experiments do not distinguish 
between MT through dipole-dipole interactions (cross-relaxation) and MT due to chemical 
exchange processes. A partial distinction between these processes can be obtained for small 
molecules, where cross-relaxation can induce positive NOE enhancement, whereas chemical 
exchange always leads to signal decays, vide infra.
The involvement of the y-phosphate of ATP in multiple enzymatic exchange reactions (fig. 2.5B) 
complicates a clear distinction between MT effects due to relaxation mechanisms and the 
multiple exchange reactions. In this paragraph, time dependent changes in the resonance 
intensity of the phosphate groups of PCr, Pi, ADP and ATP occurring as a consequence of the 
selective saturation of the y-ATP signal will be described based on the equations of motion of the 
corresponding magnetizations. Additionally, the inevitable co-saturation of ß-ADP in these
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experiments will be considered. A schematic overview of the m ost important exchange 
reactions involving phosphorylation and dephosphorylation of ATP is provided in figure 2.5A.
For convenience we first list the notations used in this section. The magnetization of the 
different spins is denoted by:
a-ATP : Faz
ß-ATP : Fßz
Y-ATP : Fyz
a-ADP: Daz
ß-ADP: Dßz
PCr: PCrz
Pi: Pz
Unless indicated otherwise all exchange rate constants represent pseudo first order rate 
constants, meaning that they include not only the rate constant but also enzyme, substrate 
and/or product concentrations.
Creatine kinase: kcK
Adenylate kinase: kAK
GAPDH+PGK: kglyATPases: kATPases
ATP-Pi exchange: kPi — kgly + kATPase *
ATP-ADP exchange: kADP = kcK + kAK + kPi *
* The use of pseudo first order rate constants in the equations of motion of the magnetization, allow for the implementation of linear combinations of the individual reaction rate constants for kPi and kADP.
For clarity, we characterize all ATP-synthesizing reactions by adding for in the subscript of the 
corresponding rate constant, e.g. kcK,f0r, and by adding rev in the subscript of the rate constant 
for the reverse reaction, e.g. kcK,rev.
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PCr
Pi
Creatine kinase :
P C r-2 +  M gA D P-1 + H  +1 < > Cr + MgATP -2
F 1F 0 ATPase :
3ADP + 3Pi + NADH + / 2O2 + H  + < F-ATPme > 3ATP + NAD+ + H 2O
Coupled GAPDH/PGK:
GAP + NAD  + +  Pi < GAPDH > 1,3 DPG + NADH + H +
I,3DPG + ADP < pgt > 3PGA + ATP
Adenylate kinase :
2ADP < t  > AMP + ATP
Figure 2.5: Schematic overview of phosphoryl exchange between ATP, Pi, PCr and ADP. Chemical 
exchange reactions involved in experiments of simultaneously saturation of the co-resonating y-ATP and ß- 
ADP signals at -2.5 ppm (selective saturation is indicated by the flash). Phosporyl exchange between y-ATP 
and PCr is mediated by creatine kinase (CK), exchange between y-ATP and Pi is mediated by ATPases and 
GAPDH/PGK (glycolysis).The small signal originating from theß-ADP pool, which is below the detection level 
and overlapping with the y-ATP signal, is inevitably co-saturated. ATP-ADP conversion is mediated by 
adenylate kinase (AK), CK, ATPases and glycolytic enzymes. y-ATP to ß-ADP conversion in both directions is 
also mediated by AK, although this does not have any effect when both spin systems are co-saturated. 
Exchange mediated MT effects could be detected on PCr, Pi and ß-ATP signals, which are therefore 
represented by the grey blocks.
A b b re v ia tio n s :  PCr: phosphocreatine, Cr: creatine, NAD: nicotinam ide adenine dinucleotide, GAPDH: glyceraldehyde-d-phosphate  
dehydrogenase, PGK: phosphoglycerate kinase, GAP: glyceraldehyde-3-phosphate; 1,3DPG: 1,3-diphosphoglyceric acid, 3PGA: 3- 
phosphoglyceric acid, AMP and ADP: adenosine mono- and diphosphate.
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A T P ^P C r  exchange mediated by CK— First we describe a simple two-site exchange problem, 
taking the reaction mediated by CK as an example.
k CK,rev ^
A -  Pa -  Pß -  Py+ Cr 4_____________A -  Pa -  Pß + PCr + H +
 ^ k CK, for
In this reaction phosphoryl groups and thus their magnetization is exchanged between the y- 
ATP and PCr. For the sake of convenience we disregard cross relaxation either in the ATP or the 
PCr spin systems. For this situation the equations of motion of the magnetization of y-ATP (FYz) 
and PCr (PCrz) are given by:
d P C r
=  ~pPCr (PCrz - P C r 0) -  kCKJorPCrz + k ^ F y  [2.19]
dF
dt
y _  P y (Fyz - F y ) + kCK,forPC rz - kCK,revF yz [2.20]
Fr0 and PCr0 are the equilibrium magnetizations of y-ATP and PCr, respectively. Note that these 
equations only contain the magnetizations of PCr and ATP, thus concentrations of ADP, Cr, H+ 
and CK are included in the rate constants kayor and koKrev, which are therefore pseudo first order 
unidirectional rate constants.
When the y-ATP spins are continuously saturated, then, starting at t = 0, Frz= 0 and eq. [2.19] 
adopts the following form:
dP C r _  P pct(P C rz - P C r 0) - kCKJorP C rz [2.21]
Note that this equation has become decoupled from eq. [2.20]. We find a mono-exponential 
expression for the general solution:
PCrz (t) - P C r 0 _  k,CK , for -(l -  e (PpCr+kcKJor) [2.22]
PC r P  PCr +  kCK, for
This behavior is illustrated in figure 2.6, where the change in signal intensity of PCr, normalized 
to PCr0, is plotted as a function of the saturation time, t. For steady state saturation, the decrease 
in PCrz reaches a maximum:
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PCrz (t ^  œ) -  P C r c 
P C r 0
k,CK, for
P  PCr +  k CK, for
[2.23]
This example demonstrates that a two-site exchange problem leads to a mono-exponential decay 
of the magnitude of magnetization of the non-irradiated spin system (in this case PCr) that is in 
exchange with the spins that are irradiated (here of y-ATP) for a time t.
P C r,(t)
p e r0
saturation time (s)
Figure 2.6: Time dependent M T effect on the PCr resonance upon saturation of the y-ATP signal. The
PCr signal intensity exhibits a mono-exponential reduction upon selective saturation of the y-ATP resonance 
as a function of the duration of the saturation pulse according to eq. [2.22]. This figure was obtained using 
PPCr = 0.4 s-1 and kcfr = 1.4 s-1. For short saturation times, kcfr may be determined from the slope of the 
initial data (dashed line).
y-ATP^Pi exchange— Phosphorylation and dephosphorylation of ATP by glycolytic and/or  
ATPase activity can be described as a single two-site exchange reaction between the y-ATP and 
Pi spin systems in a similar manner:
A -  Pa -  P„ -  Py A -  Pa -  P„ + Pi
k
P i,  f o
The equations of motion for the magnetization of y-ATP and Pi (Pz) for this two-site exchange 
problem are given by:
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dP
_  -PPi (P z - P0 ) - kPi,forPz + kPi,revF z  [2.24]
dFz n
~~dt~ _  P Y (F }z - F Y ) + kPi,forPz - kPi,revF yz [2.25]
When we saturate the y-ATP spins then, as in the preceding examples, Frz= 0. The general 
solution for the z-magnetization of Pi is:
Pz(t) P  _ kpi,for (  ( (ppi + kpi, for)t ) ro n n
-----P -----  ~ ~ P V k ------ ' -  e ' [2.26]P  P Pi +  kPi, for
Note the similarity between eqs. [2.26] and [2.22].
ß-ATP^ß-ADP exchange— In 31P MRS we observe the ß-phosphorous signals in two different 
positions: at -16.3 ppm for ß-ATP and at -2.5 ppm for ß-ADP. If the system is in dynamic 
equilibrium the ß-phosphorous spin jumps back and forth between these two positions due to 
the conversion of ATP in ADP and vice versa. In the 31P NMR experiment where we selectively 
irradiate y-ATP at -2.5 ppm, inevitably the ß-ADP signal is co-saturated. The multiple exchange 
reactions can be characterized by one overall pseudo first order exchange rate. Therefore the 
conversion can be reduced to a normal two-site exchange problem for the ß-phosphorus signals:
K j D P ^ r e v  ^
A  -  P a  P ß -  P Y  < ___________________ A  -  P a  -  P ß +  X
k A D P ,  f o r
in which kADPjor and kADP.rev represent the overall pseudo first order exchange rates between ADP 
and ATP, mediated by CK, AK, ATPases and glycolytic enzymes. X represents PCr, AMP or Pi, 
respectively. This means that the pseudo first order rate constants kADPjor and kADP.rev are a 
complex functions of the involved enzymes and metabolite concentrations. As in the previous 
section we disregard cross relaxation for both the cytosolic ATP and ADP spin systems. Although 
ATP and ADP are involved in multiple exchange reactions, it is appropriate to consider the 
transfer of magnetization through chemical exchange as two-site exchange problems. This has 
been demonstrated previously by Ugurbil et al.(S); i.e. as long as you saturate the y-ATP signal,
6ó"f
31P-31P magnetisation transfer I 2
both decreases in PCr and Pi can be considered as independent two-site exchange problems. 
This is also the case for saturation of ß-ADP, which is only in exchange with ß-ATP and y-ATP 
(see grey arrows with AK in fig. 2.5). As the latter is co-saturated, this has no contribution to a 
multi-site exchange problem.
d D R7 0
= ~P Dß(D ßz -  D ß) -  kADP,forD ßz + kADP,revF ßz [2 .27]
dF ß 0
~dt~ = -PFß (F ßz - F ß ) + kADP, forD ßz - kADP,revF ßz [2.28]
When the magnetization of ß-ADP is saturated from t = 0, then Dßz = 0 and the general solution 
for the time dependence of the magnetization of ß-ATP as a function of the saturation time is:
Fßz (t) - F ß kßz\l>  _  ADP, rev L -(p
F ß P Fß + kADP,rev
(  -  e ~(Prß+kADp,rev )t ) [2.29]
Thus, in theory, (co)saturation of the ß-ADP signal could result in a decrease in z-magnetization 
of the ß-ATP spins, if the values for kADP,rev and pFß are in the right range. Equation [2.29] enables 
the estimation of the MT effect due to the ß-ATP^ß-ADP exchange if we make some 
assumptions for the values of the spin-lattice relaxation rate constant and the pseudo first order 
rate constant for ADP^ATP exchange. In section 2.1 we already calculated pFß = 0.724 s 1 (for 
Pcsa + Pdip ). Considering just the contribution of the reverse CK reaction: kADP,rev = 1.4 s 1 that has 
been measured in skeletal muscle (see Chapter 3), we can now calculate the steady state MT 
effect on the ß-ATP signal Fßz(t^-m) - Fß0 = -0 .66 • Fß0 for steady state selective saturation of the 
ß-ADP signal. In other words, we expect the z-magnetization of the ß-ATP spin system  to reduce 
to only 33 % of its initial value solely due to reverse CK activity. This will be an important point 
of discussion for the interpretation of the results in vivo experiments in Chapter 3.
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2.3 TRANSFERRED NUCLEAR OVERHAUSER EFFECT
So far we have investigated the potentials MT effects due to cross relaxation and exchange 
reactions on the ß-ATP signal when applying a selective saturation pulse at the y-ATP/ß-ADP 
resonance. However, it was shown in paragraph 2.1 that ATP with a Tc of 0.3 ns will not give 
rise to detectable NOEs in ST experiments. Nevertheless, in Chapter 3 we will provide 
experimental data that indeed demonstrate the occurrence of 31P-NOE effects in ATP in skeletal 
muscle. This may occur when the rotational mobility of ATP is restricted, for example when it is 
dissolved in a highly viscous medium or it binds to a large protein. In the latter situation Tc may 
increase to such a level that NOEs are induced during the time ATP is in its “immobilized” state, 
which we will refer to as the bound state. The NOEs created in ATP in the bound state may be 
transferred to ATP in the free state by exchange of ATP between these two states. This type of 
MT effect is called transferred NOE (or in short trNOE). Here we will explore which 
requirements have to be m et in order to observe trNOEs in ATP.
31P  Cross-relaxation in motion-restricted spin systems— First, we further investigate the 
dependence of the individual relaxation processes on Tc, leaving trNOE aside for the m om ent 
The rotational correlation time Tc (normative for the tumbling rate of the molecule) is related to 
random rotational motion that occurs with a spread of frequencies due to the molecular 
collisions, associations and other interactions experienced by the molecule. According to the 
Stokes-Einstein relation for a spherical molecule (9):
_  8nRV 
Tc _ 6kT
[2.30]
A higher viscosity (v), a larger radius (R) of the molecule and/or a lower temperature (T) leads 
to an increase of Tc. Hence restriction of the m olecules’ random rotational motions can have 
major implications for the relaxation rate constants (fig. 2.7). As temperatures in vivo (« 310 K) 
do not deviate too much from circumstances of in vitro measurements (usually 278 -  298 K), 
temperature cannot be held responsible for a major slow  down of the rotational motion of 
cytosolic ATP. Since the translational diffusion of cytosolic ATP is only reduced by a factor of 2 to
3, it is reasonable to assume that the rotational motion of cytosolic ATP is not too different from 
that of ATP in solution (10-12). In other words, cytosolic viscosity cannot be responsible for
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potential trNOEs to occur in ATP in vivo. Eq. [2.30] shows that Tc increases with the power of 
three of the molecular size. Hence, this is a major factor in determining the value of the 
rotational correlation time. Before considering its significance for the relaxation behavior of ATP 
w e first examine the relaxation properties of a 31P-31P two-spin system. To this end we plot the 
spin-lattice relaxation rate constants pdip, Pcsa and a as a function of Tc based eqs. [2.7]-[2.10] (see  
fig. 2.7).
Figure 2.7: Relaxation rate constants as a function of Tc for a 31P-31P spin system at 7T. (A): relaxation 
rate constants plotted on a linear scale, (B): absolute values of relaxation rate constants on a logarithmic 
scale. Solid grey lines: auto-relaxation due to dipole-dipole interactions (pdip), dashed grey lines: cross­
relaxation (a), solid black lines: Pcsa. The calculations were based on eqs. [2.7]-[2.10] using the parameter 
values in Table 2.1. Dotted vertical lines from left to right indicate Tc = 0.3,1.2, 7, 35 and 300 ns.
This figure shows that for 31P relaxation in a two-spin system  with a spin-spin distance of 3-10-10 
m at 7T, the CSA relaxation predominates over the dipole-dipole auto relaxation for 0.001 ns < Tc, 
< 5 0  ns,. In this range the cross-relaxation rate constant (a) is so small, that the large 
contribution of the CSA relaxation results in negligible NOE effects (fig. 2.8). For increasing 
values of Tc, the situation is reversed in that pdip becomes larger than pcsa. In addition, the 
magnitude of the cross relaxation rate is increasing to become of the same order of magnitude as 
the auto-relaxation. Thus for larger values of Tc, NOE is coming into play. It is important to note 
that for Tc ~ 1 ns, a changes sign. Consequently, steady state NOEs are positive but very small for 
Tc < 1 ns and negative but substantial (i.e. nss ^  -1) for Tc > 100 ns. Relaxation constants and 
steady state NOEs for a 31P-31P two-spin system for Tc = 0.3, 1.2, 7, 35, 300 and 1000 ns are listed 
in Table 2.2.
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Tc (s)
Tc (S)
Figure 2.8: Steady state NOE as a function of Tc for a 31P-31P spin system. This function for nss is
described by eq. [2.18]. For 10-10 < Tc< 10-8s, the large value of the CSA and the small value of a impair the 
generation of NOEs; As long as a << p, the NOE will stay negligible. Only for Tc > 10 ns, NOEs become manifest 
during saturation transfer experiments. Assumed parameter values: see Table 2.1. Dotted vertical lines 
indicate Tc = 0.3, 7 and 300 ns.
Table 2.2: Relaxation rate constants and NOEs for mobile and immobilized ATP at 7T
Tc
(ns)
pdip
(s-1)
a
(s-1)
P csa
(s-1)
P = 1 /T 1
(s-1)
nss
0.3$ 0.006 0.003 0.718 0.724 0.004
1.2 0.010 0.001 1.643 1.653 0.001
7# 0.017 -0.014 0.596 0.613 -0.023
35 0.074 -0.074 0.123 0.197 -0.373
300 0.632 -0.632 0.014 0.647 -0.978
1000 2.108 -2.108 0.004 2.112 -0.998
NB: Values based on Table 2.1 and eqs. [2.7]-[2.10] and [2.18]
$ for ATP free in solution # Tc = 7.4 ns for a 35 kD CK enzyme, (4)
In order to investigate the possibilities to detect NOE in ATP we have a closer look at the time 
dependence of the 3iP-3iP NOE for various rotational correlation times; see NOE buildup curves 
for different Tc values given in figure 2.9. At a Tc of 35 ns, 1 /g  equals 8 s and steady state NOE can
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be reached only at saturation times exceeding 20 seconds. Suppose we could detect a signal from 
an ATP whose mobility is even further restricted, having a Tc of 300 ns. Then within a few  
seconds substantial NOEs would be observable (fig. 2.9); the NOE effect would cause the MR 
signal of the ß-ATP to decrease to about 0.2 of its original amplitude. Such effects may be 
achieved when ATP binds to larger cellular structures, thereby providing a basis for the 
detection of transferred NOEs.
n (t) =
Mz(t)
Mz
saturation time (s)
Figure 2.9: NOE buildup as a function of saturation time. NOE buildup in a 31P two spin system for Tc = 
0.3, 7, 35, 300 and 1000 ns. The time dependence of the NOE is based on eq. [2.17] and the values given in 
Table 2.2.
In summary, for steady state direct NOEs in a 31P-31P spin system to occur, smaller molecules like 
ATP have to be severely restricted in their rotational mobility compared to their situation free in 
solution Ergo, we suggest that the NOEs observed for ATP (see Chapter 3) result from its 
association with very large receptor molecules (> 100 kD) or other macromolecular structures.
Accounting for transferred NOEs in the Solomon equations— We extend our treatment of the 
relaxation behavior of cytosolic ATP by including the possible occurrence of trNOE effects. To
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this end we assume that the ß- and y- phosphate groups in ATP can be considered as a two-spin  
system. ATP is either free in solution (cytosol) or bound to an acceptor [E], see fig. 2.10. As 
before the magnetization of the ß and y-phosphates is indicated by Fßz and Frz.
BOUND STATE
FREE STATE
Figure 2.10: Schematic overview of transferred NOE in ATP. NOE between neighbouring 31P spins is only 
present in the bound ATP, as illustrated in the top of the figure. The MT effect that is generated in the ß-ATP 
in the bound form can be detected on the ß-phosphate signal of the free ATP, when there is fast exchange 
between the two pools of ATP. Note the ß-ATP signals (in grey blocks) both of the free and the bound pool 
may exhibit an MT effect upon selective saturation of the y-ATP spins (indicated by the flash).
For this situation we introduce new  notations:
Bßz z-Magnetization of the ß-ATP spin in bound state
BYZ z-Magnetization of the y-ATP spin in bound state
kfb = kass[E] Pseudo first order rate constant of complex formation
kbf = kdis Dissociation rate constant of complex
Pf, Of Auto- and cross-relaxation of and between ß and y  ATP in free state
Pb, Ob Auto- and cross-relaxation of and between ß and y  ATP in bound state
where kass is the diffusion limited rate constant. Note that kfb includes the concentration of 
receptor sites as the complex formation is assumed to be defined by diffusion. i.e. kass = 1 • 108 
M ^s1 (13). Consequently, the life time of ATP in its free state equals 1/(kfb[E]), whereas the 
lifetime of the ATP-complex is 1/kbf. The equations of motion for the ß-ATP magnetization in 
this situation are given by:
- F
- F -  = -P ,F  - Fi ) - , F  - F ) -k,  (Fß - Fß)+ k ,  (B„  - Bl ) [2-31]
^  = -p, ( B „ - Bß) -a, ( B z - B0 ) + k,  ( Fß - Fß ) - ku ( Bß - Bß ) [2-32]
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Where use has been made of kßFß0 = kbfBß0. Fi0 and Bi0 are the equilibrium magnetizations, which 
are equal for the ß and y  spins in ATP, i.e. Fß0 = Fr0 = F0 and Bß0 = Br0 = B0. We now investigate 
what happens to the magnetization of the ß-spins when the y-spins are selectively saturated 
during a period t. We assume that the chemical shift difference of the phosphorous resonances 
between the bound and free state are sufficiently small so that the y-ATP spins in these states 
are simultaneously saturated. Because of the saturation of the y-ATP spins, the terms FYz and BYz 
in the equations above can be omitted. Eqs. [2.31] and [2.32] now reduce to:
d  ( Fß Fß - = -(Pf + kb )( F ß - Fß ) + k ,  ( B ,  - Bß) + a  F  [2.33]
dt
d  ( B  n, - Bß) n n n
1 k  = - ( P  - k‘f )<-B ß -B ß) + k , ( F iz -F ! ) + a B  [2-33]
For this set of two coupled differential equations we find the following expressions for the time 
dependence of the z-magnetization of the ß-phosphate in the free and bound ATP.
F ß -  F 0 = cn e "  + C‘2e "2t + K x [2.34]
Bß - B  = c21e"  + c22eht + K 2 [2.35]
where we made use of Fß0 = FY0 = F0 and Bß0 = Bß0 =B0 and with A’s:
"  = -  ( p f  +  p b +  k f l  +  k bf ) ±  V  ( P f  - p b +  k ß  -  k bf ) 2 +  4 k b fk ß  [2 36]
The particular solutions yield the expressions for Ki and K2 '.
K  = (Pb + kbf )a fF ° + kbf a bB ° [2 .37]
[(Pb + kbf ^ (Pf + k fb ) -  kbfkfb ]
K  =, (Pf + kfb )a bB ° + kfba fF
[(pb + kbf )(P f + k fb ) kbfk fb ]
For the constants cii, we find:
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A2 K ‘ + a fF a
cii = --------  
11 a2 - a1
A K  ‘ + a fF a
c = ------------ ------
c‘2 A2 - A  [2.38]
A2 K  2 + a bB°
c 91 = --------------------
21 a2 - a  
A K  2 + a bB 0 
c 22 = a2 - a
Eqs. [2.34] and [2.35] show, that if cross-relaxation between 31P spins in ATP in the bound state 
is sufficiently large, a bi-exponential decay as a function of the saturation time, t, might be 
observed in the free ß-ATP when irradiating the y-ATP spins. We assume that the chemical shift 
difference of the 31P MR signals of the bound and free state is negligibly small. Thus, the 
observed signal is given by the sum of eqs. [2.34] and [2.35]. After normalizing this expression to 
the equilibrium magnetizations (F0 +B0) we obtain the commonly used expression for the steady 
state trNOE factor (i.e. t ^  <x>):
= Fß H  + Bß H  -  F 0 -  B0 = Ki + K 2
F 0 + B0 F 0 + B0 [2.39]
[p-+ k-b+ kb- f a  p  [pb+ k-b+ kb- Y-  p
iPb +  kbf \Pf +  kfb ) k-bkb- iPb +  kbf \Pf +  kfb ) kfbkbj 
Where Pb and Pf are the fractions of ATP in the bound and free state respectively:
B 0 F 0Pb =~o -------0" and Pf = — -------- [2.40]b B 0 + F 0 -  B 0 + F 0
Equation [2.39] is equivalent to the expression for the steady state trNOE derived by Clore and 
Gronenborn (13) for the same conditions, i.e. a negligible chemical shift difference between the 
free and bound state.
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Now we can explore the steady state trNOE effects as a function of the Tc of the bound fraction 
(Tc,bound), see fig. 2.10 dashed line. In the calculations we assumed a bound fraction of 10 % and 
exchange between the free and bound ATP was fast: kfb/kbf = 1000 s-1/9 0 0 0  s-1, which 
corresponds to a 1 • 10-5 M-1s-1 concentration of free binding sites. We note in passing that the Tc 
of the free (cytosolic) ATP was taken equal to 0.3 ns. Examination of fig. 2.10 shows that MT 
effects become detectable in vivo when Tc,bound exceeds ~  5 x 1 0 7 sec. In other words, if 10 % of 
the ATP transiently associates with a structure, which has Tc in the order of half a micro second, 
it becomes feasible to detect 3ip-3ip trNOEs in ATP in vivo.
Tc Or Tc,bound (s)
Figure 2.10: Steady state NOE and trNOE as a function of Tc and Tc,bound, respectively. NOE is presented 
as a function of Tc for the situation of free ATP only (solid line), while trNOE (dashed line) is plotted as a 
function of the Tc of the bound fraction (Tc,bound), assuming a bound fraction of 10 %  . Both curves are given 
for a 31P-31P spin system at 7T using the values in Table 2.1
In order to examine the dependence of trNOE on the lifetime of the ATP-complex, 1/kbf, we 
calculated the same plot for different exchange rates, see fig. 2.11. This figure shows that the 
trNOE effects are not very sensitive to the choice of kbf and kp.
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Figure 2.11: Steady state trNOEs for variable exchange rates. Steady state trNOEs as a junction of rebound
for variable exchange rates: kfb/kbf=1000 s-1/9000 s-1(---), j/kbf=10 s-1/90  s-1(—), j/kbf= 1s-1/9  s-1(••••). All 
curves were calculated based on a 31P resonance frequency mq = 121.4 MHz. The distance between the 
phosphorous nuclei amounts to r =3.010-10 m, and the bound fraction of ATP is 10 %  (Pb = 0.1).
The time dependence or buildup of this transferred NOE can be studied if we sum eqs. [2.34] and 
[2.35] and normalize the resulting expression to the equilibrium magnetizations (F0+B0). Figure 
2.12, presents the trNOE buildup for different values of Tc assuming that 10 % of the ATP is in 
the bound condition. We see that only the amplitude of the steady state NOE is affected by the 
value of Tc,bound, i.e. in case ATP would bind to rapid tumbling molecules (relatively small 
difference between Tcjree and Tc,bound) a slight positive NOE can be observed, while association of 
ATP with slowly tumbling molecules (i.e. Tc,bound 300 ns) a negative NOE will become visible at 
saturation times > 2s.
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n (t) =
F Z t i + B  ß Z (t)-F 0- B 0
^ ^ ~ f 0+ b °
saturation time (s)
Figure 2.12: trNOE buildup in ATP as a function of saturation time. trNOE buildup in a 31P two spin 
system for Tc = 0.3, 7,35, 300 and 1000 ns. The time dependence of the trNOE is based on the sum of eq. [2.34] 
and [2.35], and normalized to the equilibrium magnetization (F0 + B0). The used parameter values are given 
in Table 2.2 and fy/faf = 1000s-1/9000s-1.
Interestingly, in all cases the steady state is reached after ~5 s. Hence, Tc,bound only affects the 
amplitude, not the rate of NOE buildup. This is reasonable because in this example the values of 
the A/s are mainly determined by the exchange constants and not the relaxation constants 
(k«10-10000 s-1, p«0.5-2 s 1). Moreover, for all Tc,bound values the buildup curves represent a 
mono-exponential growth or decay, although eqs. [2.38]-[2.39] suggest otherwise. This can be 
understood when having a more detailed look at the time constants of the exponential decay 
functions given by eq. [2.36]. Table 2.3, which provides values for both Ä1 and X2 for different 
values of Tc,bound ranging from 0.3 -  1000 ns, demonstrates that both A's do not vary much as a 
function of the rotational correlation time; therefore they are rather robust, especially X2. The 
value of the latter is so large and the decay of the second exponential so fast that it isn’t 
detectable in our measurements. Consequently, the trNOE buildup follows a mono-exponential 
decay determined by the smaller Ai. For Ai having a value of about 0.7 s 1 steady state MT will be 
reached in about 7 seconds of saturation (i.e. 5 4 /  Ä1 ~  7.1 s), which is just within acceptable 
limits for in vivo measurements. Table 2.3 also presents the steady state NOE factor for variable 
Tc,bound (see also fig. 2.10) . From these values we can conclude that when 10 % of the total ATP
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pool would form slow-tumbling complexes, having a Tc,bound of 300 ns, saturation of the y-ATP 
spins would result in a 8.5 % signal loss at the ß-ATP resonance at saturation times of 7s and 
longer. In the case of a Tc,bound of 1000 ns the MT effect is even 24%.
Table 2.3: Time constants and steady state trNOE factors for a 31P-31P spin system
Tc,bound Xt X2 ss
sr
ns s s due to trNOE
0.3 -0.7236 -10001 0.0035
1.2 -0.8165 -10002 0.0029
7.0 -0.7125 -10001 0.0012
35 -0.6710 -10000 -0.0076
300 -0.7159 -10001 -0.0852
1000 -0.8624 -10002 -0.2418
Values calculated according to eqs. [2.36] and [2.39]. We assumed a free fraction of 90 
% ( Tcfree = 0.3 ns) and a bound fraction of 10 %.
If the fraction of bound ATP becomes larger, the trNOE will become more important in the 
buildup of the MT. In order to investigate the influence of the fraction bound ATP on the trNOE, 
we have to account for the assumption that the association rate constant is diffusion-limited. On 
this basis and given the concentration of 7.8 mM of the cytosolic ATP we calculated the 
corresponding dissociation rate constant according to:
[E ] kß [A TPf ]
~ = J A P ]  [ 2 ' 4 1 1
Figure 2.13 shows the buildup curves for the following fractions for bound ATP: 1 %, 5 %, 10 %, 
20 %, 30 % in case Tc = 1000 ns. In Chapter 3 we will see that in vivo experiments show a steady 
state NOE of ~25%, which according to this figure would be possible with a bound fraction of 
10% .
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Figure 2.13: Transferred NOE buildup for different values of the immobilized fraction. Transferred 
NOE buildup curves for the following fractions of bound ATP: 1 % , 5%, 10% , 2 0% , 30 %. The calculations 
were performed with Tc = 1000 ns.
2.4 COMBINING RELAXATION PROCESSES, ATP COMPLEX FORMATION AND 
ATP-ADP CONVERSION
Here we combine the relaxation processes (paragraph 2.1) with the MT originating from 
exchange of the ß-phosphate in the ADP and ATP form (paragraph 2.2) and ATP complex 
formation (paragraph 2.3). Using the previously introduced abbreviations for the 
magnetizations of ADP and ATP free in solution and in the bound state, we consider the reaction 
scheme shown in fig. 2.14. In this scheme Pß jumps back and forth between ATP-free, ATP-bound 
and ADP-free. In the present calculation we consider the time dependence of the Pß resonance at 
conditions where the PY-resonance and the Pß-resonance of ADP are continuously saturated. 
Hence, we can disregard the phosphate exchange between PCr and y-ATP, as well as that 
between Pi and y-ATP, since the Solomon equations for the time dependence of the PCr and Pi 
magnetization are not coupled with the ones that describe the time dependence of the ß-ATP 
magnetization. For the moment we leave the magnetization of the Pa's out of consideration for 
simplification.
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BOUND STATE
NOE NOE
Y-l ß-P a-P Adenosineribose
Receptor E
FREE STATE
wVv-p ß-p a-P Adenosineribose
&
ß-P --------  a-P --------
Adenosine
ribose
Figure 2.14: Schematic overview of ATP-ADP phosphoryl exchange and trNOE. Selective saturation of y- 
ATP and ß-ADP signals at -2.5 ppm, as indicated by the flashes, allow monitoring of exchange between ß-ATP 
and ß-ADP and of trNOE between ß- and y-ATP 31P spins. Note that both MT effects can result in a reduction 
of the ß-ATP signal intensity (shown in grey).
The equations of motion for the Pß-magnetization read:
d F aßz
d t
d B ,
d t
d D
-  - p f  (F ßz -  F ß ) - a f  (F yz -  t f ) - ( k ADPrev +  k f i ) (Ff i  -  F ß )  +  k b f(B ß  -  B ß )  +  k ADP,for(D zß -  D0)
’ -  - p b ( B ßz -  B ß )  - a b ( B yz -  B y ) -  k b f ( B ßz -  B ß )  +  k fb ( F ßz -  F  ß )
d t
zß -  „  ( n  n ß \  (  D  -  D 0) +  k  ( F  -  F 0 )ADP, fo r \  zß ^  ß  )  ^  ADP.revV1 ßz )P D (  D zß -  D  ß  )  -  k
[2.42]
[2.43]
[2.44]
Where use has been made of kADP,revDß0= kADPforFß0 and kpF0= kßF0. Since we assume here that 
both the PY-resonance and the P ß-resonance in ADP are continuously saturated, we can simplify 
the set of equations using FYz = BYz = Dzß = 0. This means the first equation becomes decoupled 
from the third and we are left with two coupled eqs. [2.42] and [2.43], which after some 
rearranging become:
d  (  F z  -  F ß  )ßz_* ß >
d t
'  ßz__^  ß '
d t
- - ( p f  + k ADP ,rev + k  fb ) ( F  ßz -  F ß ) + k bf ( B  ßz -  B ß ) + f F Y -  k ADP, forD ß
d  (  B  ßz -  B  ß )
-  - ( P b  + kb f ) ( B  z  -  B ß )  + kfb  ( F  z  -  F ß )  + a bB°Y
[2.45]
[2.46]
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The general solution for this system is given by:
ßz 11 12
3 pz - B  0 = c 21e 21 + C 22L '^ 2B ß  c  e2t + K  2 [2.48]
With A/s:
2  = -  ( P f  +  P b  +  k fb +  k b f +  k  ADP ,rev )  ± - \ j  ( - P  f  -  k  fb  -  k  ADP ,rev +  P b  +  k  b f  Ÿ  +  4 k  f b k  b f  [2 49]
The particular solutions yield the expressions for K 1 and K2:
K  = (pb + kbf )a fF  + kbf °bB — (pb + kbf )kADP ,revF  [2 50]
(pb + kbf )> f + kADP,rev + kfb ) -  kfbkbf 
y kfb°’fF  + if’f + kADP,rev + k fb }7bB ~ k fbk ADP ,revF
K  = —
( b + kbf \p f + kADP,rev + k fb ) k fbk bf
were we made use of Fß0 = Fr0 = F0 and Bß0 = Bß0 =B0. For the constants c;;, we find:
c11 =  -A2K 1 +  (a f - k ADP,rev )F  0
c12
A2 -A1
- kf ADP, revA  K 1 + (<J - k  )F  0
A2 -A1 
A2 K  2 + ° b B  0 
A2 - A1 
A K  2 + o bB 0c =  * L2 ' wb
22
[2.51]
A2 - A1
Similar to eq. [2.39] we have to sum the solutions for the free and bound state, as we assume a 
fast exchange on the chemical shift scale. Thus, we calculate the enhancement factor (n(t)) that 
should be measured at the signal of the ß-ATP, by adding the expressions [2.47] and [2.48] and 
normalize this sum to the total z-magnetization of ATP in equilibrium (i.e. F0 + B0). The steady 
state solution for the situation that long saturation pulse is applied to the y-ATP and the ß-ADP 
resonance is given by:
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n =  F ßz- F  0 + B ß- - B  0 = K ± K .  [2 52]
Vss F 0 + B 0 F 0 + B 0
= (kbf + Pf + kADP,rev + kfb)(Tb D (kfb + pb + kbf f D (pb + kbf + kfb)kADP,rev „=------------------------------------- Pb +---------------------------------------Pf--------------------------------------- Pf
(Pb + kbf )(Pf + kADP,rev + kb)- kbkbf (Pb + kbf )(Pf + kADP, rev + kb) - kbkbf (Pb + kbf )(Pf + kADP,rev + k lb) k fbkbf
The first two terms of the last expression on the right hand side represent the trNOE effect 
expected for the ß-ATP signal. Note that they are the same as eq. [2.39] except for the extra term  
kADP.rev. The third term presents the influence of the exchange contribution on the ß-ATP 
resonance brought about by the ATPfree^ADPfree reaction. In Chapter 3 we will make use of eq. 
[2.52] and investigate experimentally whether the ATP-ADP exchange may clutter the 
Overhauser effect or perhaps dominate it.
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The k in etics of phosphoryl exchange involving ATP and ADP have been  investigated  
su ccessfu lly  by in vivo 31P MR spectroscopy using m agnetization  transfer (MT). However, 
MT effects seen  on the signals of ATP also  could arise from  intra-m olecular cross  
relaxation. This relaxation  p rocess carries inform ation on the cellu lar state of ATP.
To d isentangle contributions of chem ical exchange and cross relaxation to MT effects 
seen  in  31P MR sp ectroscopy of skeleta l m uscle w e perform ed saturation transfer  
experim ents on w ild  type and double-m utant m ice, lacking cytosolic  m uscle creatine  
k inase (CK) and adenylate kinase.
We find that cross relaxation, observed  as nuclear O verhauser effects (NOE), is 
resp on sib le  for MT b etw een  ATP phosp hates both in  w ild-type and m utant m ice. A nalysis 
of 31P relaxation  p rop erties iden tifies th ese  effects as transferred NOEs, i.e. underlying  
th is p rocess is an exchange b etw een  free cellu lar ATP and ATP bound to slow ly  rotating  
m acrom olecu les. This exp lains the ß-ATP signal decrease upon saturation of the y-ATP 
resonance.
Although th is usually  is  attributed to ß-ADP o  ß-ATP phosphoryl exchange, w e did not  
d etect an effect o f th is exchange on the ß-ATP signal as expected  for free [ADP], derived  
from  the CK equilibrium  reaction. This ind icates that in  resting  m uscle conditions prevail, 
w hich p reven t saturation of ß-ADP sp ins and puts in to q uestion  the derivation  of free  
[ADP] from  the CK equilibrium .
We p resen t a m odel, m atching the experim ental result, for ADP o A T P  exchange, in 
w hich ADP is only transiently  p resen t in  the cytosol.
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3.1 INTRODUCTION
Phosphoryl exchange reactions are the backbone of energy transduction in living systems (1). 
The possibility to assess the rates of some key phosphoryl exchange reactions in vivo is a unique 
property of magnetization transfer (MT) methods in 31P MR spectroscopy (2-3). These methods 
involve specific magnetic labeling of a phosphate spin system and subsequent observation of 
exchange of its members with other phosphate spin systems. In MT studies performed on 
muscles and brain, y-ATP phosphate has played a central role. This phosphate participates in 
multiple exchange reactions, m ost prominently those catalyzed by creatine kinases (CK) in these 
tissues, but also by adenylate kinases (AK), nucleotide diphosphate kinases (NDKs) and ATPases. 
In skeletal muscle, magnetic labeling by selective saturation of the y-ATP phosphorus signal is 
known to reduce the intensity of the signals of phosphocreatine (PCr) and inorganic phosphate 
(Pi). The decreases result from ATP-producing chemical exchange reactions:
kCK, for k  Pi, for [3 11P C r-.— — yATP—jL-: Pi LJ,1Jlr ICK ,rev k  Pi,rev
Upon saturation of the y-ATP signal, CK activity reduces the PCr signal intensity, whereas the Pi 
signal intensity decays proportional to the activity of mitochondrial FjFrATPase and the 
combination of glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
phosphoglycerate kinase (PGK) (4).
Apart from the reduction of the PCr and Pi signal intensity also the ß-ATP signal intensity 
decreases upon irradiation of the y-ATP spins (3, 5-14). This effect, which has received relatively 
little attention, is usually attributed to contributions from several phosphoryl exchange 
pathways. As y-ATP and ß-ADP spins resonate at nearly the same frequency, the ß-ADP spins are 
easily co-saturated with the y-ATP spins. This may affect the ß-ATP signal according to the 
reverse CK reaction (ATP+Cr ^  ADP+PCr+H+) and even more so if also AK, FjFrATPase and/or 
glycolytic enzymes contribute to the ATP to ADP conversions involving the chemical exchange:
k ADP, for [3 21ß - A T P  . ß - A D P  [3.2]ƒk ADP,rev
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A more detailed investigation of the reduction of the ß-ATP signal has been carried out by Le 
Rumeur et al.(5). They studied the kinetics of ATP to ADP ß-phosphoryl exchange in resting and 
contracting rat skeletal muscle. An interesting conclusion following from their work was that 
deriving the ß-phosphoryl conversion from the reduction of the ß-ATP signal in resting muscle 
highly underestimates the expected value which is obtained from the y-ATP -  PCr exchange in 
the CK reaction. In fact, a more complex picture applies as in addition to chemical exchange, the 
effect on the ß-ATP signal could be caused by cross-relaxation leading to Nuclear Overhauser 
Enhancement (NOE).
In this study we aimed to assess contributions from cross relaxation and from chemical 
exchange to the reduction of the ß-ATP signal. This is of importance, first for a proper 
understanding of this effect, but also because the extent of these contributions critically depends 
on the physical state of ATP and ADP in vivo. And finally, the results also constitute a test for the 
validity of the common practice to calculate free ADP concentrations in skeletal muscle from the 
CK reaction, which assumes that this reaction is at (near-)equilibrium (15-17). To assist in the 
distinction between cross relaxation and chemical exchange we compared MT effects in 31P MR 
spectroscopy of skeletal muscle of mutant mice, which have strongly reduced CK and AK 
activities (18), and of wild type littermates.
By carefully analyzing the 31P relaxation properties of all three phosphates in ATP, we show that 
the reduction of the ß-ATP signal is not caused by phosphoryl exchange reactions, but by so- 
called transferred NOE’s brought about by the interaction of ATP with slowly tumbling cellular 
components. Our experiments also indicate that in resting skeletal muscle conditions prevail in 
which the ß-phosphate resonance, of ADP participating in the ß-phosphoryl exchange, cannot be 
saturated. To account for these experimental results we propose that ADP is bound to solid- 
state-like cellular structures and participates in the ADP o  ATP exchange reaction via ADP, only 
transiently present in the cytosol of cells in muscle at rest.
3.2 MATERIALS AND METHODS
Animal subjects and in vitro samples— In vivo MR experiments were performed on transgenic 
mice lacking cytosolic CK and AK1 activity (MAK=/= , n = 13, 8.5 ± 5.0 months, 29.5 ± 4.0 g) and 
on wild type littermates (WT, n = 10, 10.1 ± 3.0 months, 27.7 ± 3.5 g). The generation of MAK=/= 
mice has been described elsewhere (18). In the mutants, residual activity of CK was 8% and of
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AK ~1-2 % when compared to activities of wildtype controls (18). All experimental procedures 
were approved by the local animal ethics committee. In vitro measurements were performed on 
a solution containing: 7 mM ATP, 10 mM MgCl, 35 mM PCr and 1 mM EDTA in 100 mM Tris-HCl 
buffer, pH = 7.5.
N M R  experiments— 31P MR experiments on murine skeletal muscle were carried out at 7.0 T, in 
a 120 mm horizontal bore, magnet (Magnex Scientific, Abingdon, UK) interfaced to an M.R.S. 
spectrometer (MR Solutions, Surrey, UK) operating at 121.53 MHz for 31P. MR spectra were 
acquired from the hind leg of the mice with a 9 mm diameter solenoid coil (19). A low  power 
continuous wave pulse was applied prior to the acquisition pulse to saturate signals selectively 
for variable durations (t): 0.2, 0.5, 1.0, 1.5, 2.0, 3.0 and 5.0 s. The spectra were acquired using 64 
averages at a repetition time of 7 s. Signal decreases in PCr, Pi, ß-ATP and a-ATP were 
determined upon saturation of the y-ATP/ß-ADP signals. Similarly, signal decreases in y-ATP, ß- 
ATP and a-ATP were observed when positioning the irradiation pulse at the PCr, a-ATP and ß- 
ATP resonances, respectively. For each experiment, control spectra with the irradiation pulse at 
mirror frequencies were acquired in order to correct for RF bleeding.
Data analysis M R  spectra— Signal integrals were fitted in the time domain with AMARES 
(www.mrui.uab.es) using Gaussian line shapes for Pi, PCr, y-ATP, a-ATP, NADPH and ß-ATP at 
4.8, 0, -2.5 -7.5, -8.2 and -16.2 ppm, respectively. The line widths of Pi and NADPH signals were 
constrained to 1.5 and 1.0 times that of PCr. The PCr and Pi signal intensities were scaled to the 
ß-ATP signal and corrected for T1 saturation. Tissue concentrations were calculated assuming 
that ATP levels of both WT and MAK=/= mice in this study were 7.8 ± 0.08 mM (19). Tissue pH 
was obtained from the chemical shift difference between PCr and Pi (20).
Mono-exponential functions were fitted to the time dependent decays obtained in the relaxation 
measurements using a non-linear least square method: the Levenberg-Marquardt algorithm  
(GraphPad Prism, San Diego CA, USA).
3.3 RESULTS
High energy phosphate levels and CK activity— In vivo 31P MR spectra of WT and MAK=/=
skeletal muscle acquired without the application of saturation pulses look very similar (fig. 3.1).
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Analysis of the resonance positions and intensities shows that the pH and the levels of 
phosphate-containing metabolites in MAK=/= mice are virtually equal to those in WT littermates 
except for slightly decreased PCr levels (Table 3.1). Thus, stationary conditions with near­
normal levels of phosphorylation of Cr are achieved in MAK=/= mice, despite the lack of cytosolic 
M-CK. However, the rate at which this steady state is reached is quite different. This point 
becomes clear by the smaller reduction of the PCr signal upon selective saturation of the y-ATP 
spins in the MAK=/= mice. The PCr signal declines as a function of the length of the saturation 
pulse (fig. 3.2) according to:
M a (t) _ M j  = kfor p  + f  )t _ [3.3]
M j  P a + kfor
in which M za0 is the PCr-equilibrium magnetization, MzA(t) is the PCr-magnetization after the 
saturation pulse of duration t, pA is the is the relaxation constant of the PCr spins, A, and kfor is 
the pseudo-first order rate constant in forward direction, PCr/ATP. For a derivation of eq. 
[3.3] see Chapter 2 (eqs. [2.19]-[2.23]).
PCr
MAK=/= WT
5 0 - 5  -10 -15 5 0 -5 -10 -15 5 0 -5 -10 -15 5 0 -5 -10 -15
Figure 3.1: 31P MR spectra of skeletal muscle of MAK=/= and W T  mice recorded in the presence and 
absence of saturation of the y-ATP(/ß-ADP) signals. For both groups the spectra on the left are 
unperturbed; in the spectra on the right hand side the y-ATP resonance at -2.5 ppm is saturated by a pulse of 
5 s duration (grey arrow). The spectrum on the far right (WT mice) shows a large decrease of the PCr signal 
intensity as a result of the saturation of the y-ATP resonance, whereas the second spectrum on the left hand 
side (MAK=/= mice) shows only a very small perturbation as a result of the saturation of the y-ATP signal. 
Both groups show decreases in ß-ATP signal and a small decrease in Pi.
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Table 3.1: Tissue concentrations and pH in hind limb muscle of W T  and MAK=/= mice
[PCr] (mM) [Pi] (mM) pH
W T 23.7 ± 2.3 2.8 ± 0.4 7.27 ± 0.08
MAK=/= 21.0 ± 2.6# 2.6 ± 0.8 7.25 ± 0.04
All values are presented as mean ±SD. Muscle tissue concentrations of Pi and PCr are 
calculated assuming a tissue [ATP] of 7.8 mM and corrected for T1 relaxation effects. 
# Statistical difference determined with a two-tailed student t-test (p<0.05).
It is clear that the absence of cytosolic M-CK activity in the mutants results in strongly reduced 
MT effects on the PCr signal intensity compared to MT effects in WT. The time dependence of the 
WT PCr-signal could be fitted with a mono-exponential function, indicating that a possible 
coupling to the exchanging protons on the neighboring N-H group in PCr is negligible as is tacitly 
assumed in the derivation of eq. [3.3]. The pseudo first-order rate constants (k C f )  of the CK- 
mediated exchange in forward direction (PCr/ATP) obtained in this way reflects the strongly 
decreased exchange in the mutant mice compared to that of the WT littermates (Table 3.2).
saturation time [ms]
Figure 3.2: Reduction of the PCr signal intensity upon selective saturation of the y-ATP resonance in 
W T (m) and MAK=/=(•)  mice as a function of the duration of the saturation pulse. MAK=/= mice show a 
clearly reduced MT effect on the PCr resonance when compared to WT littermates, which implies a lower 
forward rate through the CK reaction. Control spectra with the irradiation pulse at mirror frequency (at 
2.5ppm) were acquired in order to correct for RF bleeding: i.e. the magnetization of PCr upon saturation of 
the y-ATP was corrected for off-resonance effects by subtraction of the magnetization of PCr (Mg).
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M T  effects in  A T P  in  the presence and  absence o f M-CK and  A K  a c tiv ity— In order to 
determine the flux via the CK-mediated reaction from decreases in PCr signal intensity the y-ATP 
resonance is selectively saturated in in vivo 31P ST applications. When we applied this procedure, 
we observed that the PCr-signal also decreased upon saturation of the ß-ATP signal. This 
unanticipated behavior was only found for the WT mice, in the mutants the PCr remained 
unaltered (fig. 3.3). This suggests participation of the CK-mediated reaction in this MT effect in 
the WT mice. However, between ß-ATP and PCr no direct phosphate exchange occurs. Since the 
absence of this effect in MAK=/= eliminates off-resonance saturation as a cause of this effect, the 
reduced PCr signals in WT mice can only be ascribed to a chemically relayed NOE, i.e. cross­
relaxation between ß- and y-ATP spins, followed by CK-mediated exchange.
Table 3.2: Unidirectional pseudo first order rates and fluxes in muscle of W T and MAK=/= m ice
W T MAK=/=
kCK,for 0.43 ± 0.05 0.04 ± 0.01 # [s 1]
P C r/ A T P CrPP 0.41 ± 0.06 [s]
F CK,for 10.2 ± 1.5 0.84 ± 0.24 # [m M 's1]
P i^ A T P kPi,for 0.23± 0.03$ 0.18 ± 0.04 [s 1]
FPi,for 0.64 ± 0.13 0.47 ± 0.18 [m M 's1]
Rates and fluxes were determined from decreases in PCr and P i upon saturation of the y- 
ATP/ß-ADP resonances. # Curve is significantly different from WT (F-test using a 0.95 
confidence interval). * To improve the accuracy of the determination of the small kCKfor in 
the MAK=/= mice the value for T1int was assumed to be equal to the value determined in the 
W T mice and fo r both MAK and W T . $ The mono exponential function fo r P i^A TP was 
fitted according to eq. [3.3] assuming an intrinsic auto relaxation of 1.95 s (19, 21) All 
values are presented as mean ± SD.
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Figure 3.3: The 31P  MR signal of PC r under the influence o f the saturation o f the ß-ATP resonance as 
a function of the duration o f the saturating pulse. Length of the saturation pulse, from left to right: 0.2, 
0.5,1,1.5,2, 3 and 5 sec. PCr signals are shown fo r MAK=/= (left) and WT mice (right). Line broadening 5 Hz.
Indeed, steady state saturation of the ß-ATP signal leads to a signal reduction of 22 ± 5 % , not 
only at the y-ATP resonance, but also at the a-ATP signal intensity (25 %  ± 8 %  for WT). To 
complete the picture we also irradiated the a-ATP and y-ATP resonances, which led to similar 
MT effects on the ß-ATP spin system. W ithin experimental accuracy, all these effects were of 
similar magnitude ranging from 21-26 %  (fig. 3.4). This symmetry is expected if the MT effects 
are caused by dipolar cross relaxation between the phosphorous spins, leading to NOE effects. 
NOE involvement is corroborated by the MT to the ß-ATP signal upon irradiation of the a-ATP 
signal, which rules out the contribution of chemical exchange reactions to these magnetic 
transfer effects. In this respect it is worth mentioning that the decrease in signal intensities upon 
saturation of directly neighboring phosphates are equal in WT and MAK=/= skeletal muscle. 
Hence M-CK and AK1 activity cannot be held responsible for the MT effects between the 
phosphates of ATP. In contrast to the NOE effects that occur between directly neighboring 
phosphorous spins, the magnetization transfer between a- and y-ATP spins (only investigated 
for WT mice) turned out to be very small (y-ATP decreased with 5 ± 4 %  upon a-ATP 
saturation). This can easily be explained by the larger distance (4.5Â) between the two outer 
phosphates.
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Figure 3.4: Saturation transfer effects between 31P  spins w ithin ATP as a function o f the duration of 
the saturation puise. MT effects between a-ß and ß-y are similar for both W T and MAK=/= mice. MT effects 
between a- and y-ATP were small and within the detection limits (see results obtained for W T mice) Signal 
intensities are presented as mean values ± SE. Dotted lines represent fits of mono-exponential curves to the 
experimental data assuming p  to be equal in all mice and for all ATP signals.
Absence o f N O E in A T P  in  v itro — To further investigate the results, we set out to measure NOE 
effects between the phosphates of ATP for a 7 mM ATP solution, but without success. No NOEs 
could be detected. The different behavior of ATP in vivo and in vitro  becomes clear when we 
consider the relaxation properties of the phosphorous spins in ATP in more detail. It has been 
well established that two relaxation mechanisms dominate the relaxation behavior of the 31P 
spins in ATP: the dipole-dipole relaxation and the relaxation induced by the chemical shift 
anisotropy (CSA). For a 31P two-spin system, e.g. the a- and ß-phosphates in ATP, the 
longitudinal relaxation is determined by the auto-relaxation constants pdip and pcsa arising from 
the dipole-dipole and the CSA relaxation, respectively, and by the cross-relaxation constant, a, 
arising from the dipole-dipole interaction. The contributions of these different relaxation 
constants to the relaxation behavior of a two-spin 31P-31P spin system with an inter-spin distance 
of 3Â have been plotted in fig. 3.5A as a function of the rotational correlation time, t . This figure 
shows that the CSA contribution is dominating the relaxation entirely for 3-10-11 < tc < 2-10-8 s.
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Figure 3.5: Spin-iattice relaxation rate constants, steady state NOEs, trNOEs and chemical exchange 
induced M T effects as a function of t c, derived fo r a 31P  two-spin system. A: The different relaxation rate 
constants contributing to the relaxation in a 31P-31P system: pdip and Pcsa are the auto-relaxation rate 
constants due to dipole-dipole interactions (dark grey) and chemical shift anisotropy (CSA, black), a is the 
cross-relaxation rate constant (grey). B: Steady state Overhauser enhancement factor (nss) fo r a 3iP-3iP  
two-spin system (grey) as a function of Tc calculated on the basis of eq. [3.4] and steady state transferred 
NOE as a function of the Tc of the bound fraction (  Tc,bound )  calculated using eq. [3.5] fo r Pb = 10% (---) and Pb 
= 5%  (—). C: Simulated steady state MT effects on ß-ATP due to trNOE and ATP^ADP conversion based on 
eq. [3.7]. trNOE without (---) and with ATP^ADP conversion assuming kADP.rev = 0.01 s-1 (•••), kADP,rev = 0.1 s- 
1(—), kADP,rev =1 s-1 (  —), kADP,rev =1.4 s-1 (—). Note that for kADP,rev = 1.4 s-1 (corresponding with the reverse 
rate of the CK reaction) a reduction of about 65% is expected at the ß-ATP signal. D: Simulated steady state 
MT effect due to transferred NOE fo r varying exchange rates between the free and bound ATP pools: kß/kbf = 
1000 s-1 /9000 s-1 (—), kfb/kbf = 10 s-1 /90s1 (---), kß/kbf = 1s-1 /9 s-1 (•••), where kADP,rev =1.4 s-1. Note that kfb 
and kbf have a minor influence on nss only for Tc,bound > > 10-6. All plots were calculated based on a 31P 
resonance frequency of 121.4 MHz and a distance between the phosphorous nuclei r =3.010-10 m.
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For larger tumbling times, i.e. tc > 2-10-8 s, the dipolar relaxation starts to contribute significantly 
and for Tc > 107 s it becomes the predominant relaxation mechanism. For ATP free in solution, Tc 
= 0.3 ns (22) (indicated by the dashed vertical lines in fig. 3.5). As expected, in this situation the 
CSA relaxation rate constant (pCSA = 0.718 s 1) largely exceeds the auto-relaxation and cross 
relaxation constants due to dipolar interactions, which amount to pdip = 0.006 s 1 and u=  0.003 s-
1 Given the expression for the steady state NOE (for derivation, see Chapter 2, eq. [2.18]),
n  =  M z T -  M j0  u  [3.4]
'I SS , ,  o ,
Pdip + P csa
we expect a negligible steady state NOE effect (nss = +0.004). Only when the dipole-dipole 
mechanism becomes predominant NOEs may be induced. This is shown in fig 3.5B (solid line), 
where the steady state NOE has been plotted as a function of Tc. It is clear that NOE effects are 
negligible for molecules with Tc < 10 ns, which is in agreement with the aforementioned 
experiments on ATP free in solution.
Transferred  N O E in  A T P— Further examination of the solid curve in fig. 3.5B shows that NOE 
effects can only be expected for higher values of the rotational correlation time, e.g. the NOE 
effects observed in vivo for the phosphates in ATP (nss ~ -0.25) occur when Tc = 30 x 109 s. This 
would mean that Tc has increased by a factor of 100, when proceeding from the in vitro to the in 
vivo situation. This seems very unlikely; several experiments indicate that the Tc of cytosolic ATP 
in skeletal muscle does not deviate much from its in vitro value (see Discussion). The effective 
correlation time of ATP may increase however, when the rotational motion of ATP gets 
restricted by binding to larger molecules. In case exchange between the bound and free ATP 
occurs, NOE effects generated in the bound state may be transferred to ATP in the free state, 
designated the transferred NOE (trNOE). For this situation the expression for the steady state 
trNOE is given by (see Chapter 2, paragraph 2.3, eq. [2.39] and (23)):
n (P f+kb + hi K  P U + kb + kv U f P
s {  + hi h i  + hb )-kfikbf b (Pb + h i h i +hb )-kfikbf 1 [3.5]
Here kß is pseudo first-order association rate constant of complex formation, kbf  the 
dissociation rate constant, Pb and Pf the fractions of ATP in the bound and free state,
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respectively, pf and pb the auto relaxation rate constants in the free and bound state and 
similarly af and ab the cross relaxation constants in the free and bound state. Using eq. [3.5], the 
steady state trNOE effect was calculated as a function of Tc of the bound fraction (Tc,bound), for Pb 
equal to 5 and 10% (dashed lines in fig. 3.5B). In the calculation it was assumed that kfb = kass[E] 
in which kass = 1-108 M-1s-1 (23) the association constant and kbf  = 9000 s-1, leading to a 
concentration of free binding sites [E ] = 1.10-5 M. Examination of fig. 3.5B shows that ATP has to 
bind to structures with a Tc,bound = 106 s to be able to account for the observed trNOEs. The result 
is not very sensitive to the choice of kbf, (vide infra and fig. 3.5D).
Com bining tran sfe rred  N O E and  ATP-AD P exchange— Above, we have shown that the MT 
effects between ATP phosphate signals arise from cross relaxation, which is responsible for the 
observed NOEs. However, it seems odd that the decrease of the ß-ATP signal during selective 
saturation of the y-ATP/ß-ADP resonance is not influenced by ATP producing chemical exchange 
reactions. To investigate this aspect we considered the following reaction:
kbf kADP, for ro n
ATPbound f^ATPjree k =  A D P  [3.6]
k fb kADP ,rev
The left-hand part of this expression represents the exchange between bound and free ATP and 
the right-hand part the transition between ß-ATP and ß-ADP mediated by CK, AK, ATPases 
and/or GAPDH/PGK activities. We focus on the behavior of the ß-ATP resonance when the y-ATP 
and ß-ADP resonance are saturated. The steady state MT effect for this reaction scheme is 
presented in eq. [3.7] (for the derivation, see section 2.4). The first two terms on the r.h.s. give 
rise to the trNOE, discussed in the previous section; the last term on the r.h.s. represents the 
effect of the additional exchange on the ß-ATP resonance.
n = (kbf + pf + kADP,rev + kfb )Ub P  +_________ (kfb +Pb + kbf K f_________ P
(-pb - kbf )(-pf - kADP,rev - kfb ) - kfbkbf (-pb - kbf )(-pf - kADP,rev - kfb ) - kfbkbf f
(- p b - kbf - kfb )kADP,rev
(- P b - kbf ) (- P f  - kADP,rev - kfb ) - kfbkbf Pf [3.7]
The pseudo first order rate constant of the reverse CK reaction, was determined in WT mice by 
saturating the PCr spins: kCK,rev = 1-4 s-1, It dominates over the contribution of the
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ATPase/glycolysis in the ATP^ADP reaction in resting skeletal muscle (~  0.08 s-1) and the AK 
reaction, which is known to be only 15% of the total ATP turnover in WT skeletal muscle at rest 
(18). Using eq. [3.7], we calculated the MT effect expected on the ß-ATP resonance for kADP.rev 
ranging from 0.01 to 1.4 s-1 (fig. 3.5C). For the maximum value (1.4 s-1), corresponding with the 
CK mediated exchange, the ß-ATP signal shows a reduction of 65 %. Thus far, such a large MT 
effect on the ß-ATP signal has not been detected in vivo.
To assess the effect of different conversion rates between free and bound ATP on the ß-ATP 
signal, we calculated this MT effect, including ADP-ATP exchange, with kADP.rev = 1.4 s-1 for 
different values of the conversion rate concstants kfb and kbf (fig. 3.5D). This reveals that the 
influence of these rates is negligible.
3.4 DISCUSSION
The participation of ATP in phosphoryl exchange reactions can be analyzed by magnetization 
transfer (MT) experiments in 31P MR spectroscopy. However, MT may also occur by cross 
relaxation between spins leading to signal attenuation called NOE. The nature and extent of 
NOEs can provide interesting information on the biophysical state of molecules in cells. The MT 
effect on the ß-ATP resonance after saturating the co-resonating y-ATP and ß-ADP signals is of 
particular interest as it may arise both from cross relaxation and from chemical exchange, which 
in muscles is dominated by cytosolic muscle creatine kinase (CK) and adenylate kinase (AK) 
reactions. To resolve this ambiguity we performed MT experiments on skeletal muscles of wild 
type mice and of mice, lacking CK and AK activity. The results indicate that in resting muscles a 
small fraction of ATP is bound to large macromolecules, and that the magnetization effect on the 
ß-ATP resonance mentioned above is caused by cross relaxation.
Cross re lax atio n  betw een the phosphorous sp ins in  A T P— MT experiments carried out on 
solutions of ATP do not demonstrate the presence of 3ip-3ip NOEs (see Results and (5, 24)). 
Here, however, we present several experiments that show that Overhauser effects between the 
phosphorous spins of ATP do occur in vivo. A case in point is the experiment in which saturation 
of the ß-ATP signal leads to decreases in the PCr signal in WT mice. Since the ß-ATP phosphate is 
not converted into the phosphate group of PCr by any reaction, this decrease can only be 
attributed to a relayed Overhauser effect (25), i.e. magnetization is transferred by cross
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relaxation from ß-ATP to y-ATP and subsequently to the PCr signal through the CK reaction. In 
MAK=/= mice the flux through the CK reaction is lowered so much that the last step becomes 
ineffective, explaining why the effect is no longer observed (fig. 3.3). 
By the same token, saturation of the a-ATP resonance leads to a reduction of the ß-ATP 
resonance intensity. Again, since no direct or relayed reactions are known in which a a- 
phosphate is promoted to a ß-phosphate in ATP, the reduction in signal intensity has to be 
attributed to an NOE effect.
Saturation of the ß-ATP resonance not only leads to an effect on the PCr signal, but also reduces 
the intensity of the a- and the y-ATP resonances. And it does so in a symmetric way, i.e. the 
signal reductions are about the same as that of the ß-ATP resonance if either the a-ATP or the y- 
ATP resonances are saturated. This is expected when dipole-dipole relaxation is governing the 
MT. These physical considerations are corroborated by the results obtained for the double­
mutant MAK=/= mice. The mutants, which are M-CK deficient, exhibited only a minor flux through 
the CK reaction in both directions. As the AK activity in MAK=/= mice is only about 1% compared 
to WT mice (18), we assumed negligible fluxes through the AK reaction as well. In this light, the 
equal reductions of the ß-ATP signal in WT and MAK=/= mice lead us to the conclusion that M-CK 
and AK1 activity contribute insignificantly to the observed MT effect. Furthermore, it is 
remarkable that not only all steady state MT effects between nearest neighbor phosphates are 
about the same in WT and MAK=/= mice, also the time constants of the signal decays are equal.
T ransferred  N O Es— Although the preceding section implies that NOE effects explain the MT 
between ATP phosphates seen in vivo, we have to discuss the observation that no NOEs are seen 
for solutions of ATP. Overhauser effects are only observed, when the dipole-dipole relaxation 
mechanism dominates the spin-lattice relaxation. It is, however, well established that 31P spins 
are also subjected to relaxation induced by the chemical shift anisotropy (26-27). We calculated 
the auto relaxation constants pdip and pCSA, and the cross-relaxation constant, u, for a 31P two-spin 
system as a function of Tc and demonstrated, given that Tc ~ 3-10-10 s for ATP in solution, the CSA 
contribution dominates the relaxation process (fig. 3.5A). Consequently, the NOE effect in ATP in 
solution is negligible (fig. 3.5B). It is generally assumed that the rotational correlation time of 
cytosolic ATP is not too different from that of ATP in solution. This is reasonable because the 
translational diffusion of cytosolic ATP is only reduced by a factor of 2 to 3 (28-30) and the Tc of 
small proteins in intact oocytes diminishes by the same amount compared to that in aqueous 
solutions (31). This means that the observed NOEs can only be interpreted as being transferred
97
3  31P saturation transfer experiments involving ATP
NOEs. When the rotational motion of ATP becomes restricted by binding to larger molecules this 
is feasible. Given there exists a dynamic equilibrium between the free and a “bound” form of 
ATP, NOEs created in the bound form may be transferred to the free form, where they become 
NMR visible as trNOE effects.
To estimate the magnitude of these effects we calculated trNOEs assuming that 5% or 10% of 
the intra-cellular ATP occurs in the bound form. Although an enormous variety of proteins are 
known to form complexes with ATP (32), the calculations show that we can rule out already a 
large class of proteins: the Tc of the ATP-complexes must be around 106 s to obtain a trNOE of 
about 20% for the ß-ATP signal when the y-ATP resonance is saturated (fig. 3.5B). This sets a 
limitation to the size of molecular structures involved. Smaller enzymes like CK (81 kD dimeric 
isoform with a Tc of 7.4 ns (22)), and/or AK (25 kD monomeric isoform 1) can thus be 
disregarded as candidates. In fact, this is confirmed by the similar NOEs observed for the MAK=/= 
and WT littermates.
Not only does the size of a receptor molecule determine the magnitude of the trNOE. The 
rotational motion of a small ATP-binding protein can also be greatly restricted when it is 
embedded in a membrane. This was for instance demonstrated for adenosine nucleotide 
translocases (ANT, ~30 kD), which, when embedded in the inner mitochondrial membrane, 
obtain a Tc = 106 s (33). The binding of ATP to macromolecules does not necessarily need to be 
functional in energy metabolism. The adenosine moiety and phosphate group make ATP a 
suitable candidate for stacking and electrostatic interactions with other compounds (32).
Absence o f exchange-m ediated M T  effects on the ß-ATP s ig n a l— The conclusion that the 
reduction of the ß-ATP signal upon saturation of the y-ATP signal is a trNOE effect raises the 
question: Why do chemical ß-ATP^ß-ADP conversions not or only negligibly contribute to this 
effect? To investigate this, we derived an expression for the steady state reduction of the ß-ATP 
signal (eq. [3.7]) for the situation that both trNOE and ADP-ATP exchange are present. For 
simplicity, we only incorporated the MT effect arising from the reverse CK reaction (i.e. kADP.rev = 
1.4 s 1, see Table 2)). This leads to an expected reduction of 65% of the ß-ATP signal, which is at 
odds with our experimental results and those in the literature, where reductions of 20-30% have 
been observed. It is noted in passing that a similar observation has been made previously by Le 
Rumeur et al. (5) in their study of rat skeletal muscle. Accounting for additional phosphorylation 
reactions (i.e. AK, glycolytic activity, ATPases and nucleotide di- or mono-phosphate kinases) 
would have lowered the expected ß-ATP resonance intensity even more.
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The calculation of the exchange-mediated reduction of the ß-ATP signal is based on the practice, 
which uses the creatine kinase equilibrium to derive the free cytosolic ADP concentration. The 
fact that in vivo no MT effects > 0.65 have been seen on the ß-ATP resonance, casts serious 
doubts on this approach.
However, relatively large MT effects can be observed in in vitro experiments, as reported by 
Koretsky et al. (24). They showed that, for solutions containing CK, PCr, Cr, ADP, ATP and free 
Mg2+ mimicking the in vivo concentrations presumed for the near-equilibrium CK-reacion, 
saturation of the y-ATP/ß-ADP indeed resulted in a significant reduction of the ß-ATP resonance 
intensity. The effect could not be attributed to an NOE effect, which accords with our analysis: 
NOEs cannot be expected at in vitro conditions. Thus, in this situation the reduction of the ß-ATP 
signal is caused by the ATP to ADP conversion.
So how can the apparently conflicting in vivo and in vitro  results, of which the latter are in 
accordance with our predictions in fig. 3.5C, be reconciled? The following possibilities come to 
mind:
1. The ß-ADP signal is not properly saturated.
2. The ß-ADP is properly saturated, but the effect of the ß-phosphoryl exchange is 
outcompeted by spin-lattice relaxation due to ATP binding to various proteins or 
receptors.
3. The ADP taking part in the CK reaction is in a state in which its ß-resonance cannot be 
saturated.
With respect to the first point we notice that the co-saturation of the ß-ADP resonance (« 0.4 
ppm upfield from y-ATP) may not be optimal. However, control experiments in which we 
observed an unchanged signal reduction of the ß-ATP in human muscle at 3T, when the carrier 
frequency of the saturation pulse was varied from +0.1 to -0.8 ppm (steps 0.05-0.1 ppm) and the 
observations of Koretsky et al. (24), renders this option very unlikely.
In situation 2) ß-ADP is saturated but due to its low concentration with respect to ATP the effect 
of ß-phosphoryl exchange is less effective than that of exchange between y-ATP and PCr. 
Basically, this need not form an impediment for the observation of the ß-phosphoryl exchange as 
was shown in the experiment of Koretsky et al. (24). However, in vivo, ATP is involved in many 
reactions in which it binds to proteins and one could imagine that the effect of the ß-phosphoryl 
exchange on the ß-ATP resonance is undone by a much more effective T1-relaxation than in the
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in vitro situation. Careful examination of fig. 3.5A shows that this is not to be expected. At in- 
vitro-like conditions (tc « 0.3 ns), the Ti relaxation through the chemical shift anisotropy is very 
effective and still the MT effect of ß-phosphoryl exchange is observed (24). For higher values of 
the rotational correlation times, corresponding with ATP binding to medium-sized proteins, Ti 
becomes even longer. For complex formation, leading to much longer rotational correlation 
times (e.g. 10-6 s), Tl becomes shorter, but not dramatically (T1 « 0.5 s). In Eq. [3.7], which 
describes the decrease of the ß-ATP resonance as a result of ß-phosphoryl exchange and the 
binding of ATP to slowly tumbling receptors at the presumed CK equilibrium, these effects are 
incorporated and it leads to the reduction of the ß-ATP signal indicated in fig. 3.5C. In summary, 
at the conditions prevailing in our experiments, this relaxation effect does not nullify the MT 
effect of the ß-phophoryl exchange.
In situations 1 and 2 the assumption that the cytosolic ADP concentration can be derived from 
the CK equilibrium still holds. This is no longer true for the third situation. Below we consider 
situation 3 in which ADP is involved in the CK reaction, while its ß-resonance cannot be 
saturated.
A m odel fo r  A D P 4+A T P  conversion— We propose a model in which the CK reaction proceeds 
via transiently free ADP, which is drawn from a pool of bound ADP of which the spin population 
cannot be saturated (fig. 3.6). This situation can be represented by the following two equations:
kst
ADPbou„d~ADPrn
kts [3.8]
k ADP _  CK, for
and A D P r a n s  + CKk „  ' ATP+CK
Here ADPbound is the bound, non-saturable ADP and ADPtrans is the ADP transiently present in the 
cytosol. For this situation the overall rate constants for the conversion of ADPbound to ATP (kex) 
and its reverse (kex,rev) are:
k„ == kstkADP _ CK, for [CK ]
“  K  + kADP _ CKJor [CK ] [3.9]
, kts kADP CK,rev \ÇK\kx „„„ = - ~
and k,s + kADP CK,or [CK]
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In this model, the steady state situation is maintained and an equilibrated free concentration of 
ADP, commonly derived from the CK equilibrium, need not be invoked.
We consider the lim it that kts >> kADP_cK,for[CK]. In this case, the overall rate constants reduce to:
kex -  ^  CK, for M  [3.10]
k s _
and k ex,rev =  k ADP CK,rev \C K - ]
Characteristic of this lim it is that ADP exchanges many times between the free and the bound 
state before it gets caught in the CK reaction. In other words, the overall forward reaction (kex) 
proceeds via a pre-equilibrium, which lies far to the left In the reverse direction, the reaction 
from ATP to ADPtrans, kADP_cK,rev and the CK concentration determine the overall rate constant. 
Thus, in both directions the overall rate constants are linearly dependent on [CK]. This concurs 
with the observation that the pseudo first order rate constants ( k c f  and kcK,rev) that can be 
derived from fig. 3.2 for the mutant and WT mice indicate that they are proportional to CK 
activity reflecting its concentration. A linear relation between k c f  and CK activity (Vmax) has 
been noticed previously with different expression levels of the M-CK isoform (34).
It is inherent in the present approach that saturation of the spin population of bound ADP is not 
possible. This condition applies if the ADP resonance is inhomogeneously broadened, which 
occurs for example, when ADP is bound to a solid-state-like lattice. Due to the anisotropy of the 
chemical shift, the resonances are then spread over a region of about 180 ppm and only a 
negligible part of the bound spin population will be saturated. Relatively rigid cellular structures 
with ADP binding capacity, e.g. components of the cell cytoskeleton, for instance myofibrils and 
actin filaments are possible candidates for this type of binding (35), but also mitochondria have 
been suggested for this role.
Conclusions— Central to the discussion in this paper has been the small reduction (~20% ) of 
the ß-ATP signal upon saturation of the y-ATP signal. Understanding this effect requires that a 
distinction is being made between chemical exchange and cross relaxation and that the 
relaxation properties of the phosphorous spins are properly accounted for. The results obtained 
show that the reduction of the ß-ATP signal is caused by transferred NOE effects made possible 
by exchange of ATP in the free cytosolic form and in a bound state in which the rotational 
freedom of ATP is
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restricted. The reduction of the ß-ATP signal is not or only negligibly caused by ß-phosphoryl 
exchange. Consequently, ADP participating in the CK reaction comes from a source where its 
spin system cannot be saturated. To account for these results we propose a model in which free 
cytosolic ADP is only present in transient form in skeletal muscle at rest. This is much less than 
the free cellular [ADP] derived from the CK equilibrium, which is already too low for in vivo 
detection by 31P-MRS.
It remains to be investigated whether in circumstances of high intensity exercise in muscle, the 
free ADP concentration may increase to such an extent that its binding sites on the solid-state­
like structures become saturated and the free ADP pool might become accessible to NMR 
saturation To our knowledge NMR visible in vivo signals of free ADP have only been observed in 
AKi-deficient muscle during isometric tetanic contractions (36).
The reduction of the ß-ATP signal upon saturation of the y-ATP resonance has been reported in 
numerous papers. For instance, in an early study on perfused heart (14). Later, similar effects 
have been reported for perfused hearts repeatedly by others (7, 12-13), as well as for skeletal 
muscle (5, 10-11), for kidney (7), for T47D human breast cells (9), for Chlamydomonas 
reinhardii (37) and for rat and human brain (6, 8). Taken collectively, these findings imply that 
the observed magnetization transfer between y-ATP and ß-ATP is not tissue specific. This MT 
effect was frequently attributed to ATP^ADP exchange mediated by CK, AK and/or ATPases. In 
view of the present results it is more likely due to NOE effects. Interestingly, the similarity of the 
effect suggests a common mechanism, i.e. type of ATP binding.
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Figure 3.6: Scheme o f the phosphoryl exchange reactions in which cytosolic ATP is involved, including 
the role of bound ATP and ADP. The NOEs generated in the bound ATP are transferred to the free ATP through 
the exchange reaction characterized by kst and kts. The ATP^ADP conversion proceeds via transiently free ADP. 
The rate constant kex,rev does not represent a separate path but is a combination of the rate constants in the 
individual reaction steps (see eq. [3.9]). The scheme presented explains the experimental observations.
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Creatine in its phosphorylated form plays an im portant role as a high energy phosphate 
reserve in tissues w ith a high and fluctuating energy demand. Recently, a knockout mouse 
model for i-Arginine:glycine amidino transferase deficiency (AGAT-/-) has been generated 
as a model for human creatine deficiency. AGAT catalyzes the first and rate-lim iting step 
in the biosynthesis of creatine. In the present study, we investigated pathophysiological 
consequences of AGAT deficiency.
Deletion of the AGAT gene resulted in undetectable AGAT expression levels and caused 
changes in serum and urine metabolite levels, reflecting a total body Cr deficiency. 
Compared to w ild type controls, AGAT-/- mice on a norm al creatine-free diet had a 32 %  
reduction in body weight, and a 2 9 %  decrease in fractional fat mass, due to a reduced 
amount of white adipose tissue. Additionally, triglyceride levels and de novo lipogenisis in 
the liver were significantly reduced in AGAT deficient mice when compared to wildtype 
litterm ates. The effects on body weight and composition could not be explained by 
increased locomotor activity or im paired food intake. Interestingly, AGAT-/- mice on a 
normal creatine- free diet showed an enhancement in glucose clearance, when compared 
to w ild type controls. Even a high fat diet did not affect the lower fat content nor the 
enhanced glucose clearance in the knockout mice. In contrast, creatine adm inistration 
resulted in normalized creatine levels and a gain in weight. Additional normalizations 
were observed in the adiposity and glucose clearance upon creatine intake.
W e conclude that creatine has an essential role in the homeostasis of whole body 
carbohydrate and lipid metabolism. The creatine deficient condition and its effects on 
energy metabolism were reversible by oral intake.
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4.1 INTRODUCTION
In cells and tissues with high and rapidly changing energy demand, such as skeletal muscle, 
heart, brain, retina, uterus, placenta and spermatozoa, the phosphocreatine (PCr) - creatine 
kinase (CK) system facilitates the maintenance of energy homeostasis (1). The importance of 
this phosphotransfer system is reflected in the presence of high concentrations of various 
isoforms of CK and their substrates creatine (Cr) and PCr. Several studies in mouse models with 
CK isoform deletions have been undertaken to elucidate the role of CK in this system (e,g, see (2­
14). These studies have uncovered various distinct features of CK involvement in energy- 
requiring processes, for instance in muscle to enable the rapid (burst) phase of contraction.
Since Cr degrades non-enzymatically by 1-2 %  per day, there is a need to replenish Cr levels. 
This is accomplished by dietary intake and de novo Cr synthesis. The biosynthesis of Cr is a two- 
step process, which mainly takes place in the kidneys, pancreas and the liver (fig. 4.1). L- 
Arginine-glycine amidinotransferase (AGAT, EC 2.1.4.1) catalyzes the first and rate-limiting step 
in the biosynthesis of Cr; i.e. the transfer of an amidino group from arginine to glycine 
generating ornithine and guanidinoacetic acid (15). The latter is further converted into Cr 
mediated by guanidinoacetate methyl transferase (GAMT, EC 2.1.1.2) (1, 16).
In general, CK isoform deletions did not result in immediate gross health problems for the 
knockout animals, apparently because of compensatory metabolic networks. Only rarely a 
patient with CK deficiency is discovered with relatively mild symptoms (17). This is different 
from deficiencies in Cr, another element of the PCr-CK system. The essential need for an intact 
biosynthesis of Cr has been demonstrated over the last decade by the severe symptoms of 
patients with inborn errors in the genes encoding for AGAT and GAMT (18-20). If not treated, 
these genetic disorders result in a systemic depletion or absence of Cr. Especially in brain, Cr 
deficiency is thought to have a major health impact, as it is associated with developmental delay, 
mental retardation and a prominent disturbance of cognitive and expressive speech (for review 
see (21) and (22)).
One way to investigate the biological functions of Cr, is to study animal models in which de novo 
synthesis of Cr is disturbed, which can lead to Cr depletion or total deficiency. Moreover, such
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models allow for detailed studies of the pathophysiology of Cr deficiencies and their treatment, 
which is difficult in humans as the various diseases are rare. For these reasons, GAMT-deficient
kidney + pancreas
S-Adenosyl methionine 
S-Adenosyl homocysteine
liver
uptake in Cr 
dependent tissues
e.g muscle, brain
Non-
enzymatic
kidneys
urine
Figure 4.1: Biosynthesis of creatine. De novo synthesis of creatine mainly takes place in the kidneys, 
pancreas and liver. The first step of the biosynthesis of Cr is rate limiting and is catalyzed by arginine:glycine 
amidinotransferase (AGAT). The second step is catalyzed by guanidinoacetate methyltransferase (GAMT). 
The produced Cr is transported by Cr transporters (CRT) towards tissues that have a high energy demand, 
such as muscle or brain, where it is phosphorylated in the creatine kinase (CK) reaction, which plays an 
important role in maintaining ATP levels. ~1.5 %  of all Cr is non-enzymatic converted into creatinine (Crn), 
which is secreted by the kidneys.
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knockout mice (GAMT-/) were generated by Schmidt et al. in 2003 (23). Systemic and tissue- 
specific metabolite profiling of these mice showed that on a Cr-free diet, GAMTV- mice indeed 
become Cr deficient. However, they also demonstrated accumulation of guanidinoacetic acid 
(15, 23-25). The ability to use phosphorylated GAA as a substrate for the CK system and its 
supposed neurotoxic effect made GAMTV- mice a proper model to study the effect of GAA 
accumulation and its metabolic potentials (26). On the other hand, the interference of GAA made 
them a less sufficient model to study the biological consequences of pure Cr deficiency.
To elucidate the physiological functions of Cr in vivo, a new murine knockout model for AGATV- 
has been generated recently by targeted disruption of the murine AGAT gene in embryonic stem 
cells (27). The AGAT gene in these mice was inactivated at amino acid tryptophan 149 leading to 
a stop codon 3’ downstream of exon 3. With a non-sense mutation in the gene encoding for 
AGAT, this mouse model for AGAT deficiency (AGATV) could provide new opportunities to study 
consequences of Cr deficiency without accumulation of GAA.
The aim of this study was to characterize the general phenotypic and whole body metabolic 
consequences of AGAT deficiency in this murine knockout model. The results of this study show 
that AGATV- causes significantly reduced Cr, GAA and creatinine (Crn) in plasma and urine, 
which could be normalized by oral Cr supplementation. The Cr deficiency in the AGATV- mice 
was associated with a severe reduction in body weight, enhanced insulin-stimulated glucose 
clearance and a decreased adiposity. Apparently, in the AGATV- knockout mice, Cr deficiency 
leads to major consequences or adaptations in energy metabolism.
4.2 MATERIALS AND METHODS
G enotyp ing— Genomic DNA isolated from mouse ear biopsies or mouse-tail was used for 
routine genotyping of the offspring. This was performed by a multiplex polymerase chain 
reaction (PCR) analyses using internal primers located external to exon 3 and internal to the 
introduced neo cassette described by (27). The wild type band should be at 523bp and the 
knockout band was to be found at 468bp.
A G AT expression— To demonstrate the creation of an AGAT null allele, we performed western 
blot experiments with kidney preparations obtained from AGATV- and control animals.
1111
4  Creatine deficiency in AGAT-/- mice
Kidney extracts were prepared as described previously by (23). Briefly, kidney tissue was 
homogenized in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.5 %  Triton X-100) 
supplemented with proteinase inhibitor cocktail (Sigma, Taufkirchen, Germany) at 4 °C and 
incubated on ice for 15 min. Subsequently, after centrifuging (10 000 g), the protein content of 
the supernatant was determined using the Bradford method. The cell extracts were separated by
12,5 %  SDS polyacrylamide gel electrophoresis and transferred by electroblotting to 
nitrocellulose membranes (Protran, Schleicher and Schüoll, Germany). The blot was blocked 
with phosphate buffered saline (PBS) containing 5 %  milk powder and incubated with rabbit 
anti-mAGAT antibodies (1:1000 in blocking solution). After two times washing in PBS containing
0.05 %  Tween 20, the blot was then incubated with horseradish peroxidase-conjugated anti­
rabbit IgG (1 : 10000 in blocking solution; Dianova, Hamburg, Germany) and washed as before. 
Finally, signals were visualized using the enhanced chemi-iluminescence (ECL) technique and 
BioMax MR X-ray films (Amersham, Freiburg, Germany).
A n im a l sub jects— Mice that were heterozygous for AGAT were used for breeding, since 
knockout mice were infertile. After genotyping, knockout and control mice were housed 
separately to impede intake of Cr from excrements of littermates. The mice were housed in 
standard mouse cages under conventional laboratory conditions (12/12h dark-light cycle, 
constant temperature (20 ± 2°C), constant humidity, and food and water ad libitum ). The food 
was put at the bottom of the cage to prevent reduced food intake in weaker animals to interfere 
in our results. The food did only contain vegetable ingredients and was free of Cr (rodent 
maintenance chow R/M; ssniff, Soest, Germany). This was regularly checked. All experimental 
procedures were in accordance with the German Laws for the Protection of Experimental 
Animals and complied with the regulations of the National Institutes of Health. In addition, all 
experiments were approved by the respective local animal ethics committees.
C reatine supp lem entation— In order to see whether the phenotype of the AGATV- animals 
could be normalized with oral Cr supplementation, knockout mice on a normal diet (ND) were 
compared with knockouts on a diet that was enriched with 0.5 %  of Cr (CRD, 5 g Cr per kg 
chow).
H igh  f a t  d ie t— In order to investigate lipid and glucose homeostasis, AGATV- and control mice 
(age 10-12 weeks) were fed with a high fat diet (HFD, 60% fat content, Ssniff, Soest, Germany) 
for 12 weeks.
112 I
Creatine deficiency in AGAT-/- mice 4
P lasm a  and  u rin e  m etabo lite  an a lys is—Venous blood samples were collected from 12-20 
week old AGATV- and wild type littermates. Blood was centrifuged at 2000 g and concentrations 
of the guanidino compounds in plasma and 24h urine were determined using a Biotronic LC 
5001 amino acid analyzer (Biotronik, MAintal, Germany) adapted for guanidino compound 
determination. The guanidino compound concentrations were separated via a cation exchange 
column using sodium citrate buffers and were detected with the fluorescence ninhydrin method, 
which is described in detail elsewhere (23, 28). Using this method, we quantified the following 
guanidino compounds: a-keto-ô-guanidino valeric acid (a-Kd-GVA), guanidinosuccinic acid 
(GSA), creatine (Cr), guanidino acetic acid (Gua), a -N-acetylarginine (a-N-AA), argininic acid 
(ArgA), ß-guanidino proprionic acid (ß-GPA), creatinine (Crn), y-guanidinobutyric acid (y-GBA), 
arginine (Arg), homoarginine (HArg), guaninidine (G) and methylguanidine (MG).
Bo d y com position— 1 year old knockout and wild type mice were euthanized and the carcasses 
were weighed and oven-dried at 60 °C for at least 2 weeks until the weight did no longer 
decrease. Total body water was calculated as the difference between the weights before and 
after drying. The carcass was then extracted with chloroform using a Soxhlet apparatus. The 
extracted carcass was dried and weighed to calculate fat mass and lean mass.
F a t  d is trib u tio n — Adult knockout and control mice were euthanized and the following fat 
tissues were collected and weighed: brown adipose tissue (BAT) and intestinal, subcutaneous 
and gonadal white adipose tissues (WAT). The weight of the different adipose tissues were 
expressed as a percentage of the total body weight.
H orm one leve ls— Blood samples were collected in EDTA tubes after retro-orbital puncture. 
Plasma levels of leptin and adiponectin were measured by ELISA assays (leptin: Crystal 
Chemistry, Downers Grove USA; adiponectin: BioCat, Heidelberg, Germany). Plasma insulin 
levels were determined from <100uL blood samples before and during an IPGT-test (see below) 
and measured by an ELISA assay (Millipore, St. Charles, USA).
Locom otor a c tiv ity— The locomotor activity was measured by a technique modified from 
Crawley and Goodwin (29). Animals were individually housed in a transparent mouse cage. 
Locomotor activity was monitored over at least 48 hrs with infra-red motion detectors with a 
sampling frequency of 1Hz and a bin size of 4 min (INFRA-E-MOTION GmbH, Hamburg, 
Germany). Activity levels detected during 12 hr day light and 12 hr dark phases, were expressed
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in percentages (the average infrared beam crossings per min/the number of samples per min * 
100).
Food in take— Food intake was determined in metabolic cages that allow free access to tap 
water and food after animals reached a steady state (2-3 days).
IP  g lucose to lerance  test— The mice were fasted for 16-18 hrs before the fasting glucose levels 
were taken from the tail vein. Glucose concentrations were determined before and 30, 60, 90 
and 120 minutes after the i.p. injection of glucose (1.5 or 2 g/kg of body weight). Glucose 
concentrations during the i.p. glucose tolerance test (IPGT-test) were determined with a 
glucometer (Glucosensor, Roche, Netherlands). Areas under the curve (AUC) over the 120 
minute post-injection period were compared between groups of different genotypes on various 
diets.
H ep atic  trig lyce rid es  (H T G ) and  de novo lipogenesis (D N L )— HTG content and its fractional 
synthesis by de novo lipogenesis (DNL) using 2H2O as a tracer, were determined by XH/2H NMR 
spectroscopy of liver extracts (31). Mice received an intraperitoneal injection with 99.9% 2H2O 
(Sigma-Aldrich, St Louis, MO, USA). Subsequently, the mice were kept 18 hrs (including 
overnight) on ad libitum  access to ND chow. As we aimed for 3% enrichment of body water, the 
drinking water was enriched with 3%  2H2O to maintain constant body water enrichment until 
decapitation and collection of liver tissue. Lipids from freeze-clamped livers were separated by a 
Folch extraction (32). A detailed description of this method has been reported previously (33). 
The lipid-containing extract was dissolved in chloroform. Pyrazine for 1.1% uniformly 2H 
enriched, was added as an internal standard for the NMR analysis.
XH and 2H NMR spectra were acquired on a 11.7T NMR system (Bruker Instruments, Billerica, 
MA). Proton-decoupled 2H-NMR spectra were recorded using a WALTZ-16 pulse sequence. 2H 
enrichment of the body water was determined by proton decoupled 2H spectra (TR = 10 s, 32 
ave), at 25 °C without field frequency lock. 2H enrichment of the HTG methyl hydrogens was 
determined using TR = 4s and 2K averages. All spectra were processed with MestreNova 
(MestreLab research, Spain). Total HTG and DNL fraction were quantified against the 1.1% 
enriched 2H4 Pyrazine mixture as internal reference. The enrichment of HTG methyl hydrogens 
from 2H2-enriched body water provides a measure of the contribution of DNL to the total HTG 
pool (33):
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Fraction DNL (in %) = [2 H HTG] :100 [4.1]
S ta tis tic a l an a lys is— Data are given as mean ± SD, if not stated otherwise. The following 
statistical tests were applied: two-tailed t-test for comparisons between the WT and AGATV- 
mice, two-way ANOVA for multi-parametric measurements with Bonferroni’s post test 
(GraphPad Prism, version 4, La Jolla, USA). Statistical significance was considered for P < 0.05.
4.3 RESULTS
A G AT expression— In order to investigate the creation of a true AGAT deficient mouse knockout 
model, we performed western blots for AGAT enzymes on kidney extracts of AGAT/- and control 
mice. The lysates, probed with polyclonal anti-AGAT antiserum, showed that AGAT-specific 
immunoreactivity was completely absent (fig. 4.2).
Figure 4.2: Absence o f AGAT expression in kidneys. A western blot with kidney lysates was probed with 
affinity-purified polyclonal anti-AGAT antibodies. Note the loss of AGAT-immunoreactivity at the 46 kDa 
band in western blot. The signals with higher molecular weight represent unspecific bands present in all 
samples.
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Figure 4.3: Guanidino compounds in plasm a and 24h urine. Concentrations of guanidino compounds 
were determined in plasma and urine of wildtype (W T  ND) and knockout mice (AGAT ND) on a normal diet, 
and on knockout mice that had been on a 0.5 %  Cr enriched diet for 12 weeks (AGAT CRD). Levels were 
determined by the fluorescence ninhydrin method and expressed in mean ± SD. Note the logarithmic scale of 
the y-axis. Concentrations of ß-GPA in plasma were all below the detection threshold and therefore not 
shown. Concentrations of Crn and HArg levels in AGAT/'-plasma represent the detection limit, and are 
therefore presented without error bar. Significance levels when compared to WT mice on ND: ** P  < 0.01, *** 
P < 0.001, Significance levels when compared to AGAT-/- mice on ND: # P  < 0.05, ### P < 0.001 (One-way 
ANOVA with Bonferroni post test).
Abbreviations: a-keto-5-guanidino valeric acid (a-Kd-GVA), guanidinosuccinic acid (GSA), creatine (Cr), guanidino acetic 
acid(Gua), a -N-acetylarginine (a-N-AA), argininic acid (ArgA), ß-guanidino proprionic acid (ß-GPA), creatinine (Crn), y- 
guanidinobutyric acid (y-GBA), arginine(Arg), homoarginine (HArg), guaninidine (G) and methylguanidine (MG).
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Reduced Cr leve ls— AGAT deficient mice on a Cr-free diet (normal diet: ND) demonstrated 
significantly lower levels of the guanidino compounds Cr, GAA —the direct precursor of Cr— 
and creatinine (Crn) —the breakdown product of Cr— in both blood and 24hr-urine when 
compared to normal WT levels (fig. 4.3, NB: note the logarithmic scale on the y-axis). In plasma, 
Cr levels in AGATV- on a ND (3.7 ± 48.4 |j.M) were only 3% of that of WT littermates (114.9 ± 48.4
H.M, P < 0.01). Also HArg levels were also significantly reduced below the detection level in those 
mice. Levels of arginine (Arg) and glycine (G), the direct precursors of Cr, were not different 
between control and knockout mice in both body fluids.
Upon 12 weeks of oral Cr intake, Cr levels in both fluids normalized to wild type levels. Also the 
breakdown product of Cr, i.e. Crn, was no longer significantly different from normal WT levels in 
urine and plasma. GAA levels did not normalize in AGATV- upon Cr supplementation. In urine 
they were even further decreased. Also plasma HArg levels did not reach normal levels during 
the 12 week period of Cr supplementation.
Bod y w e ig h t developm ent and  body com position— Body mass of AGATV- mice were 
determined weekly and compared with body weight development of heterozygous (+/-) and 
wild type (+/+) littermates (fig. 4.4A). AGAT/- animals consistently weighed less than control 
littermates. The weight difference was already noticeable during the first week after birth and 
further increased with time. At the age of 12 months, the mutants demonstrated a 32 %  
reduction in total body weight when compared to wild type littermates (fig. 4.4E).
At least part of this reduction in weight can be attributed to a significantly smaller body length 
(fig. 4.4C,D). However, a strong reduction of the relative fat content also has considerable effects 
on total body weight, i.e. total fat mass in one-year old female knockout mice on a ND was only
21.6 %  of the total body weight, whereas in female WT this was 30.6 %  (P < 0.05). For age- 
matched male WT and AGAT/- mice absolute and relative contents of water, fat and lean mass 
are plotted in fig. 4.5G. Relative values are normalized to whole body weight. These figures 
show that fat content is also significantly reduced in male AGATV- mice on a ND. Although 
absolute water and lean mass are lower in mutants than in WT littermates, their contents 
account for a significantly larger part of the whole body mass. We investigated whether the 
reduced fat content was normally distributed over the various fat tissues (Fig. 4.4H). This 
revealed a pronounced difference in subcutaneous white adipose tissue (WAT), which is 
significantly decreased in the mutants (1.3 %  of total body mass in AGATV- mice on ND, vs 3.1 %  
in WT mice on ND).
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Figure 4.4: Reduced body weight and composition in AGAT-/- mice. (A ) Weight development of male WT 
mice (+/+, n = 10), knockout mice (-/-, n = 13) and heterozygous mice (+/-, n = 12). (B ) Changes in weight 
during 12 weeks ofC r supplementation (CRD) or normal diet (ND), n = 5-7. (C) Example of two littermates 
(males, age 20 weeks). (D ) Mean body lengths and (E ) mean body weights of female WT mice (  n = 12) and 
knockout mice (n = 10) aged 12 months. Significance tested with a student t-test. (F ) Body composition: 
water, fa t and lean mass. Absolute values are expressed in gram, relative values are normalized for total body 
weight). (G) Fat distribution over brown and white adipose tissues in AGAT-/- mice and W T (35-40 week old 
males, n = 5-7) on ND and CRD normalized to total body mass. A-B in mean ± SEM, all bar graphs in mean ± 
SD. Significance levels when compared to WT on ND: * P  < 0.05, ** P  < 0.01, *** P  < 0.001, Significance levels 
when compared to AGAT-/'- mice on ND: # P < 0.05, ### P < 0.001 (Two-way ANOVA with Bonferroni post test). 
WAT: white adipose tissue, BAT: Brown adipose tissue, intest: intestinal, subc: subcutaneous, gona: gonadal.
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In order to investigate whether the alterations in body weight and composition in the AGATV- 
mice when on a Cr-free diet (ND) could be reversed in the mutants, we changed the diet to a Cr- 
enriched chow (CRD) by adding 0.5 %  Cr. Upon oral Cr intake, indeed a considerable increase in 
body weight was observed in the AGATV- mice after 12 weeks of CRD (fig. 4.4B). W ild type mice 
on CRD also gained a little weight, although this increase was less pronounced. The relative body 
composition was completely normalized in AGATV- on a CRD (fig. 4.4G). Upon Cr administration 
both in WT and AGATV- mice the subcutaneous WAT showed significant increases; in the 
mutants subcutaneous WAT were no longer significantly different from WT on a ND. In addition 
a gain in gonadal WAT was observed in the mutants.
Food in take  and  locom otor a c tiv ity— We examined whether a change in food intake was 
associated with the lower adiposity of the AGATV- mice. Analysis of food intake over a three day 
period revealed a significant increase of 18% in absolute food intake in the mutant mice (Table
4.1). W ild type animals consumed 3.37 g of food per day, mainly eaten during the night, whereas 
food intake of AGATV- mice was 3.99 g per day (P=0.0035). Note that if we take into account the 
smaller size of the AGATV- mice, the food intake expressed per gram of body weight exceeded 
that of WT almost two-fold (P=0.0015). This result brings about an important question: what 
happens with large energy intake per body weight in the AGATV- mice: i.e. do they have an 
inefficient digestion or do they have an enhanced combustion?
To investigate the former, we checked whether an enhanced part of the energy intake was not 
taken up by the intestines. However, both the amount of excreted faeces as well as the energy 
content of the excretions did not differ between AGAT/- and WT littermates.
Home cage activity levels during day or night were not different between the two groups of mice 
(Table 4.1). Hence, disturbed body weight regulation and altered body composition cannot be 
explained by altered cage activity.
Table 4.2: P la sm a  ad ipok ine concen trations on a  Cr-free and  Cr-enriched d ie t
Mice
Diet ND
W T
CRD ND
AGAT-/-
CRD
Leptin (ng/mL) 
Adiponectin (^.g/mL)
34 ± 36 
125 ± 18
150 ± 74** 
85 ± 27 **
15 ± 11 
127 ± 13
25 ± 25 xx
56 ± 22 *** ###
Values in mean ± SD. Significance levels when compared to WT mice on a ND (Cr-free diet): ** P < 0.01, *** P < 0.001. 
Significance levels when compared to WT on CRD, xx P < 0.01. Significance levels when compared to AGAT-/- mice on a ND, 
### p  < 0.001. One-way ANOVA with Bonferroni post-test, n = 6-8 per group. See also figure 4.10.
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Table 4.1: F ood in take  and  locom otor a c tiv ity
Controls AGAT-/-
Absolute food intake (g) 3.37 ± 0.48 3.99 ± 0.27 **
Relative food intake 
(g/g body weight)
0.11 ± 0.02 0.22 ± 0.02 ***
Absolute water intake (g) 4.92 ± 1.19 4.92 ± 0.76
Relative water intake 
(g/g body weight)
0.16 ± 0.04 0.27 ± 0.05***
Excreted faeces (g/day) 0.83 ± 0.05 0.70 ± 0.04
Energy content of faeces (kJ/g) 16.5 ± 0.04 16.4 ± 0.06
Locomotor activity day (% ) 7.2 ± 1.6 7.3 ± 3.1
Locomotor activity night (% ) 30.2 ± 5.8 29.3 ± 5.9
Locomotor activity expressed in % (number of crossings/total samples per hour * 100) , mean ± SD, group sizes: food 
intake n = 9-10, all males. Excreted faece: n = 6-7. Locomotor activity: 9-11 
Statistical significances: ** P > 0.01 *** P > 0.001, t-test.
A d ipokines— Leptin and adiponectin levels in serum usually reflect the status of the energy 
reserves of the animal, i.e., these hormones are known to regulate body weight and fat content. 
In order to study possible alterations in the regulation of energy metabolism in AGATV- mice, we 
compared serum levels of adipokines (leptin and adiponectin) between wild type and knockout 
mice. Serum leptin levels in AGATV-, were not significantly different from WT mice on a ND 
(table 4.2, see also fig. 4.10). Upon oral Cr supplementation, serum leptin levels in WT increased 
more than fourfold, while in AGATV- mice leptin did not increase beyond normal levels. 
Adiponectin concentrations in the serum of knockout mice on a ND, were similar to WT 
littermates on a ND. Note that as AGATV- have a lower fat mass, which means that the same 
amount of adiponectin is produced by a significantly reduced amount of fat tissue: 22 ± 1 
Hg/mL/g fat in WT versus 86 ± 10 ng/mL/g fat in AGAT-/- (P < 0.001). Upon Cr administration, 
both in the WT and AGAT-/- mice adiponectin levels decreased significantly, when compared to 
the ND-levels.
Glucose to le ran ce— Adiponectin production is associated with a stimulated fatty acid oxidation 
and insulin stimulated glucose uptake. To investigate potential adaptations in the latter, we
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challenged the AGAT-/- mice, first on a Cr-free diet (ND), with an intraperitoneal glucose 
tolerance (IPGT)-test. Later also on a creatine-enriched diet (CRD). Independent on the diet, 
fasting glucose levels were not different between AGAT-/- (4.0 ± 0.9 mM on ND, 4.7 ± 0.6 mM on 
CRD) and WT (4.1 ± 1.2 mM on ND, 5.3 ± 0.7 on CRD ) mice. However, upon a ND, peak levels of 
blood glucose (30 min after the i.p. glucose injection) were significantly lower in the knockout 
mice, i.e. 11.7 mM, than the rise to 17.0 mM in the WT mice (fig. 4.5). The average AUC value 
over the 120 min post-injection period was decreased with 28% in the AGAT-/- mice when 
compared to the average AUC of the WT littermates on a ND.
Cr administration did not influence glucose clearance in WT, which is shown by the similar AUC 
values in WT on ND and CRD. In the mutants, however, plasma glucose levels during the IPGT- 
test were no longer significantly different from controls, when the AGAT-/- mice were 
administered with Cr, which can also be observed in the normalized AUC values. Hence, an 
enhanced glucose clearance was only present in knockout mice that were refrained from 
exogenous Cr intake.
Figure 4.5: IPGT-test in AGAT-/- and W T mice on a Cr-free and Cr-enriched diet. (A): Blood glucose 
levels after a 2 g/kg i.p. glucose infusion, measured in AGAT-/- and WT mice on a normal diet (ND, Cr-free) or 
a 0.5% Cr enriched diet (CRD). Values in ± SEM. (B ) Corresponding areas under the curves (AUC). All males, 
age ~35 weeks. Values in mean ± SD. Significance levels when compared to WT on a ND: * P  < 0.05, ** P  < 
0.01. Significance levels when compared to AGAT-/- mice on a ND: # P  < 0.01. Curves: two-way ANOVA with 
Bonferroni post-test, Bar-graphs: one-way ANOVA with Bonferroni post-test.
In order to investigate insulin sensitivity in the AGAT-/- mice we performed additional IPGT tests 
in which we also determined insulin levels. To this end 11.5 ± 4 month old AGAT-/- mice with a 
body mass of 17.9 ± 2.5 g on ND were compared with age matched WT controls, weighing 32.1 ± 
7.9 g (fig. 4.6A). Fasting glucose levels of these WT mice were elevated with 32 %  (7.2 ± 1.4 mM) 
when compared to Cr deficient AGAT-/- (4.9 ± 1.2 mM), which had glucose levels that were in the 
range of normal fasting glucose levels for mice (fig. 4.6B). The glucose tolerance test (1.5 mg/kg
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i.p. glucose injection) confirmed the previously observed enhanced glucose clearance in AGAT-/- 
when compared to the WT mice. AUC of glucose responses over 120 minutes were significantly 
lower in the AGAT-/- mice (889 ± 225 mM*min), when compared to controls (1396 ± 377 
mM*min). Interestingly, the enhanced glucose clearance in the AGAT-/- mice was not a 
consequence of elevated insulin secretion upon i.p. glucose injection. In contrast, insulin levels 
during the 120 min post-injection period showed significantly lower peak levels and AUCs in the 
knockout mice when compared to the WT controls.
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Figure 4.6: Glucose and insulin responses during an IPGT-test. (A ) Weights and (B ) fasting blood 
glucose levels. (C) Blood glucose levels and (D) insulin levels after 1.5 g/kg i.p glucose infusion. Measured in 
AGAT-/- (n = 16) and W T mice (n = 18) at older age (11.7 ± 4.5 months) and ad libitum food supply. 
Corresponding areas under the curves (AUC) over 120 minutes are plotted in the bar graphs on the right and 
expressed in mean ± SD, values in the glucose and insulin curves are in mean ± SEM. Significance levels when 
compared to controls on a normal diet: * P  < 0.05, ** P  < 0.01, *** P  < 0.001. Curves: two-way ANOVA with 
Bonferroni post-test, Bar-graphs: unpaired t-tests.
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H ep atic  TG and  de novo lipogenesis— In  vitro NMR measurements were performed on hepatic 
extracts in order to determine tissue levels of HTG and their origin. Extractions were performed 
on livers collected from a subset of the mice we used for the IPGT test shown in fig. 4.6. HTG 
concentrations were significantly decreased in the AGAT-/- mice when compared to WT controls 
(Table 4.3). HTGs can be formed (i) in situ by de novo lipogenesis (DNL) of fatty acids from 
acetyl-CoA, (ii) from plasma free fatty acids (FFAs) which are taken up via lipoprotein transport 
and esterified to triglycerides (TGs) after hepatic uptake or (iii) from lipolysis of TG-stores in 
adipocytes (see fig. 4.7A). We assumed the latter to be negligible under the conditions of this 
study, since the animals had ad libitum  access to the chow.
We determined the fraction of HTG derived from DNL using 2H labelled water as a tracer 
compound. The fractional enrichment of water was comparable in WT and AGAT-/- mice, 
whereas the fraction of labelled TG was significantly higher in the AGAT-/- liver than in liver of 
WT controls (Table 4.3). Hence, we found a twofold increased contribution of DNL to AGAT-/- 
HTG, whereas the total HTG pool was significantly decreased.
Table 4.3: HTG conten t and  DNL fra c tio n a l syn thesis ra te
W T AGAT-/-
[HTG] 195 ± 20 106 ±19* [imol/g ww
2H body water 
fractional enrichment
2.51 ± 0.15 2.38 ± 0.30 %
2H HTG 
fractional enrichment
0.19 ±0.05 0.36 ± 0.15* %
DNL synthesis 7.3 ± 3.3 17.1 ± 7.3** %
Non-DNL 92.9 ± 1.2 83.1 ± 2.7** %
Values in mean ± SD. WT n =6, AGAT-/- n = 5, all males. Data were determined from 1H and 2H NMR spectra using 
1.1% 2H enriched pyrizine as an internal reference. Significance levels when compared to WT mice on a ND (Cr- 
free diet): *P < 0.05, ** P < 0.01, t-test.
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F ig u re  4.7: HTG concentration  and  source. (A) Schematic overview of the use of deuterated water to 
determine the contribution of DNL to the HTG content. Protons of deuterated water are in exchange with 
pyruvate originating from dietary carbohydrates. The pyruvate is converted in to acetylCoA to generate fatty 
acids (FA) which are esterified into triglycerides (34). Thus, a steady state labeling fraction of water yields a 
measure for fraction of HTG originating from DNL. Non-labeled HTG present sources of dietary lipids or 
lipolysis. (B ) 1H MRS spectra of liver extractions showing lower concentrations of methyl TG in the AGAT-/- 
mice compared to WT controls. (C) 2H MRS spectra showed higher concentrations of 2H methyl HTG in the 
AGAT-/- mice compared to WT control, indicating an increase in DNL. All spectra were scaled to pyrazine or 
2H4 pyrazine, which was added as a reference signal.
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AGAT-/- m ice on a h igh f a t  d ie t— In order to investigate uptake and storage of lipids, AGAT /- 
and control mice were fed with a high fat diet (HFD) starting at the age of 10-12 weeks. Body 
weights in AGAT-/- mice on this diet did not change with respect to those of knockout mice on a 
Cr-free diet, whereas the total body weights of the WT mice showed significant increases on a 
HFD (24.4 g before vs 41.6 g after 9 weeks HFD, fig. 4.8A). The HFD resulted in an increase in 
absolute water and fat mass (fig. 4.8C) as well as the relative amount of all white adipose tissues 
in the WT mice (fig. 4.8D). Interestingly, AGAT-/- mice show no significant increases in either of 
the white adipose tissues upon HFD, although we did observe a small increase in relative body 
fat mass (p < 0.05). No differences in brown adipose tissue were observed between the two 
genotypes and the two diets. When comparing the results with those shown in fig. 4.4, we note 
that in contrast to the CRD, which normalizes WAT stores in AGAT-/-, a high fat diet does not.
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Figure 4.8: AGAT-/- and W T mice on a high fa t  diet. (A) Changes in body weights in knockout and control 
mice upon a normal diet (ND) and a high fa t diet (HFD) (30-35 week old females, n = 5-6). (B ) Histology of 
hepatic biopsies stained with Oil-red-O showing increased numbers and sizes of TG-rich lipid droplets upon 
HFD in only the WT mice. For color figure, see Appendix. (C) Absolute and relative values of body 
composition and (D) fa t distribution determined in AGAT-/- mice and WT littermates on ND and after 12 
weeks of HFD, n = 5-6 per group. Relative values were normalized to total body weight. Significance levels 
when compared to WT mice on ND: * P  < 0.05, ** P  < 0.01, *** P < 0.001. Two-way ANOVA with Bonferroni 
post-test.
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The impact of HFD on liver was investigated by Oil-red-O staining which showed that liver 
tissue of WT mice on HFD revealed increased numbers and size of lipid droplets, whereas AGAT- 
/- did not show signs of hepatic steatosis on this diet (fig. 4.8B, for color figure, see Appendix).
We observed that serum leptin levels were not significantly different between AGAT-/- and 
controls on a ND (Table 4.2). Interestingly, whereas in WT leptin did increase more than tenfold 
upon changing the diet to HFD, AGAT-/- leptin levels did increase almost threefold but barely 
exceeded the values of the WT mice on ND (fig. 4.9). Adiponectin levels in serum of knockout 
mice are similar to WT mice upon ND and a high fat diet (HFD). However, when normalized for 
body fat content, adiponectin production in ND and HFD fed AGAT-/- mice was significantly 
enhanced. When supplemented with a 0.5 %  Cr enriched diet, adiponectin levels were elevated, 
while the production per gram of body fat in the knockout mice was no longer different from 
control levels.
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Figure 4.9: Leptin and adiponectin levels on different diets. (A ) Serum leptin and (B ) adiponectin levels 
in AGAT-/- and WT mice on normal Cr-free diet (ND), 12 weeks of Cr enriched diet (CRD, 0.5 % ) and 12 weeks 
on a high fa t diet (HFD). Plasma concentrations were expressed in mean ± SD. Significance levels when 
compared to W T mice on a ND: ** P  < 0.01, *** P  < 0.001. Significance levels in when compared to W T on the 
same diet, xx P  < 0.01,xxx P  < 0.001, Significance levels when compared to AGAT-/- mice on a different diet, ### 
P < 0.001, One-way ANOVA with Bonferroni post-test, n = 5-9 per group. See also table 4.2.
We also investigated the effect of HFD on glucose tolerance with an IPGT-test. The WT mice 
clearly showed a lower glucose clearance (i.e. significantly larger AUC) when they were kept on a 
HFD for 12 weeks (fig. 4.10). Interestingly, the HFD did not affect the rate of glucose clearance in 
the AGAT-/- mice, as shown both by the similar curve and AUC values in AGAT-/- on ND and HFD. 
Hence, AGAT-/- mice do not only seem resistant to diet induced obesity, but also to the 
development of glucose intolerance.
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Figure 4.10: Glucose tolerance on a high fa t diet. Glucose levels (mM) after an i.p. injection of 2 mg/kg 
glucose in AGAT-/- and W T mice on a ND and a HFD. All females, age ~30 weeks. Two-way ANOVA with 
Bonferroni post-test. Corresponding areas under the curves are plotted on the right. One-way ANOVA with 
Bonferroni post-test. Significance levels when compared to W T mice on ND: * P  < 0.05, ** P  < 0.01, *** P  < 
0.001. Significance levels when compared to W T mice on HFD: ### P  < 0.001.
4.4 DISCUSSION
In the present study, we investigated a knockout mouse model of AGAT deficiency that was 
generated through targeted disruption of the mouse AGAT gene in embryonic stem cells. 
Deletion of the gene resulted in undetectable AGAT expression and caused biochemical changes 
in body fluids corresponding with total body Cr depletion. AGAT-/- mice reveal a severe decrease 
in body weight and a significant reduction in fractional fat mass. Additionally, Cr depletion was 
correlated with an enhancement in glucose clearance. Even at high fat feeding AGAT-/- mice do 
not develop signs of decreased glucose clearance or obesity. All abnormalities were reversed by 
oral Cr supplementation.
AGAT-/- resu lts  in  to ta l body Cr dep letion— This study shows that, when kept on a Cr-free diet, 
AGAT deficiency in mice leads to a depletion of circulating guanidino compounds that are 
directly involved in Cr metabolism, i.e. Cr, GAA and Crn. The depleted Cr and Crn levels in plasma 
and urine confirm that AGAT-/- mice truly are exhibit impaired Cr biosynthesis. Low levels of Crn, 
the breakdown product of Cr, are a direct result of Cr deficiency. The absence of AGAT 
expression in kidney tissue and the reduction of GAA in the body fluids further confirm the 
absence of AGAT activity. In the case of GAMT deficiency, GAA accumulates (20, 23), while in 
body fluids of AGAT-/- mice GAA is reduced, in agreement with the deficiency of the enzyme in 
the metabolic pathway towards Cr synthesis. Although no precursors or guanidine compounds 
of Cr are accumulating in AGAT-/- mice, we observed decreased HArg levels in plasma.
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The reduced circulating GAA levels match with the depleted levels that were found in body fluids 
of AGAT deficient patients. Cr and Crn levels in these patients were low, although not always 
below normal reference ranges. Thus, we considered the Cr depletion in the AGAT-/- mice in this 
study more severe than those of the reported patients (35). This can be explained by the 
complete restriction of dietary Cr intake, whereas it is likely that patients absorb some Cr from 
the diet, which is, however, not sufficient to replenish cerebral Cr to adequate levels.
Cr deficiency affects lip id  d is trib u tio n — The AGAT /- deficient mice on a Cr-free diet 
demonstrated a severe decrease in body weight as a consequence of a Cr deficit. The reduction 
in weight partly relates to their decreased body length. The other part is due to the lower fat 
content that is associated with a reduction in subcutaneous WAT. The leanness is a true 
consequence of Cr deficiency, as both total body fat content and subcutaneous WAT increase 
upon Cr supplementation. Moreover, they are neither caused by decreased food intake, impaired 
nutrient absorption (energy content of feces was equal in WT and knockouts) or increased 
locomotor activity. This raises the question: where do all the nutrients go? At this moment, the 
increased food intake and reduced WAT point towards a general enhancement in energy 
expenditure associated with a higher lipid turnover, although more evidence is required at the 
level of different tissues to confirm those conclusions. Interestingly, a reduction in body mass 
and leanness has also been demonstrated in knockout mice that lack both CK isoforms in the 
brain (cytosolic B-CK and mitochondrial CK-mit, abbreviated as BubCK=/=) with a 24% decline in 
WAT and 7% in BAT (36). In contrast, these abnormalities were not observed in mice with 
single or double mutations of the muscle specific CK isoforms (cytosolic M-CK and mitochondrial 
ScCKmit). Hence, the altered adiposity in BubCK=/= and AGAT-/- mice suggest a role for the CK 
system and/or Cr involving the nervous system in the regulation of lipid homeostasis and 
distribution, but also in temperature homeostasis (36).
WAT not only serves as a major energy reservoir, but also functions as an endocrine organ that 
is central to energy homeostasis regulation by excreting adipocytokines: hormones that are 
involved in the regulation of food intake, body weight and fat content. Plasma leptin 
concentrations, which are normally correlated with WAT content and are inversely related with 
food intake, were not significantly different between AGAT-/- and WT mice on a Cr-free diet. 
Thus, leptin levels do not appear to be responsible for the decreased fat content and the increase 
in food intake. Experiments with cobaltic porphorin IX and ß- GPA administration suggest that 
decreased Cr is related to reduced food intake and body weight by acting on specific
128 I
Creatine deficiency in AGAT-/- mice 4
hypothalamic nuclei (37). Indeed, in AGATV- mice body weight is decreased, but in contrast we 
found an increased food intake.
It is generally accepted that adiposity is associated with reduced circulating adiponectin levels 
(38). Previous studies on mice that demonstrated an inverse relationship between body fat and 
adiponectin levels (39). Adiponectin levels in the AGAT-/- mice on a Cr-free diet (ND) were in a 
normal range; however, the production per gram of lipid tissue was fourfold increased.
Cr deficiency is  associated  w ith  enhanced in su lin  sen s itiv ity— The combination of lower 
insulin secretion and enhanced glucose tolerance, shown by IPGT tests, implies a relation 
between the absence of Cr and insulin-sensitivity. Insulin stimulated glucose uptake in skeletal 
muscle have been associated with adiponectin receptor pathways by Mao et al. 2006 (40-41). 
However, the normal adiponectin levels in the AGAT-/- mice, led us to the conclusion that the 
enhanced insulin sensitivity must have its origin via pathways other than adiponectin signalling. 
At this moment one can only speculate on possible causal relations.
Recently, it was demonstrated that p53 can stimulate GAMT activity leading to increased Cr 
levels and fatty acid oxidation, which strongly suggest the presence of metabolic crosstalk 
between Cr synthesis and cellular energy metabolism (42-43). Our results indicate the opposite; 
in AGAT-/- mice the appeared to have an increased energy expenditure that was associated with 
decreased Cr, which suggest a more complex relationship.
With respect to isoform and tissue specific CK knockouts it is worth mentioning that in the 
AGAT-/- mice the whole CK system in all tissues has become inactive. Its function as a high energy 
phosphate buffer for the maintenance of ATP, may be differently compensated by other catabolic 
pathways in energy requiring situations. In particular, carbohydrate combustion and lipid 
oxidation might be upregulated, with especially major effects on insulin-sensitive tissues like 
muscle. This tissue in particular is capable of combusting any energy source that is sufficiently 
available. Cr and the CK system have been linked with an increased expression of GLUT4 
transporters (50%) and a shift towards a more oxidative metabolism in skeletal muscle of rats 
fed with the metabolically inactive Cr-analogue ß-GPA (44-45). Thus, these studies suggest that 
absence of Cr leads to increased glucose uptake in muscle, which is in agreement with the 
elevated glucose tolerance that we observed in depleted AGAT-/- mice. The enzyme AMP- 
activated protein kinase (AMPK) might play an important role in muscle under circumstances of 
energy deprivation induced by Cr depletion. A critical energy-sensing role for AMPK in 
promoting mitochondrial biogenesis in muscle was found in a comparative study between WT
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mice and AMPK knockouts both treated with GPA (46). AMPK activation counteracts energy 
deficiency by increasing glucose transport by enhancing GLUT4 translocation (47-49), 
stimulating ß-oxidation by inhibition of acetyl CoA carboxylase (50-51) and increasing the 
mitochondrial enzyme activities (52). Those adaptations point into the direction upregulation of 
oxidative combustion and fit well with the enhanced energy expenditure and increased lipid 
turnover that we propose in depleted AGAT-/- mice. More research on skeletal muscle is 
warranted to elucidate if those muscle specific effects are indeed present in AGAT-/- mice and 
thereby explain the enhanced glucose clearance and insulin sensitivity.
Several studies have also reported on a correlation between Cr concentrations in pancreatic cells 
and glucose homeostasis. A stimulating effect of Cr, GAA and Arg concentrations on the release 
of insulin and glucagon has been shown in incubated mouse and rat pancreatic islets (53-54). In 
addition, Rooney et al. have reported that prolonged Cr supplementation in rats (8 weeks) 
increases Cr levels in pancreas and enhances insulin secretion in response to a glucose 
challenge (55). The enhanced glucose tolerance that we found in the AGATV- mice with depleted 
Cr levels is well in agreement with those findings, whereas the reduced insulin production in 
AGAT-/- mice is not. This discrepancy points towards local effects of changes in Cr concentration 
on both pancreas and insulin sensitive tissues, such as muscle. Future research should aim at 
investigating altered insulin production in pancreatic ß-cells and use of energy substrates in 
AGAT-/- muscle and liver in order to elucidate the exact mechanisms behind the relation between 
Cr deficiency and enhanced insulin sensitivity
AGAT-/- m ice a re  rescued  fro m  diet-induced obesity and  im p a ired  in su lin  sen s itiv ity— Our
results showed that during ad libitum  feeding with a HFD, body weight and subcutaneous WAT 
of the WT mice gained substantially, while the low body weight and WAT of the AGAT-/- mice 
were not affected. Hence, the Cr deficient knockout mice were protected from diet-induced 
obesity. Moreover, we observed that in WT mice leptin levels and subcutaneous WAT increased 
as a result of a HFD. This is in accord with the relation between diet-induced-obesity and 
elevated leptin levels. In contrast, both plasma leptin and WAT in the AGAT-/- mice were not or 
only minimally affected by HFD. Apparently, not its circulating levels, but leptin regulating 
pathways seem to be altered in the Cr deficient AGAT-/- mice. The inverse relation between 
adiponectin and body fat was not observed in the WT mice; they gained a lot of weight and 
subcutaneous fat tissue during 12 weeks of HFD, while adiponectin concentration in plasma 
remained the same. Most surprising was the maintenance of high insulin sensitivity in the AGAT- 
/- mice under the circumstances in which age-matched WT clearly show diet-induced reduction
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in insulin sensitivity. The absence of hepatic steatosis corroborates the prevention of decreasing 
insulin sensitivity in the AGAT-/- mice.
Increased glucose tolerance and an insulin sensitive phenotype have also been observed in 
knockout mice lacking adipose triglyceride lipase (ATGL) (56). These ATGL/- mice accumulated 
large amounts of lipid in brown and white adipose tissues, however they were not able to draw 
on these fat depots as lipolysis was drastically reduced. Thus, some similarities between ATGL-/- 
and AGAT-/- mice are observed; while ATGL do not have access to the lipid reserves in WAT, 
AGAT-/- have a lower amount of WAT available for lipolysis. In both cases, the availability of FFA 
from WAT is lowered and associated with an improvement in glucose tolerance.
The increased contribution of DNL to a reduced HTG pool in AGAT-/- liver indicated that the 
remaining (unlabeled) HTG pool was either obtained from dietary sources or present before the 
administration of deuterated water. Based on complete HTG turnover in rat liver within two 
days (33) and the faster basal metabolic rate of mice, we assumed that under the conditions of 
our study, the unlabeled HTG pool reflects predominantly dietary lipid sources. Thus, in the 
AGAT-/- mice a very low fraction of dietary lipids end up as HTG in hepatic tissue, suggesting re­
direction of dietary fatty acids to other high energy demanding tissues as muscle.
Reco very by o ra l C r supp lem entation— After Cr supplementation we observed restored Cr 
content in body fluids indicating recovery of normal whole body Cr levels. Also the breakdown 
product of Cr, i.e. Crn, recovered to normal concentrations in urine and plasma. The latter 
reflects normal Cr content in muscle tissue, as skeletal muscle normally contains >90% of the 
total body Cr. In urine GAA levels were even further decreased after Cr administration. This 
confirms that all Cr in the treated AGAT-/- mice must have its origin from dietary intake and not 
from endogenous synthesis. Virtually all abnormalities that we observed in the AGAT-/- mice on 
ND, were completely reversed by oral Cr supplementation. As such, these mice can easily be 
switched to and from a Cr deficient condition. We efficiently made use of this feature in order to 
investigate whether adaptations in AGAT-/- mice were directly associated with their Cr deficient 
state, by simply comparing knockouts on a Cr-free and Cr-enriched diet.
In conclusion, our data confirm that the AGAT knockout mice are a valuable model to study the 
effects of Cr deficiency on whole body level. The findings of this study indicate that Cr seems to 
play important role in feeding behavior, body weight, fat distribution and insulin stimulated 
glucose uptake. The Cr supplementation showed that abnormalities were a direct consequence
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of the Cr deficit. Although further studies on tissue or cell level are needed to investigate the 
mechanism of the energy related adaptations that are associated with Cr deficiency, the results 
of the present study provide a breakthrough in our understanding of the role of Cr in preventing 
the metabolic syndrome. This may also lead to new intervention and prevention strategies (e.g. 
diet).
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Creatine plays an im portant role in energy homeostasis of the muscle by the ATP- 
phosphocreatine phosphoryl exchange reaction mediated by creatine kinase (CK). In this 
study we assessed morphologic, metabolic and functional consequences of systemic 
creatine depletion on skeletal muscle in a knockout mouse model w ith i-arginine:glycine 
amidino transferase deficiency (AGAT-/-), the enzyme which catalyzes the first step in the 
biosynthesis of creatine.
In  v ivo  !H and 31P magnetic resonance spectroscopy (M RS) measurements showed a 
nearly complete absence of creatine and phosphocreatine in hind limb muscle, when the 
AGAT-/- mice were kept on a creatine-free diet. Inorganic phosphate/ß-ATP ratios in 
resting AGAT-/- muscle were increased four-fold, while biochemical and MRS 
determ inations demonstrated an almost two-fold decrease in ATP levels (w ildtypes 25.1 
± 3.1, AGAT-/- 13.5 ± 3.9 |imol/g dw). Proton-pumping respiratory chain enzymes were 
downregulated, while FjFo-ATPase activity and overall m itochondrial content were 
increased. Grip strength in the AGAT-/- mice was reduced by 70%  and MR images showed 
a relation between muscle atrophy and decreasing creatine content. Increased amounts 
of intram yocellular lip id  droplets and crystal form ation w ithin m itochondria were 
observed by electron m icroscopy in part of the AGAT-/- muscle fibers. Uptake of creatine 
in skeletal muscle was very efficient, as total creatine levels were already increased to the 
norm al w ild  type levels after 1 day of supplementation. A ll muscular abnorm alities were 
reversible by oral creatine adm inistration.
Our results show that a systemic creatine depletion has a major impact on skeletal muscle 
physiology indicating a shift towards oxidative metabolism, which corroborates previous 
studies on muscle of CK-deficient mice and ß-guanidine propionic acid (ß-GPA) feeding. 
Interestingly, the consequences of AGAT deficiency on skeletal muscle were more 
pronounced than the effects of muscle-specific CK deficiency, which suggests a 
multifaceted role for creatine in muscular energy homeostasis apart from its role in the 
CK system.
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5.1 INTRODUCTION
Phosphocreatine (PCr) is one of the major sources for ATP supply in tissues with rapidly 
fluctuating energy demand, such as skeletal muscle. This supply is facilitated by the creatine 
kinase (CK) reaction, in which creatine (Cr) and ADP are reversibly phosphorylated to PCr and 
ATP respectively To keep this energy backup intact, a sufficiently high level of cellular Cr is 
required, which, in mammals, is accomplished both by endogenous production (fig. 5.1) and by 
dietary intake (1).
The CK system has been thoroughly investigated in cardiac and skeletal muscle using knockout 
models with partial or complete deletions or over-expression of muscle specific CK-isoforms. 
These studies have been very valuable in defining the role and importance of the PCr-CK system 
in skeletal muscle at different circumstances, e.g. at rest and upon stimulation or ischemia, for 
reviews see (2-6). Surprisingly, resting muscle of double knockout mice with complete absence 
of the both cytosolic (M-CK) and mitochondrial (Sc-CKmit) CK isoforms still demonstrated a 
substantial amount of PCr, however, this could not easily be recruited for ATP buffering. The 
lack of burst activity in these muscles has unequivocally shown that the energy buffering role of 
the CK system in skeletal muscle is in particular important during the initial phase of intense 
contraction (7-8).
As these double knockout mice still contained substantial amounts of (P)Cr, possible other roles 
of Cr in skeletal muscle could not be investigated. For this purpose replacement of creatine or 
disruption of its synthesis is needed. Depleted levels of Cr do occur in patients with defects in 
the expression of one of the enzymes involved in the last 2 steps of de novo Cr synthesis, 
arginine:glycine amidinotransferase (AGAT; EC 2.1.4.1) and guanidino actetate 
methyltransferase (GAMT; EC 2.1.1.2).
Previous studies on knockout mice with targeted disruption of the GAMT gene, the enzyme that 
catalyzes the second step in the biosynthesis of Cr, showed that upon a Cr-free diet these mice 
become Cr deficient. GAMT deficient (GAMT / ) mice accumulate guanidino acetate (9), the 
precursor of Cr (10), as well as its phosphorylated form PGAA. As this compound was able to 
buffer ATP in (mild) energy demanding conditions (11), the accumulated (P)GAA, at least partly, 
compensates for the lack of (P)Cr, which hampers the assessment of the ultimate consequences 
of Cr deficiency.
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Figure 5.1: Biosynthesis of creatine. De novo synthesis of creatine mainly takes place in the pancreas and 
kidney. The first step of the biosynthesis of Cr is rate limiting and is catalysed by arginine:glycine 
amidinotransferase (AGAT). The second step is catalysed by guanidinoacetate methyltransferase (GAMT). 
The produced Cr is transported towards tissues that often have a high energy demand, such as muscle or 
brain, where it is phosphorylated by creatine kinase (CK). This reaction plays an important role in 
maintaining global and local ATP levels to meet cellular energy demands.
The recent generation of a mouse model with a nonsense mutation in the gene encoding for 
AGAT (AGAT-/-) provides new opportunities to study consequences of Cr deficiency (12). On a Cr 
free diet AGAT-/- mice demonstrated an absence of Cr, GAA and creatinine (Crn) in plasma and 
urine. This mouse is not expected to accumulate a particular precursor metabolite of Cr in 
skeletal muscle. Hence, if no alternative high energy phosphate (HEP) compounds are found in 
AGAT-/- muscle, this mouse model for AGAT deficiency may serve as a model for pure Cr 
deficiency.
In a previous study on those mice, it was shown that the depletion of Cr results in a significantly 
reduced total body weight, a reduction in adiposity and a significantly enhanced insulin- 
stimulated glucose tolerance (Chapter 4). Even more interesting, AGAT-/- mice were resistant to 
the development of diet induced impairments of insulin sensitivity. The adaptations in whole 
body energy metabolism in the AGAT-/- mice appeared completely reversible by oral Cr 
administration, which indicated an important role for Cr in whole body carbohydrate and lipid 
metabolism. The precise mechanism behind the relation between altered energy metabolism 
and Cr deficiency has not been elucidated yet, but might be found on the level of tissues that are
140 I
Creatine deficiency in AGAT-/- muscle I 5
insulin sensitive and contain large Cr concentrations, i.e. in muscle. Studies on rat and mice fed 
with ß-GPA, a Cr analogue, have previously found relations between Cr deficiency and altered 
metabolism in skeletal muscle (13-18). Therefore, we here divert from the examination of whole 
body physiology, and instead concentrate on the detailed examination of the impact of Cr 
deficiency on skeletal muscle.
The aim of this study was to assess some key metabolic and functional deficits caused by 
systemic Cr deficiency in skeletal muscle of AGATV- mice. In addition, we explored to which 
extent the effects or adaptations could be reversed by Cr supplementation.
5.2 MATERIALS AND METHODS
A n im a l p rep a ra tio n — Arginine:glycine amidinotransferase knockout mice (AGATV- mice) were 
generated by homologous recombination in embryonic stem cells (12). Mice that were 
heterozygous for the AGAT knockout allele were used for breeding, since homozygous knockout 
mice were infertile. Before experiments, the mice were kept on an ad libitum  but Cr-free diet (for 
> 3-6 months) to prevent exogenous Cr contamination. After genotyping, knockout and control 
mice were housed separately to impede intake of Cr from excrements of littermates. The food 
was put at the bottom of the cage to prevent interference of starvation in our results, as some 
mutants did not have the strength to reach the food cage. Upon Cr supplementation changes in 
body mass were determined weekly. All experiments were approved by the local animal ethics 
committees.
H istopatho logy— To analyze morphology of the muscle tissue, wild type (W T) mice and AGATV- 
mice that were kept either on a Cr free diet or on a chow containing Cr (12 weeks, 0.5% of dry 
weight) were perfused transcardially with 2% glutaraldehyde (GA) in PBS. Tissues were 
postfixed in 1% OsO4, dehydrated and embedded in Epon. Light-microscopic images were 
recorded after toluidine blue-staining of semi-thin longitudinal sections from gastrocnemius 
muscle. Additionally, ultra thin sections were stained with uranylacetate and lead citrate and 
examined with a Zeiss EM902 electron microscope (EM).
Grip streng th  m easurem ents— Maximum grip force of male AGATV- knockout mice (-/-), 
heterozygous (+/-) and wild type (+/+) mice aged between 15-20 weeks was measured using a
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grip strength meter (TSE-Systems, Bad Homburg, Germany) and compared with mice that had 
been on a Cr containing diet (12 weeks, 0.5% dry weight). W ithin each group, the mean grip 
force of each mouse was calculated from 15 appropriate trials.
In  v ivo  M R  Spectroscopy— Metabolite levels in hind limb skeletal muscle were studied non- 
invasively by 31P and XH magnetic resonance spectroscopy (MRS) measurements. For these 
experiments, the mice were anesthetized with 1.0-1.8% isoflurane in a gas mixture of 25/75 %  
0 2/air. Body temperature was controlled at 37 ± 1°C with a rectal temperature sensor (Luxtron 
712, California, USA) and a warm water blanket. Between two subsequent MR measurements a 
recovery period of at least 10 days was taken into account to minimize effects of recovery from 
anesthetics on the results.
The MR experiments were performed on a 200 mm horizontal-bore magnet (Magnex Scientific, 
Abingdon, UK) interfaced to an MR Solutions spectrometer (MR Solutions, Surrey, UK) operating 
at 300.22 MHz for XH and at 121.53 MHz for 31P. The horizontal magnet was equipped with a 
gradient insert with gradient strength of 150 mT/m, rise time of 150 .^s and free bore size of 120 
mm.
1H MR spectra of skeletal muscle of the lower hind limb were acquired in AGAT-/- and WT mice 
using a solenoid RF coil positioned under the magic angle with respect to the direction of the B 0 
field (19). Multislice gradient echo images were recorded in three orthogonal directions in order 
to determine voxel positions for the localized XH MRS measurements and for a relative measure 
of muscle volume. The latter was determined by drawing the regions of interest (ROIs) around 
the muscles in five subsequent cross-sectional gradient echo images (TR = 250 ms, TE = 5 ms, 
FOV 20x20 mm, 256 x 256 matrix) positioned 3 mm distal from the knee joint of the hind leg. 
The surface areas of the five ROIs were multiplied by the 1 mm slice thickness to yield muscle 
volume over a 5 mm length of the hind leg. Muscle growth upon Cr supplementation, could now 
be determined relative to the volume of day 0.
For the XH MRS measurements, localization was performed with STEAM on a 16 |jL voxel using: 
VAPOR water suppression (20), TE = 15 ms, TM = 10 ms, TR = 5 s and 128 averages. For absolute 
quantification an additional spectrum was recorded without water suppression and 8 averages. 
The voxel was positioned in the tibialis anterior/extensor digitorus longus region. All XH spectra 
were analyzed with AMARES (http://sermn02.uab.es/mrui/). Neither zero-filling nor 
apodization were applied. First order phases were fixed and frequencies were fitted with 
Gaussian line shapes. Absolute levels of total Cr (tCr) and taurine (Tau) in muscle were
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determined from XH spectra assuming a water content of 77% (9) and corrected for T2 
relaxation using values that were determined in a previous study (10).
31P MR spectra were obtained in AGAT-/- (n = 8) and controls (n = 6) by non-localized pulse 
acquire experiments (40 |j.s pulse, a ~ 90°, TR = 7s, 256 averages) using a three turn solenoid RF 
coil with a diameter of 8 mm (21). PCr, Pi, PME and the three ATP signals were determined from 
31P MR spectra. PME and Pi line widths were fixed to 0.7 times the line width of ß-ATP 
(experimentally observed in the spectra with the highest signal to noise). All signals were 
corrected for T1 relaxation and metabolite levels were expressed as a ratio over the signal 
intensity for ß-ATP (11). Determination of the intracellular pH from the chemical shift between 
Pi and PCr (22) was not possible in the AGAT/- deficient mice due to the lack of PCr. Therefore, 
we determined pH levels in both tissues from the chemical shift difference (S) between Pi and a- 
ATP; the frequency of the latter does not shift in the physiological pH range (22).
In four WT and five mutants, ISIS localized 31P MR spectra were recorded from hind limb muscle 
over a 5 mm length and over the whole cross-sectional area of the limb. The corresponding 
muscle volume within the ISIS VOI was obtained from multi spin echo images (TR/TE=1500/12 
ms, 10 slices, 1 mm slice thickness, FOV = 12 x 12 mm, matrix = 128 x 128, 2 averages) by 
manual selection of the muscle area in the slices of interest In this way, we could compare the 
ATP signal intensity per muscle volume between WT and AGAT/- in order to see whether ATP 
tissue concentrations were similar.
C reatine uptake and  breakdow n in  m uscle— In order to study Cr uptake in AGAT /- muscle 
tissue and its effect on other metabolite levels, we performed sequential MRS measurements 
during 35 days of ad libitum  Cr supplementation via the drinking water (5.32 g/ 500mL). 
Additional glucose (4.32 g/500mL) was added to compensate for the bitter taste of Cr when 
dissolved in water (19, 20). XH spectra and 31P spectra were recorded in hind leg muscle at 0, 1,
2, 11, 16, 21, 24 and 34 days of supplementation in eight AGAT/- mice (two groups, n = 4 per 
time point). In these mice, the supplementation was followed by a period of Cr free diet, which 
allowed the assessment of the rate of Cr breakdown. To this end, MR spectra were acquired at 5,
15, 35, 55 and 85 days of Cr restriction. Breakdown rates of Cr were determined by fitting the 
MRS data to the following equation representing the kinetics of non-enzymatic degradation:
[tCr] = [tCr ] 0 • e -k r51l
1143
5  Creatine deficiency in AGAT-/- muscle
In which t represents the number of days on a Cr free diet, [tCr]0  is the concentration of tCr at 
the last day of the Cr supplementation period and k is the Cr breakdown rate.
M R S du rin g  ischem ic occlusion— AGAT/- and WT mice were subjected to ischemia 
experiments during the Cr suppletion and the breakdown period. Reversible obstruction of 
blood flow through hind limb skeletal muscle was accomplished in the MR magnet by clamping 
the hind limb above the knee with a diaphragm plate (5). 31P spectra were acquired in with a 
time resolution of 1.46 min (TR = 1400ms, 76 averages) 7 minutes prior to the ischemic period, 
during 25 minutes of ischemia and during 16 minutes of recovery (11). The ischemia 
experiments in AGAT/- were performed after a long period of Cr deprivation (i.e. day 0) and at 2 
and 21 days of Cr suppletion, n = 5 per group. All metabolite signals acquired before, during or 
after the ischemic occlusion were normalized to the mean signal intensity of ß-ATP before 
ischemia was applied (ß-ATP0). The resting ATPase flux of muscle was calculated from the slopes 
of PCr and Pi signal intensity decreases and increases respectively, by calculating a linear 
regression line through the concentration before ischemic occlusion and the first 7 minutes (4 
spectra) of the ischemic period, when no pH changes occur (23-24).
B io ch em ica l determ ination  o f m uscle m etabo lites— For absolute quantification of 
metabolites, hind limb muscles (hamstrings) were snapshot frozen in liquid nitrogen and stored 
at -80 °C. After freeze-drying, a quantity of 10-15 mg of dry muscle tissue was extracted with 1 M 
perchloric acid. After centrifugation, the supernatant was neutralized with 2 M KHCO3. The 
neutralized extracts were used for spectrophotometric determination of Cr, PCr, ATP, ADP, AMP 
and lactate (25). The biochemically determined metabolite concentrations for each muscle 
sample were expressed in ^mol/g dry weight.
M ito ch o n d ria l a c tiv ity  in  v itro — Hamstring muscles from adult AGAT /- and control littermates 
were removed under anesthesia and stored in liquid nitrogen. Mitochondria were isolated from 
70-120 mg samples of wet muscle tissue for spectrophotometric determination of mitochondrial 
enzyme activities of NADH dehydrogenase (complex I, EC 1.6.5.3), succinate dehydrogenase 
(complex II, EC 1.3.5.1), ubiquinol-cytochrome-c reductase (complex III, EC 1.10.2.2), 
cytochrome-c oxidase (complex IV, EC 1.9.3.1), succinate dehydrognase (SCC, EC 1.3.5.1) and 
F ^ 0-ATPase (complex V, EC 3.6.3.14) were all expressed in mU per U citrate synthase activity 
(CS, EC 2.3.3.1). Details of the methods have been described previously (26-29). CS activity was 
used as a marker for mitochondrial content. The ratio of complex V activity over total ATPase
144 I
Creatine deficiency in AGAT-/- muscle I 5
activity was determined in presence and absence of oligomycin (8 mg/mL), the specific inhibitor 
of the F0-part of complex V (28).
S ta tis tic a l an a lys is— Data are given as mean ± SD, if not stated otherwise. The following 
statistical tests were applied: two-tailed t-test for comparisons between the WT and AGATV- 
mice, one-way ANOVA when comparing WT, AGATV- and Cr supplemented AGATV- mice, and 
two-way ANOVA for multi-parametric measurements with Bonferroni’s post test using 
GraphPad Prism (version 4, La Jolla, USA).
WT on Cr-free diet (ND) WT on CRD
Figure 5.2: Microscope images o f skeletal muscle sections. Light-microscopic images show toluidine blue- 
stained semi-thin longitudinal sections from hind limb muscle o fW T  (A) and AGAT-/- mice (D ) on a normal 
diet (ND, Cr-free). Magnification: 440x. AGAT-/- muscle shows an increased number of lipid droplets (small 
white dots in (D )) when compared to the muscles of the controls. EM  images of hind limb skeletal muscle of 
AGAT-/- muscle (E,G,H), demonstrated that the lipid droplets were mainly present in close vicinity of the 
mitochondria (see G). In AGAT-/- muscle multiple mitochondria contained electron dense bodies between the 
mitochondrial cristae membranes; an example is shown in (H). EM  images ofW T  mice on ND showed normal 
skeletal muscle for comparison (B). After 12 weeks of Cr supplementation (F), the number of lipid droplets in 
the EM  images of the AGAT-/- mice decreased to normal amounts and the abnormalities in the mitochondria 
were no longer observed. Cr supplementation did not show any changes in the WT mice. Magnification of the 
EM  images: 12000x.
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5.3 RESULTS
M orphology— Light and EM microscopy images of hind limb muscle tissue demonstrated two 
important morphological abnormalities in a part of the muscle fibers of AGATV- mice (fig. 5.2). 
First, we observed a large increase in spherical structures characteristic for lipid droplets (fig. 
5.2 D,E,G). Those lipid compartments were mainly found in the surroundings of the 
mitochondria (fig. 5.2G). Secondly, the AGATV- muscle preparations contained electron dense 
layers, typical for crystal structures, located within numerous mitochondria (fig. 5.2H). Upon 12 
weeks of Cr supplementation, muscle fibres of the knockout mice presented amounts of lipid 
droplets that were comparable to the numbers seen in the WT mice. Moreover, the crystal 
structures in the mitochondria were no longer observed. Hence, the abnormal morphology that 
we observed in the AGATV- mice on a Cr-free diet was completely restored after oral Cr 
treatment.
Grip streng th— Grip strength in the knockout mice was significantly reduced to 30% of the WT 
value (fig. 5.3). Strength of heterozygous littermates did not differ from that of WT controls. Cr 
supplementation improved grip strength in all groups; however the gain was only significant in 
the knockout mice, which showed a complete recovery of functionality as muscle force was no 
longer different from that of the WT mice. Furthermore, AGATV- were hypotone - hanging down, 
when lifted by their tail and could therefore easily be identified by the animal care takers.
1300
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Figure 5.3: Reduced grip strength in AGAT-/-. Muscle force was determined by grip strength tests in wild 
type (+/+), heterozygous (+/-) and AGAT deficient knockout (-/-) mice on a Cr free diet and after 12 weeks of 
Cr supplementation. Muscle force in mN was determined by grip strength tests. Values in mean ± SEM, n = 5­
10 per group. Significant differences determined by a student t-test: *** p < 0.001 compared with all other 
groups.
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Bod y w e ig h t and  m uscle m ass— Body weights were significantly reduced in the AGAT-/- mice 
(19.7 ± 2.2 g, n = 8) in comparison to WT littermates (37.8 ± 7.1 g, n = 5). This was accompanied 
by a severe decrease in muscle volume as seen on cross-sectional gradient-echo MR images of 
hind limb muscles (fig. 5.4A), which demonstrate a reduction in the average relative muscle 
volume in AGAT-/- mice to 34 ± 9% (n = 5) of wild type controls (100 ± 21%, n = 4). The muscle 
atrophy was not only confined to the leg muscles, also the posture and paraspinal muscles of the 
knockout mice must be affected, as all mutant mice developed thoracolumbar kyphosis.
Cr supplementation during 3 months resulted in a gain in total body weight in the AGAT-/- mice 
up to 56% of the Cr depleted value (fig. 5.4C), while the age matched WT controls showed only a 
19.3 ± 4.7% increase in weight upon Cr intake. This is not significantly different from the 
increase in weight of the WT on a normal diet, ND (15.3 ± 2.2%). Age-matched AGAT-/- mice on a 
ND, in contrast, showed no increase in body weight at all. Weights of heterozygous mice either 
on a Cr-free or Cr-rich diet (data not shown) did not differ from WT.
Besides the normalization of body composition (i.e. water, fat and lean mass) under Cr 
supplementation (Chapter 4), skeletal muscle volume was also recovering, as demonstrated by 
the increase in cross sectional muscle areas (fig. 5.4B) and disappearing kyphosis.
(A ) (B ) (C)
r r p a t i n p  c i  i n n lp m p n t a t in n
Figure 5.4: Relative muscle volumes before (left) and upon Cr supplementation. (A): Cross-sectional 
gradient echo images of hind limb acquired with TR = 250 ms, TE = 5 ms, FOV 20x20 mm, 256 x 256 matrix. 
(B ): Increases in relative muscle volume of AGAT/- mice during Cr supplementation (1.0 %  in water), as 
determined from the cross sectional spin echo images of hind leg. Some typical images are displayed below 
the graph (TR/TE=1500/12 ms, 10 slices, 1 mm slice thickness, FOV = 12 x 12 mm, matrix = 128 x 128, 2 
averages). (C): Body weights of AGAT deficient (-/-) and W T (+/+) mice before and during 12 weeks of Cr 
supplementation (0.5% in chow). Data in mean ± SEM.
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M etab o lite  leve ls  in  m uscle— In  vivo XH MR spectra of skeletal muscle of AGAT deficient mice 
kept on a Cr free diet, demonstrated a virtually complete absence of the signals for creatine at 
3.0 and 3.9 ppm. Taurine levels were not significantly different between AGAT-/- and control 
mice (fig. 5.5A and 5.6B).
As expected, the muscles without tCr signals in the XH MR spectra, also did not present a signal 
for PCr at 0 ppm in 31P MR spectra (fig. 5.5B). Moreover, these spectra did not show any signal 
for another phosphorylated guanidine compound that could replace PCr, such as 
phosphorylated forms of guanidinoacetate or arginine. The complete lack of PCr and Cr in the 
mutants only becomes manifest when the AGAT-/- mice are kept on a Cr deficient diet for a 
substantial time (> 6 months). Upon intentional Cr administration normal presence of PCr and 
tCr signals was observed, vide infra.
Interestingly, the lack of Cr in skeletal muscle of the mutants was accompanied by significantly 
elevated ratio’s of Pi/ß-ATP, i.e. 31P MR spectra of AGAT-/- muscle showed an approximately 
four-fold increase in this ratio when compared to WT levels (Table 5.1). As this could be caused 
by a lower ATP level, we determined the ratio of ß-ATP signal intensity divided by the muscle 
volume over five slices. This yielded significantly lower ATP levels per tissue volume in the 
AGAT-/- mice (63 ± 8 %  of WT levels). Muscle tissue pH as deduced from the chemical shift 
difference between a-ATP and Pi, was not statistically different between the two groups.
(A)
tCr
(B )
PCr
Y-ATPa  -ATP-  J U X J L
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Figure 5.5: MR spectra o f muscle obtained from  W T mice (top) and AGAT-- mice on a Cr free  diet. (A):
1H MR spectra obtained in a 16 \ih voxel with STEAM localization, TM = 10 ms, TE = 15ms, TR = 5s, 128 
averages. (B ): typical non-localized 31P  MR spectra obtained in hind-limb tissue. The unlocalized AGAT-~ 
spectrum was multiplied by four to increase visibility, which was a direct consequence of the severe reduction 
in muscle volume. Note the absence of tCr and PCr and the relatively large increase of the P i signal in the 
AGAT/- muscle.
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Table 5.1: Metabolite levels and pH in w ild type and AGAT-/- mice
WT
n = 5-6
AGAT-/- 
n = 8
AGAT-/- on Cr 
35 days, n = 4
In  vivo MRS
[tCr] 28.9 ± 2.9 4.1 ± 1.5 # 22.7 ± 2.0 # mM
PCr/ß-ATP 3.2 ± 0.1 0.3 ± 0.1 # 3.0 ± 0.3
Pi/ ß-ATP 0.5 ± 0.04 2.0 ± 0.3 # 0.6 ± 0.2
PCr/Pi 6.1 ± 0.6 0.1 ± 0.1 # 5.0 ± 1.5
pH 7.20 ± 0.06 7.25 ± 0.04 7.24 ± 0.04
ATP/volume 1.00 ± 0.06 0.63 ± 0.08*** Au
Biochemical
Cr 40.0 ±12.4 5.1 ±3.7### ^mol/g dry mass
PCr 75.2 ± 15.7 1.1 ± 3.2 ### ^mol/g dry mass
ATP 25.1 ± 3.1 13.5 ± 3.9 ### ^mol/g dry mass
ADP 4.5 ± 1.5 4.1 ± 1.3 ^mol/g dry mass
AMP 0.1 ± 0.1 0.4 ± 0.1 ^mol/g dry mass
Lactate 10.6 ± 5.2 11.5 ± 6.2 ^mol/g dry mass
PCr/ATP 3.0 ± 0.4 0.1 ±0.2***
ADP/ATP 0.18 ± 0.03 0.31 ±0.05***
ATP/AMP 256 ± 116 34 ± 10***
The mice used here were on Cr-free diet for at least 5 months. Values determined by in vivo MRS were 
corrected for relaxation differences (  T1., T2)  [tCr] is expressed in mmol /  liter tissue using a factor of 0.77 
for the intracellular water fraction. Absolute quantification of phosphate metabolites in skeletal muscle was 
determined in vitro on freeze-clamped hind limb muscle extracts and determined by HR liquid NMR 
spectroscopy. Data are expressed in mean ± SD. # statistically different at P < 0.05, ### statistically 
different at P < 0.001 when compared with WT littermates. Two-way ANOVA with Bonferroni pots test. ***
P < 0.001 when compared with WT littermates. tested with t-test.
Biochemical determinations of tissue metabolite concentrations confirmed the nearly complete 
absence of PCr in the AGAT-/- hamstring muscle. The homogenates demonstrated a ~87% 
depletion in Cr content in AGAT-/- muscles compared to the WT samples. PCr/ATP ratios in WT 
muscle calculated from biochemical determinations (3.0 ± 0.4) and from in vivo MR spectra (3.2 
± 0.1 ) were comparable, which indicates that both methods provide similar results.
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Remarkably, absolute ATP levels in the AGAT-/- muscle (13.5 ± 3.9 ^mol/g dry weight) were 
significantly reduced as compared to those in WT muscle (25.1 ± 3.9 ^mol/g dry weight, table
5.2). This biochemical finding of a decrease of 53% is in agreement with the MR results on a 63% 
reduction of ATP in AGAT-/- skeletal muscles. Taking this into account, absolute Pi levels in the 
AGAT-/- muscles are increased up to two-fold. Biochemically determined concentrations of ADP, 
AMP and lactate in muscle were not significantly different between WT and knockout mice, but 
ATP/ADP and ATP/AMP ratios were much lower in the AGAT-/- muscle.
M itochondrial enzyme activities— Because of the increased Pi/ß-ATP and the decreased ATP 
levels, we hypothesized that adaptive changes in oxidative phosphorylation might be present in 
AGAT-/- muscle. Therefore, we measured respiratory chain activities in isolated mitochondria of 
muscle tissue.
Enzyme activities of complex II and complex V, total ATPase and citrate synthase were 
significantly elevated when expressed per gram of ww muscle tissue. As CS is commonly used as 
a marker for mitochondrial mass, the elevation of CS activity (170% of WT levels) indicates an 
increased mitochondrial content in the mutant mice. The ratio of F-type ATPase (complex V) 
over total ATPase activity was comparable between the two groups, hence, not only F-type 
ATPase (CV) is increased by ~90%; the total ATPase activity per mitochondrial content is 
equally increased.
Using CS activity as a marker for mitochondrial content, activities of complex III and IV per 
mitochondrial content in AGAT-/- muscle were significantly decreased by 36% and 27 % 
respectively, (table 5.2). Although not significant, an increase is also seen in complex I (38%), 
thus the H+ pumping respiratory enzymes are downregulated in the mitochondria of the AGAT-/- 
muscle. The other respiratory enzyme activities per mitochondrial content were not significantly 
different between the two groups.
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Table 5.2: Respiratory enzyme activities normalized to CS activity
Enzyme activity (mU/ g ww) Enzyme activity (mU/U CS)
WT AGAT-/- WT AGAT-/-
Complex I 4.4 ± 1.1 4.4 ± 1.6 567±107 352±145
Complex II 2.8 ± 0.9 6.5 ± 2.8 * 372 ± 124 481 ± 129
Complex III 12.5 ± 2.6 13.4 ± 3.7 1622 ±208 1031 ± 273***
SCC 1.6 ± 0.4 3.2 ± 1.1 208 ± 39 240 ± 52
Complex IV 14.5 ± 3.7 17.7 ± 5.1 1866 ± 350 1355 ±295***
Complex V 4.5 ± 1.0 10.4 ± 3.2 *** 589 ± 109 815±250
Total ATPase 5.0 ± 1.4 10.8 ± 1.6 ***
CS 7.8 ± 1.6 13.3 ± 3.5 ***
Values in mean ± SD. n = 9 per group. Statistical significance when compared to WT: * p < 0.05, *** p < 0.001, two-way 
ANOVA. Abbreviations: complex I: NADH dehydrogenase, complex II: succinate dehydrogenase, complex III: ubiquinol- 
cytochrome-c reductase, complex IV: cytochrome-c oxidase, SCC: succinate dehydrognase, complex V: F1F0-ATPase, CS: 
citrate synthase.
Uptake o f creatine— Oral treatment of AGAT/- mice with Cr demonstrated a remarkably fast 
uptake of Cr in skeletal muscle, i.e. tCr signal intensities of 1H MR spectra from tibialis 
anterior/EDL muscle reached normal WT levels already in one day of supplementation (fig. 
5.6A). The majority of the Cr that was taken up by the muscle was immediately phosphorylated, 
as shown by the instant increase in PCr/ ß-ATP ratios upon Cr supplementation (fig. 5.6C). An 
initial overshoot in PCr/ ß-ATP was present during the first two days, which normalized after 11 
days of supplementation. Another initial change in metabolite content was observed; after 1 day 
of Cr supplementation, the taurine (Tau) levels in muscle showed a transient decrease (fig. 
5.6B). In contrast to the instant replenishment of (P)Cr, the high initial Pi levels in skeletal 
muscle of AGAT-/- mice normalized only slowly upon Cr administration taking more than 15 days 
to reach normal levels (fig. 5.6D).
Previously, we examined Cr supplementation in GAMT-/- mice in the same setup and with the 
same Cr dose administration (30), which allows for a proper comparison of treatment 
responses between both models with Cr deficiency (fig. 5.6A). Two apparent differences 
become visible by examining this figure. First, tCr uptake in AGAT-/- muscle occurs much faster 
than in GAMT-/- muscle. Second, the tCr amount in AGAT-/- levels off after about 2 days, while it
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continues to increase up to about 4 weeks of supplementation in GAMT-/- mice and becomes 
higher than those in AGAT-/- mice after about 2 weeks of supplementation.
Creatine breakdown— During a period of Cr restriction, both tCr and PCr levels gradually 
decreased towards zero, clearly following an exponential decay (the breakdown curve for PCr/ 
ß-ATP is shown in fig. 5.7 ■). The calculated values for the breakdown rates of tCr and PCr in 
hind limb muscle were 0.010 ± 0.002 day-1 and 0.015 ± 0.001 day-1, respectively. This 
corresponds to 1.0 and 1.5% breakdown per day. Interestingly, during the Cr restriction period 
Pi/ß-ATP ratios initially remained at normal levels, and only started to increase when PCr/ ß- 
ATP levels got below ~ 1 (fig. 5.7, Pi/ ß-ATP are represented by • ).
Days Days
Figure 5.6: Metabolic changes in muscle of AGAT-/- and GAMT-/- muscle during Cr supplementation.
Changes in total creatine (tCr) (A)and in taurine (B)tissue concentrations were obtained from 1H spectra of 
muscle from a 16 iL  voxel (STEAM) in the lower limb tibialis anterior/EDL in AGAT-/'- (m) and compared with 
tCr levels obtained in triceps surae in GAMT-/- (m) mice. GAMT-/- data were used with permission from HE Kan 
et al. 2007 (30). Changes in PCr/ß-ATP (C) and Pi/ß-ATP signal ratios (D) in hind leg muscle of AGAT-/- mice 
during Cr administration. These ratios were determined from unlocalized 31P MR spectra. Data in mean ± 
SEM, n > 3 per time point.
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Days
Figure 5.7: Changes in PCr and Pi levels in hind leg muscle of AGAT-/- mice during Cr restriction.
PCr/ß-ATP follows an exponential decay in AGAT-/- mice upon Cr restriction, whereas Pi/ß-ATP ratios 
gradually increase when Cr intake is restricted. Pi levels start to increase when PCr/ß-ATP ratios decrease 
below ~1.5. Metabolite levels in muscle were determined from unlocalized 31P MR spectra. Data in mean ± 
SEM, n = 3-4 per time point.
Ischemia experiments— In order to investigate the effect of Cr deficiency upon response to a 
metabolic challenge, we performed ischemia-reperfusion experiments on AGAT-/- and WT hind- 
limb muscles. The same experimental protocol was used previously for CK knockouts and GAMT 
deficient mice (11,19). Changes in Pi, PCr and pH during 25 minutes of ischemic occlusion of the 
hind limb were determined by 31P MRS in WT mice and AGAT-/- mice after 0, 2 and 21 days of Cr 
supplementation (fig. 5.8, for color figure, see Appendix). WT muscle showed the normal 
responses to ischemia: a decrease in PCr, an equal sized increase in Pi and, slightly delayed, a 
drop in pH, which reflects the respective roles of the CK-PCr system and glycolysis to maintain 
ATP levels in the absence of oxygen. We determined the flux through ATPase indirectly from the 
decreases in PCr levels (WT: 0.78 ± 0.86 mM/min) during the first seven minutes of ischemia, 
see also fig. 5.8.
In the AGAT-/- mice (day 0) tissue pH immediately started to decrease upon occlusion, eventually 
leading to a significantly reduced pH at the end of the ischemic period (6.52 ± 0.16) when 
compared to that of WT muscle (6.96 ± 0.04). The muscle of the AGAT-/- mice studied in these 
experiments contained small residual amounts of PCr (i.e. PCr/ ß-ATP ~ 0.5); its signal rapidly 
dropped below the detection lim it The initially elevated Pi levels demonstrated an increase 
upon ischemia, however, this was less pronounced than the elevation in the WT mice. Because of 
the very low PCr levels, ATPase rates could not be determined from ischemia experiments in
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AGAT-/- on a Cr free diet. ATP levels of these mice did not change during the ischemic period 
(data not shown).
AGAT-/- mice that were supplemented with Cr for two days, i.e. in which Cr concentrations were 
normalized, demonstrated decreases in pH at the end of the ischemic period that were 
comparable to the decreases observed in the WT mice. Interestingly, the increases in Pi/ß-ATP 
(S Pi/ß-ATP = 3.9 ± 1.5) in muscles of these mice after 25 minutes of ischemia were significantly 
larger than in WT muscle (S Pi/ß-ATP = 2.1 ± 0.7, P = 0.04, t-test). This nicely matches with the 
larger drop in PCr (S PCr/ß-ATP = 2.4 ± 0.5; see also fig. 5.8). The ATPase flux determined from 
the initial increase in PCr/ß-ATP in the AGAT knockout mice after 2 days of Cr supplementation 
was significantly larger than that of WT mice.
At 21 days of Cr supplementation all changes in PCr, Pi and pH during ischemic occlusion were 
similar to those of WT controls.
(D) ATPase flux
AGAT day 0 AGAT day 2 AGAT day 21
Figure 5.8: Metabolic responses to ischemia and calculated ATPase flux. Changes in PCr (A), Pi (B) and
pH (C) in skeletal muscle before and during an ischemic period. Concentrations and pH levels were 
determined from 31P MR spectra in WT (black), AGAT-/- on a Cr free diet (day 0, blue), and after 2 (red) and 
21 (grey) days of Cr administration. PCr and Pi signal intensities were normalized to the ß-ATP signal 
intensity before ischemia (ß-ATP0). Data in mean ± SEM, n = 5-7 per group. (D): ATPase rates were 
determined from the decreases in PCr during the first 7 minutes of the ischemic period. Data in mean ± SD, 
n=5-7 per group. * significantly different from WT muscle (P < 0.05). For color figure, see Appendix.
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5.4 DISCUSSION
In this study, we demonstrated that hind limb skeletal muscle of mice deficient in the AGAT 
enzyme completely get devoid of Cr and PCr, when the animals are kept on a Cr-free diet. This 
was not compensated by accumulation of another high energy phosphate and resulted in 
reduced tissue levels of ATP and elevated Pi levels. The absence of Cr was also associated with a 
loss of muscle mass, accumulation of intramyocellular lipids, morphological changes in the 
mitochondria, impaired grip force and increased ATPase activities. Interestingly, all 
abnormalities were reversed by oral Cr administration.
Changes in phosphate metabolites due to Cr deficiency. - Our studies showed a two-fold 
increase in muscle tissue Pi in Cr depleted AGAT-/-. Since plasma phosphate levels in AGAT-/- 
mice were not significantly elevated (data not shown), the elevated Pi levels in muscle do not 
originate from systemic hyperphosphatemia. Moreover, Pi levels in brain were only mildly 
elevated (Chapter 6). Hence, the elevated Pi levels seen in this study are a truly muscle specific 
consequence of Cr deficiency. Changes in several processes may have caused this, such as a 
direct effect of the absence of the CK-PCr system on phosphate transport or another steady state 
in ATP use and consumption (see paragraph below). An increased Pi might have several 
consequences, e.g. it may promote a cellular milieu that can maintain sustained mechanical 
output at the expense of maximal power of the fibers (31). In particular, it may be involved in 
respiratory mitochondrial stimulation at low and moderate exercise (32). In this context it 
would be interesting to confirm a potentially increased ability for endurance exercise in AGAT-/- , 
like CK deficient muscle that demonstrate a resistance to fatigue during low-intensity exercise 
(33).
However, increased Pi is also associated with inhibited force production, e.g. see (34).
The combination of elevated Pi levels, decreased ATP levels and elevated ADP/ATP ratios are 
indicative of a more oxidative metabolism, as demonstrated by the high similarity with the 
metabolite concentrations observed in cat, rat and mouse soleus muscles, which haves a high 
fraction of slow-twitch oxidative type I fibers (31, 35). Also the elevated activity of citrate 
synthase, F-type ATPase and increased availability of intra-myocellular lipid droplets point 
towards an upregulation of oxidative ATP production in mitochondria of resting AGAT-/- muscle. 
While the proton pumping respiratory enzymes are downregulated, the majority of the 
metabolic alterations suggest an increased oxidative metabolism in AGAT-/- muscle. This may be
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related to the enhanced energy expenditure that was indicated by the increased food intake in 
combination with a low body fat content (Chapter 4).
Cr deficiency and a non-functional CK system— Skeletal muscle normally contains substantial 
concentrations of Cr (~ 30 mM), which comprises > 90 % of the total body Cr content (36). At 
normal resting conditions, about 85% of the total Cr is present in the phosphorylated form. The 
virtually complete absence of Cr in the depleted AGAT-/- mice disables the PCr-CK system for all 
tissues, including skeletal muscle. Double CK knockout mice (CK=/= mice) with deletions in 
muscle specific CK-isoforms: i.e. cytosolic M-CK and mitochondrial ScCKmit (7, 21), also have to 
cope with the inability to use this system for ATP buffering in muscle fibers. Therefore, it is of 
interest to compare depleted AGAT-/- mice with these double knockout mice.
In contrast to the depleted AGAT-/- mice, in which Cr and PCr are absent, CK=/= muscle still have 
near-normal concentrations of tCr and a substantial amount of PCr in muscle (21). Further 
experiments suggested that the presence of PCr in CK=/= muscle could be due to minute amounts 
of B-CK, deposited in myotubes during the fusion process of myoblasts, which start their 
differentiation with high B-CK levels. The presence of some B-CK makes sense because CK=/= 
mice are subject to active muscle degeneration /  regeneration processes (37). As the PCr-CK 
system seems to be essential for myoblast differentiation and fusion (38), the potential for 
muscle regeneration in depleted AGAT-/- mice is likely severely hampered. Although CK=/= mice 
show reduced mass for some muscles (37), muscle atrophy is much more severe in depleted 
AGAT-/- mice. In CK=/= mice muscle atrophy may be caused by limited voluntary exercise (37), 
but as locomotor activity in depleted AGAT-/- does not appear to be different from wild type (see 
Chapter 4), it is more plausible that impaired muscle regeneration contributes to muscle 
atrophy, possibly next to other effects of severe Cr deficiency.
There are some other, but not all, aspects in which depleted AGAT-/- skeletal muscle resembles 
that of CK=/= mice. For instance both demonstrate a large(r) number of intramyocellular lipid 
droplets near mitochondria, reflecting a similar metabolic adaptation (7). In CK=/= muscle 
mitochondrial density is elevated, but no electron dense mitochondrial inter-membrane 
inclusions were reported (7, 39), indicating for the latter may be associated with mitochondrial 
ScCKmit While ATP levels are decreased and Pi is increased in depleted AGAT-/- muscle, ATP 
levels in CK=/= muscle were comparable to normal WT muscle and only mild elevations in Pi/ß- 
ATP ratios were observed under basal conditions (39-40). However, in CK=/= mice Pi/ATP ratios 
can be increased by an ischemic period without recovery of this ratio for at least a day thereafter
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(19). Moreover, both CK=/= and AGATV- muscle demonstrate abnormal functionality. Depleted 
AGAT-/- mice suffer from a reduced grip strength, while the absence of the CK system resulted in 
a lack of burst-activity upon electric stimulation (7-8).
Taken together, in comparison to muscle of CK=/= mice, depleted AGAT-/- skeletal muscle show a 
more severe phenotype at a metabolic and morphological level, which can be attributed to 
additional effects of inoperable PCr-CK systems of non- muscle cells present in (immature) 
skeletal muscle tissue and/or effects of the pure absence of Cr.
Energy metabolism in absence o f Cr— Absence or depletion of Cr in skeletal muscle and other 
body tissues has been studied for humans and mice with a defect in the genome encoding for 
GAMT. This enzyme catalyzes the final step in the synthesize route of Cr. GAMT-/- muscle in 
demonstrated accumulation of GAA and PGAA. The latter can serve as an alternative substrate 
for the CK reaction (11, 41), while hind limb muscle of AGAT-/- mice do not present an alternative 
HEP compound that can be used for ATP synthesis. In GAMT-/- muscle the grip strength was only 
reduced with 16% when compared to WT littermates (42) and Pi/ß-ATP in GAMT/- muscle was 
only increased by ~60% (11).
Upregulation in the activities of respiratory enzymes have also been observed in GAMT-/- brain 
and muscle (CS and Complex V (42)) and in GAMT-/- fibroblasts incubated in a medium free of 
creatine (complexes I, III and V (43)) . In the latter, the enhanced enzyme activities were still 
present after 1 week, but restored to normal after two weeks when the incubation medium was 
supplemented with 1 mmol/L creatine.
By administration of Cr analogs, in particular ß-GPA, creatine can be systematically depleted. 
This has several effects on muscular phenotype by inducing a rearrangement in steady-state 
levels of bioenergetically important phosphate compounds in resting muscle (14). The effects of 
Cr deficiency that we found in AGAT-/- muscle show similarities with adaptations in skeletal 
muscle of ß-GPA fed rats. Systemic GPA supplementation competitively inhibits Cr uptake by 
muscle fibers, where cytosolic GPA is reversibly phosphorylated to P-GPA by CK (44). Thus GPA 
is acting as a high energy phosphate trap and reduces Cr concentration (13). P-GPA can act as an 
alternative HEP in vivo just as P-GAA in GAMT/- mice, although the in vitro measured reactivity 
of MM-CK is much less efficient when compared to Cr (about 1500 fold decreased for P-GPA and 
100 for P-GAA (45).
Interestingly, ß-GPA fed rats showed a 50% decrease in ATP concentration in both slow and fast 
twitch skeletal muscle tissue, which is well in agreement with the decrease that we observed in
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depleted AGAT-/- muscle. Upon ß-GPA accumulation, glycolytic muscles demonstrate an 
enhancement of respiratory chain enzyme activities (complex IV and CS) in combination with a 
larger mitochondrial density (14, 17), as well as a switch from fast to slow myosin isoform 
expression and a 3.5 fold faster poststimulation oxidative recovery (46). Slow twitch muscle 
experience milder changes upon ß-GPA feeding, although poststimulus oxidative recovery was 
twofold increased (14).
The increased expression of GLUT4 transporters and a shift towards a more oxidative 
metabolism in skeletal muscle of ß-GPA fed rats (17, 46), suggest that absence of Cr leads to 
increased glucose uptake and catabolism in muscle, which is in agreement with the elevated 
glucose tolerance and insulin sensitivity that we observed previously in the AGAT-/- mice 
(Chapter 4).
It is worth to note that a critical energy-sensing role for AMP-activated protein kinase (AMPK) in 
promoting mitochondrial biogenesis in muscle was found in a comparative study between WT 
mice and AMPK knockouts both treated with ß-GPA (47). AMPK activation counteracts energy 
deficiency by increasing glucose transport by enhancing GLUT4 translocation (36, 48-49), 
stimulating ß-oxidation by inhibition of acetyl CoA carboxylase (50-51) and increasing 
mitochondrial enzyme activities (52). Those adaptations indicate upregulation of oxidative 
combustion and fit well with especially the large elevation in AMP/ATP ratio. This ratio is the 
determinant for the phosphorylation (= activation) of AMPK. The upregulation of AMPK activity 
is certainly an important point for further research to elucidate the underlying mechanism 
linking Cr depletion with increased insulin sensitivity.
Although a direct comparison between the severity of atrophy is not possible at this moment, 
the severe atrophia in the AGAT-/- mice occurs to a certain extend also in ß-GPA fed rats, as 
shown by decreases in the diameter of fast twitch fibers in the latter (17).
Moreover, electron dense mitochondrial inner membrane inclusion bodies have been reported 
in GPA muscle, presenting themselves initially only in slow-twitch muscle, but during longer 
GPA supplementation also in fast twitch muscle and heart (53). These structures were 
associated with high levels of ScCKmit, that co-crystallize within the mitochondrial cristae with 
unknown structures, possibly in the absence of a proper substrate (15, 53-54).
Altogether, findings in the present study indicate that enhanced aerobic metabolism occurs in Cr 
depleted muscle either as a consequence of ß-GPA administration, GAMT or AGAT deficiency. 
The results of our study suggest that the depleted muscles in AGAT-/- affect skeletal muscle 
tissue most severely, which could be explained by the fact that P-GAA in GAMT-/- mice, ß-GPA in
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rodents fed with this Cr analogue, or remaining PCr still can serve as a HEP buffer, whereas the 
PCr-CK system in depleted AGAT-/- muscle is completely non-functional (1). Although valuable 
information on consequences of Cr deficiency have been gained from studies performed on Cr- 
analogue fed models and GAMT-/- mice, the AGAT-/- mice in this study are the first model for pure 
Cr deficiency.
Ischemia and upregulated ATPase activity— To uncover further metabolic effects of pure Cr 
deficiency we subjected depleted AGAT-/- muscle to a period of ischemia. AGAT-/- mice showed 
an enhanced drop in pH in occluded muscle, which at least partly is due to the inability to 
employ the buffering capacity of the CK reaction, when oxygen supply is shut off. In agreement 
with this, a similar end-pH during the same ischemic protocol was observed in the double CK 
knockout, CK=/= (19). Interestingly, in these mice ATP declined by 30% during the ischemic 
period, with a proportional elevation in Pi and PME. Although ATP levels were lower in resting 
AGAT-/- muscle, they did not decline further during ischemic occlusion. This might at least partly 
be explained by ATP production from residual PCr (~ 3mM) in the muscles of the knockout mice 
that were used for the ischemia study, on top of ATP produced by glycolysis. However, the flux 
through the CK reaction was insufficient to clear all the produced H+. Further investigation is 
required to explore the responses to ischemia and exercising conditions at PCr levels below 3 
mM. Together with the upregulated ATPase activity in resting muscle after two days of Cr 
suppletion, the slow changes in Pi levels upon supplementation and breakdown indicate that 
there are slow adaptations in ATPase activity at the transcriptional level. Unfortunately, the low 
SNR of the 31P MR spectra of the small muscle volumes in AGAT-/- hampered accurate 
determination of post-ischemic recovery in AGAT-/- after two days of Cr supplementation.
Creatine supplementation— Both in patients with AGAT and GAMT deficiency, oral 
administration of Cr increased its levels in the central nervous system and improved neurologic 
condition (55-56). However, treatment responses in other tissues have not been investigated in 
patients thus far. In the present study we explored the uptake of Cr by muscle of AGAT-/- mice 
and demonstrated that muscle tissue was almost immediately replenished with Cr; i.e. tCr levels 
were normalized already after one day. The overshoot in PCr/ß-ATP ratios during the first two 
days of Cr supplementation can be explained by the lower ATP concentrations in the AGAT-/- 
muscle that are presumably caused by transcriptional adaptations and take more than a few 
days to increase from 13.5 ^mol/g dw to normal WT levels (25.1 ^mol/g dw).
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As muscle volume drastically increased upon Cr treatment, depleted AGAT-/- muscle tissue 
greatly benefits from Cr treatment not only from a metabolic point of view. The gain in muscle 
mass accounted for at least a part of the increase in body weight in response to Cr treatment, 
and is likely to involve increases in the volume of individual muscle fibers. A relation between 
muscle volume and Cr concentration was not only shown in ß-GPA fed rats in which Cr 
depletion was accompanied by decreases in the diameter of glycolytic muscle fibers ; Cr 
supplementation in healthy subjects has also frequently been associated with an increase in 
cellular volume, which might due to an osmotic effect of creatine (57-59). Interestingly, we 
observed a transient change in the level of another potential osmolite, taurine, in response to 
the rapid and large increase in tCr levels, which suggests a balance between taurine and Cr in 
osmolytic homeostasis.
A comparison between the rates of Cr uptake in AGAT-/- and GAMT-/- revealed that Cr in muscle 
of AGAT-/- mice immediately reached normal levels, whereas Cr concentrations in GAMT-/- mice 
increased substantially, but less pronounced during the first day of supplementation (30), which 
was then followed by a slower gradual increase reaching a supranormal steady state level. The 
delayed uptake in the GAMT-/- mice was explained by competition between the newly available 
Cr and the accumulated plasma GAA (44). On the other hand, it is not known whether AGAT/- 
mammals have a more profound upregulation of Cr transporters.
Creatine breakdown— The irreversible conversion of Cr and PCr into Crn is one of the few non- 
enzymatic reactions in vivo. Membrane permeability for Crn results in a constant diffusion out of 
the Cr containing tissues into the blood. Finally it is excreted by the kidneys into urine (1). Cr 
turnover is usually determined by 15N labeling studies yielding a measure for total body 
turnover. Previously, we reported on a 13C-labelling study of local turnover in human muscle 
where Cr content was increased by 13C-labelled supplementation resulting in minor changes in 
Cr content (60). The current study in the mouse model for Cr deficiency syndrome enabled the 
determination of tissue specific turnover/degradation of Cr in a 0 to 100% range. The results of 
the present study are in accordance with the total body Cr turnover of ~1.7 % (1, 61) and the 
local turnover we previously detected in skeletal muscle (60), as was expected for a non- 
enzymatic process and no involvement of rate limiting transporters.
In the case of ischemia or exercise in healthy muscle PCr and Pi concentrations change, while 
total phosphate content is maintained. Hence, there is a linear inverse relation between Pi and 
PCr levels (see dotted line fig. 5.9 for changes during ischemia in WT subjects). However, when 
we plot the different time-dependence of changes in PCr/ß-ATP (x-axis) and Pi/ß-ATP (y-axis) in
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AGAT-/- muscle during the uptake and breakdown period, as illustrated in fig. 5.9, a difference in 
kinetics in PCr and Pi between Cr uptake and Cr breakdown is apparent. Figure 5.9 
demonstrates that both during Cr replenishment and restriction total phosphate content is not 
maintained. During Cr supplementation replenishment of (P)Cr occurred instantly, while the 
high initial Pi levels in skeletal muscle of AGAT-/- mice normalized only slowly, taking more than 
15 days to reach normal levels. Apparently, the large amounts of Pi were not directly depleted to 
phosphorylate the Cr taken up by the muscle cells, The slow normalization of Pi levels upon 
administration of Cr indicates that processes at a transcriptional level are involved. This makes 
sense for Cr deficient muscles that have adapted towards a predominantly oxidative metabolism. 
A similar phenomenon was observed in the GAMT-/- mice during Cr supplementation, as (PCr 
+PGAA)/ATP ratios after two days of Cr administration were increased when compared to 
normal PCr/ATP ratios, while Pi/ß-ATP was also still beyond normal WT levels (11).
In conclusion, this mouse model, that can be switched between Cr saturated and Cr depleted 
conditions, provides a unique opportunity to study muscle metabolism and morphology in 
absence of Cr without compensation by accumulated guanidino compounds. When compared to 
CK deficient muscle, the more severe phenotype presented in AGAT-/- mice on a Cr free diet, 
provide evidence for an important role of Cr in skeletal muscle integrity, apart from being a 
substrate in the CK reaction. The effects of Cr depletion on muscle tissue show some similarities 
with the phenotype of Cr depleted GAMT-/- mice and ß-GPA fed rodents. The phenotype in 
depleted AGAT-/- muscle appears more pronounced, which is not so surprisingly as it is the only 
model in which Cr is completely depleted and no alternative HEP buffer is available. As for the 
other models of CK-PCr system deficiencies, depleted AGAT-/- muscle adapt towards a more 
oxidative metabolism. We have demonstrated that transport of Cr into muscle tissue is very 
efficient; therefore, Cr deficiency in skeletal muscle is easily rescued by dietary Cr intake.
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PCr/ß -ATP
Figure 5.9: Changes in PCr and Pi levels in hind leg muscle of AGAT-/- mice during Cr administration 
and restriction Ratios of PCr/ß-ATP and Pi/ß-ATP during Cr supplementation (■) and Cr restriction (■). 
Note the fast uptake in PCr and slow adaptation of Pi levels during Cr treatment results in an immediate 
increase of total phosphate content in muscle. During Cr restriction Pi levels start to increase when PCr/ß- 
ATP ratios decrease below ~1.5. Metabolite levels in muscle were determined from unlocalized 31P MR 
spectra. Data in mean, n = 3-4 per time point. NB: the overshoot in PCr/ß-ATP during the first two days of Cr 
suppletion can be explained by adaptations in gene-expression resulting in decreases in [ATP] that are likely 
to be still present after only two days of Cr supplementation.
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Chapter 6
Cerebral creatine: uptake, depletion and reduced 
ischemia-recovery responses 
in mice with a targeted disruption of 
arginine:glycine amidino transferase (AGAT)
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i-arginine:glycine amidino transferase (AGAT) catalyzes the first and rate-limiting step in 
the de novo synthesis of creatine, a central compound in energy metabolism of the brain. 
In patients with AGAT deficiency the lack of this enzyme results in reduced creatine levels 
with severe consequences for brain functions. Recently, a knockout mouse model for 
AGAT deficiency (AGAT-/-) has been created, which gives new opportunities to study 
metabolic and functional roles of cerebral creatine.
The aim of this study was to validate that AGAT deficiency in this mouse model has 
similar metabolic consequences for brain tissue as reported for AGAT-deficient patients. 
We monitored creatine levels during depletion and oral creatine mono-hydrate 
supplementation and tested the susceptibility of these knockout mice to cerebral 
ischemia.
Magnetic resonance spectroscopy (MRS) measurements demonstrated a virtually 
complete absence of cerebral creatine and phosphocreatine in AGAT-deficient mice, with 
only mild abnormalities in other MR detectable metabolites. Longitudinal 1H MRS 
measurements during a period of oral creatine supplementation demonstrated that 
normal cerebral creatine levels were reached after ~20 days of creatine administration. 
This is slow compared to muscle tissue, most likely due to limited uptake over the blood 
brain barrier. Breakdown rates of creatine (1.7 %  per day) corresponded with whole 
body non-enzymatic degeneration. Compared to wild type controls, cerebral ischemia- 
reperfusion experiments resulted in significantly increased infarct volumes and more 
pronounced neurological deficits in the knockout mice. Interestingly, creatine 
supplementation did not ameliorate the recovery from stroke.
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6.1 INTRODUCTION
Creatine (Cr) plays an important role in energy homeostasis of the central nervous system 
(CNS). This is accomplished by creatine kinase (CK)-mediated phosphorylation of Cr into 
phosphocreatine (PCr). The latter functions as a high energy phosphate (HEP) reserve, which 
maintains ATP levels in energy demanding circumstances. In brain, two CK isoenzymes occur: 
cytosolic brain B-CK and ubiquitous mitochondrial UbCKmit. The importance of the CK system in 
brain has been demonstrated in studies on mouse knockout models lacking one or both 
isoenzymes (1-6). The Cr/PCr system in brain is involved in energy consuming processes such as 
Na+/K+-ATPase activity, membrane potential and Ca2+ homeostasis (7-8), neuronal growth cone 
activity (9), transport processes, velocity of mitochondria in primary neurons (10), glutamate 
uptake by synaptic vesicles (11) and cytoskeletal remodeling in astrocytes (12). In addition Cr 
appears to be involved in osmoregulation (13) and neuronal signal transduction as a 
neuromodulator (14) functions not directly related to the CK system. Furthermore, Cr appears to 
have a neuroprotective role in many chronic and acute diseases, such as Huntington's disease 
(HD), amyotrophic lateral sclerosis (15), stroke and others, for review see (16).
Brain tissue normally contains 8-11 mM of Cr, however, constant supply of Cr is needed as about
2 % per day is converted to creatinine (Crn). This non-enzymatic degradation of Cr is 
compensated by Cr from dietary intake and endogenous synthesis. The first and rate-limiting 
step in the de novo synthesis of Cr is catalyzed by L-arginine:glycine amidino transferase (AGAT, 
EC.2.1.4.1). This enzyme, which is expressed mainly in the pancreas and kidneys, but which also 
has been found in neurons, astrocytes and oligodendrocytes (17-19), facilitates the transfer of 
an amidino group from arginine to glycine, generating ornithine and guanidino acetic acid (20). 
The subsequent methylation of GAA to Cr is mediated by guanidino acetate methyltransferase 
(GAMT, EC2.1.1.2.) mainly present in the liver. Creatine that is synthesized in these organs or 
obtained from dietary intake is distributed by the circulation and actively taken up into the CNS 
by sodium- and chloride-dependent transporter proteins (21).
Patients with AGAT (22-23) or GAMT deficiency (24) have a low level or complete lack of Cr and 
PCr in the CNS, as demonstrated by XH and 31P magnetic resonance spectroscopy (MRS). The 
importance of an intact Cr biosynthesis system is shown by the clinical symptoms of these 
patients, i.e., developmental delay, mental retardation and a prominent disturbance of cognitive 
and expressive speech, for reviews see (25-26).
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Both the involvement of Cr in many energy requiring processes and the clinical picture of Cr 
deficient patients indicate important biochemical function for Cr in the CNS. Thus far, the 
consequences of Cr deficiency in brain metabolism and function have only been studied in AGAT, 
GAMT and Cr-transporter-deficient patients (for review see (26)) and in a mouse model for 
GAMT deficiency (18, 27). The latter showed accumulation of GAA, which is thought to have 
neurotoxic (28) and eleptogenic (29) effects. Thus the presence of this compound in GAMT 
deficient mice is expected to interfere with studies searching for ‘pure’ Cr effects. The recent 
generation of a knockout mouse model for AGAT deficiency (30) provides new opportunities to 
study consequences of pure Cr deficiency on brain metabolism and function.
The aim of this work was to investigate the impact of AGAT deficiency on brain tissue, by 
profiling its bio-energetic status. We studied the rate of Cr uptake into AGATV- brain and its 
breakdown by monitoring Cr levels during oral creatine supplementation and depletion. Finally, 
we tested the susceptibility of these knockout mice to a cerebral metabolic challenge by 
performing ischemia-reperfusion experiments.
Here, we demonstrate a complete absence of cerebral Cr and PCr in AGATV- mice kept on a Cr- 
free diet. Cerebral Cr levels were completely replenished within 3 weeks of oral Cr 
supplementation. Absence of cerebral Cr resulted in a markedly increased susceptibility to 
ischemic conditions.
6.2 MATERIALS AND METHODS
Animal generation— Arginine:glycine amidinotransferase knockout mice (AGATV- mice) were 
generated by homologous recombination in embryonic stem cells (30). Mice that were 
heterozygous for AGAT were bred on a Cr containing diet. Before the MR experiments, the mice 
were kept on an ad libitum but Cr-free diet for a > 3 months time period to prevent exogenous Cr 
contamination. As some mutants did not have the strength to reach the food compartment, food 
was put at the bottom of the cage to prevent interference of starvation with our results. All 
experiments were performed in accordance with the Guide for the Care and Use of Laboratory 
Animals and approved by the Institutional Animal Care and Use Committees (Hamburg and 
Nijmegen).
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Proton HRMAS on microwaved brain tissue— Adult mice were anesthetized with isoflurane 
(1.5 - 3.0 % in a gas mixture of 25/75 % 02/air) before the head was microwaved for 0.95ms at 
4 kW (Gerling GA5015, US) in order to stop all enzymatic conversions. Brains were removed and 
stored at -80 °C. A piece of 4-8 mg brain tissue (cortex) was cut from the frozen brain.
HRMAS NMR was performed on a Bruker DRX 500MHz spectrometer, equipped with a XH 
optimized HRMAS probe head (31). The space around the tissue in the teflon rotor was filled 
with D2O, including tetramethylsilane (TMS, ô = 0 ppm) as a frequency reference. NMR spectra 
were acquired at 4 °C at a magic angle spinning rate of 4 kHz. Magnetic field locking was 
performed on the D2O signal. 1-D XH NMR spectra were recorded using a Carr, Purcell, Meiboom, 
Gill (CPMG) pulse sequence (32) with a 30 ms T2 filter, an excitation band width of 12 ppm, an 
acquisition time of 1.36 s and 256 transients were collected with a repetition time of 6.5 s. The 
water resonance was suppressed by presaturation. The total measurement time was 29 min. 
Signal intensities of N-aspartyl aspartate (NAA, methyl protons at 2.02 ppm), total creatine (tCr, 
methyl protons Cr at 3.03 ppm and PCr at 3.04 ppm), taurine (Tau, triplet at 3.40 ppm), myo­
inositol (Ins, 3.60 ppm, 4CH + 6CH triplets), glutamate (Glu, 2.34 ppm, multiplet), glutamine (Gln 
2.55 ppm, multiplet) and y-aminobotyric acid (GABA, 2.28 ppm, triplet ) were determined by 
fitting Lorentzian line shapes to the resonances using Topspin software (Bruker, Biospin inc.) 
and corrected for the number of protons. Tissue concentrations were calculated using the Ins 
signal intensity as an internal reference, assuming a concentration of 6.0 mM in the cortex (33). 
Spectra with a Lac concentration exceeding 10 mM were excluded, as this indicated that the 
microwaving had not been performed accurately in those cases. Statistical significance for 
individual metabolites between WT and AGAT-/- mice was tested using a two-way ANOVA.
Creatine uptake and breakdown studied by in vivo 1H MRS— Cr uptake and breakdown in 
brain of AGAT-/- mice and wildtype control mice (WT) was determined by sequential in vivo XH 
MRS measurements (34).
In vivo MR experiments were performed on a 200 mm diameter horizontal-bore magnet 
(Magnex Scientific, Abindon, UK) interfaced to an MR Solutions spectrometer (MR Solutions, 
Surrey, UK) operating at 300.22 MHz for XH and at 121.53 MHz for 31P. The horizontal magnet 
was equipped with a gradient insert with gradient strength of 150 mT/m, rise time of 150 ^s 
and free bore size of 120 mm. Cerebral metabolite levels were studied non-invasively by 
longitudinal 1H MR spectroscopy measurements. For these experiments the mice were 
anesthetized with 1.0-1.8 % isoflurane in a gas mixture of 25/75 % 02/air. Body temperature
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was controlled at 37 ± 1°C with a rectal temperature sensor (Luxtron 712, California, UA) and a 
warm water blanket. Between two subsequent measurements at least 10 days were taken into 
account to minimize effects of recovery from anesthetics on the results. All experiments were 
approved by the local animal ethics committee.
Cr uptake in brain was determined in 11 female AGAT-/- mice (divided over three groups). Each 
group underwent three or four times an MR experiment resulting in spectra at day 0, 1, 3, 7, 11,
15, 25, 30, 36 and 45 of Cr supplementation.^ was administered ad libitum via the drinking 
water (5.32 g/ 500mL) during a period of 45 days. Additional glucose (4.32 g/500 mL) was 
added to compensate for the bitter taste of Cr when dissolved in water (34-35). Significant 
differences in tCr levels between the two groups at day 0 (before Cr supplementation) were 
tested with a student-1 test.
Multislice gradient echo images were recorded in transversal (TR = 4000 ms, TE = 4 ms, 10 
slices of 1 mm) and horizontal (TR = 4000 ms, TE = 10 ms, 4 slices of 1 mm) directions in order 
to determine voxel positions for the localized MRS measurements.
XH MR spectra were obtained from brain tissue of knockout and control mice using an elliptical 
XH surface coil (15 x 11 mm) and a STEAM sequence (36), which enabled signal acquisition from 
a 2.2 x 2 x 2 mm3 voxel located partially in thalamus and hippocampus (TE = 15 ms, TM = 10 ms, 
TR = 5 sec, 256 averages) (34). VAPOR was used for water suppression (37-38). Guided by 
gradient echo images, we avoided inclusion of ventricles in the volume of interest. The XH MR 
brain spectra were analyzed with LCModel software to obtain tCr concentrations (39). Absolute 
quantification was obtained by the water signal from the unsuppressed spectra (34), assuming a 
mean tissue water content of 78% (1).
The assessment of the rate of Cr breakdown was performed in AGAT mice (n = 8, two groups) in 
which the Cr supplementation period was followed by a period of Cr free diet. XH MRS 
measurements were performed at 5, 15, 35, 55 and 85 days of Cr restriction. Breakdown rates of 
Cr were determined by fitting the tCr signal intensities to the following equation representing 
the kinetics of non-enzymatic degradation:
[tCr ] =  [tCr ]0 * e [61]
In this equation t represents the number of days on a Cr free diet, [tCr]0  is the concentration of 
tCr at the last day of the Cr supplementation period and k is the Cr breakdown rate.
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Phosphate metabolites determined by in vivo 31P MRS— In vivo 31P MRS measurements were 
performed, on the same 7T scanner. These measurements were only performed on AGAT-/- and 
controls on a Cr free diet (day 0). Two 31P surface coils working in quadrature mode were used 
to record 31P MR spectra in brain of 4 AGAT-/- and 5 control mice (3 heterozygous and 2 wild 
types). 31P localization was accomplished by ISIS using adiabatic hyperbolic secant pulses for 
inversion followed by a rectangular 90° RF pulse for excitation (TR = 6750 ms, 512 averages, 
4096 samples). The volume of interest (6x6x4.5 mm3) covered most of the brain except the 
cerebellum and excluded contributions of 31P signals originating from masseter muscles. 
Zero-filling nor apodization were applied before gaussian line shapes were fitted to the PCr, Pi, 
PME and the three ATP signals using AMARES (http://sermn02.uab.es/mrui). Line widths of the 
ß-ATP resonance complex were fixed to those of a-ATP (including the NADPH signal). Pi and 
PME line widths were constricted to 1.3 times the line width of y-ATP. All signals were corrected 
for T1 relaxation (27). Metabolite levels were expressed as a ratio over the signal intensity of y- 
ATP. Determination of the pH from the chemical shift between Pi and PCr (40) was not possible 
in the AGAT-/- deficient mice (due to the lack of PCr). Therefore we determined cerebral pH 
levels from the chemical shift difference (S) between Pi and a-ATP, whose frequency does not 
shift in the physiological pH range (40). Differences in metabolite levels and pH between AGAT-/- 
and WT animals were tested using a two-way ANOVA with Bonferroni post test.
Middle cerebral artery occlusion (MCAO)— AGAT-/- mice and wildtype controls (age 12-15 
weeks) were anesthetized with 3-4 % isoflurane during initial induction and 1.5-2 % during 
surgery obtained by passing 100 % oxygen (0.4-0.5 L/min) through an isoflurane vaporizer set. 
After initial induction, mice were injected intraperitoneally with buprenorphine (0.05 g/kg). 
Temporary occlusion of the middle cerebral artery was initiated thereafter by the intraluminal 
filament method (6-0 nylon) as previously described (41-43). Briefly, the left common and 
external carotid artery were isolated and ligated (5-0 silk). A monofilament (6-0 nylon, blunted
0.22-0.24 mm) was inserted into the external carotid artery and advanced into the middle 
cerebral artery until light resistance is felt (roughly 9 mm). The filament was removed after 
thirty minutes.
Neurological deficits were examined immediately and one day after MCAO using a six-point 
scale as described previously (44). Specifically, no neurological deficit = 0; failure to extend left 
forelimb = 1; circling to left = 2; falls while walking = 3; does not walk spontaneously = 4; dead =
5.
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To measure the infarct volume, brains were removed on day 1 after MCAO and evaluated using 
2,3,5-triphenyltetrazolium chloride staining of 1-mm thick brain slices (44). The stained 
sections were scanned (2.400 dpi), the digitized images of each brain section and the infarct 
area were quantified using a computerized image analysis program (Image J, USA).
Statistical analysis— Data are given as mean ± SD, if not stated otherwise. The following 
statistical tests were applied: two-tailed t-test for comparisons between the WT and AGAT-/- 
mice, one-way ANOVA when comparing WT, AGAT-/- and Cr supplemented AGAT-/- mice, and 
two-way ANOVA for multi-parametric measurements with Bonferroni’s post test (GraphPad 
Prism, version 4, La Jolla, USA). Statistical significance was considered for P < 0.05.
6.3 RESULTS
Cerebral metabolites — Knockout mice with a targeted disruption in the genomic locus of 
AGAT, when kept on a Cr free diet and housed separated by genotypes, demonstrated a virtually 
complete absence of signals for creatine species (tCr) in in vivo XH MR spectra (fig. 6.1). Within 
the available signal-to-noise-ratio (SNR) of these localized in vivo XH MR spectra, the levels of the 
major metabolites NAA, Tau, Ins and Glx showed no differences between AGAT-/- mice and WT 
controls. Metabolite levels also were investigated with a higher accuracy by HRMAS XH NMR 
spectroscopy of microwaved cortex tissue (fig. 6.2). In accordance with the in vivo data these 
spectra also show an absence of tCr signals at 3.0 and 3.9 ppm. As in the in vivo spectra, the 
levels of the MR visible metabolites in AGAT-/- cortex tissue were similar to the levels of WT 
samples, except for a significant increase in glutamine (6.5 ± 2.6 mM in AGAT-/- vs 3.0 ± 0.9 mM 
in WT).
To investigate the effects of AGAT-/- deficiency on the HEP-metabolite profile, we determined 
levels of the most abundant phosphate containing compounds by localized 31P MRS (fig. 6.3). 
This showed that after a period on a Cr free diet (see below) AGAT deficient mice are completely 
devoid of PCr in the brain. No accumulation of other phosphorylated guanidino compounds such 
as PGAA or PArg, was observed. Tissue pH and Pi/y-ATP ratios were not different from normal 
wild type levels, while the PME/y-ATP ratios were increased (fig. 6.4, table 6.1).
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Figure 6.1: Brain 1H MR spectra of AGAT/- and WT control m ice. The lower two spectra of the knockout 
mouse are obtained from the same mouse before and after 21 days of Cr supplementation (middle). The 
STEAM localized spectra (voxel size = 8.8 fiL, TR = 5 s, 256 average, 5 Hz Lorentzian apodization) were 
acquired in the thalamus/hippocampus region as shown in the MR images in transversal (TR = 4000 ms, TE 
= 10 ms, 4 slices of 1 mm, FOV 15x15 mm, 128x128 matrix) and coronal (TR = 4000 ms, TE = 4 ms, 1 mm slice 
thickness, FOV 12x12 mm, 64x64 matrix) directions on the right. Note that the absence of tCr in AGAT-/- is 
rescued after 21 days of Cr supplementation via the drinking water.
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Figure 6.2: Tissue levels of brain metabolites. Metabolites were determined by HRMAS measurements on 
microwaved cortex tissue ofWT (n = 8) and AGAT-/- mice (n = 6) using a CPMG sequence with a T2 filter of 30 
ms. Concentrations were calculated using 6.0 mM of myo-inositol (45) as an internal reference (33). 
Significance levels when compared to wildtype cortex tissue on a Cr-free diet: ** P < 0.01, *** P < 0.001 (two­
way ANOVA with Bonferroni post test).
Abbreviations: NAA: N-aspartyl aspartate, tCr: Cr+PCr, Tau: taurine, GABA: y-aminobotyric acid, Glu: glutamate, Gln: 
glutamine.
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Figure 6.3:31P MR spectra of AGAT-/- and control brain. The in vivo spectra shown here are the summed 
spectra of 4 mice. They were obtained with ISIS localization, a voxel size of 162 - 220 fiL, TR = 6750 ms and 
512 averages. Note the complete absence of PCr in the AGAT-/- mice.
Table 6.1: Cerebral metabolite levels and pH determined by in vivo MRS
AGAT-/- 
(n = 4)
Controls
(n = 5)
)M(mrCt 0.98 ± 0.39 ### 11.06 ± 1.10
PCr/Y-ATP 0.09 ± 0.06 ### 1.57 ± 0.45
Pi/Y-ATP 1.0 ± 0.3 0.7 ± 0.3
PME/y-ATP 1.4 ± 0.3 # 0.9 ± 0.2
PDE/y-ATP 0.5 ± 0.2 0.3 ± 0.1
PH 7.13 ± 0.11 7.19 ± 0.11
Metabolite levels and pH were determined with 1H and 31P MRS methods. All mice were on a Cr free diet. 
Values in mean ± SD. Difference in tCr levels (determined by 1H MRS) was tested with a t-test. All other values 
were obtained from 31P MR spectra and tested with a two-way ANOVA with Bonferroni post test. Statistical 
significances when compared with control mice: # p < 0.05, ### p < 0.001.
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Creatine uptake and breakdown— With in vivo XH MRS measurements it is possible to monitor 
a number of brain metabolites, including creatine, in longitudinal studies of the same subjects. 
We therefore used this technique to detect time-dependent changes in Cr levels upon oral Cr 
treatment and Cr deprivation. During oral Cr supplementation, striatal tCr levels in AGAT-/- 
gradually increased from a depleted level to normal control levels after about 20 days (fig. 6.4, 
black dots).
As we previously studied GAMT deficient mice in the same setup and administering an equal 
dose of Cr (34), a proper comparison of the treatment responses in both models is possible. For 
this purpose the uptake curves of tCr for the GAMT knockout mice is also plotted in fig. 6.4 (grey 
dots). This figure demonstrates no clear distinction in the rate of cerebral Cr uptake between the 
two murine models for Cr deficiency.
During a period of 85 days of Cr restriction of mice, first supplemented to control Cr levels, we 
observed that tCr levels gradually decreased towards zero, clearly following an exponential 
decay (fig. 6.5). The calculated value for the breakdown rate of tCr in brain was 0.018 ± 0.009 
day-1; this corresponds to 1.8 % breakdown per day.
Days
Figure 6.4: Creatine uptake in brain ofAGAT-/- and GAMT-/- mice. tCr concentrations were obtained from 
1H spectra of a 8.8 ^ L volume located in the hypothalamus/hippocampus region. GAMT-/- data were used with 
permission from HE Kan et al. 2007. Data in mean ± SEM. n = 3 or 4 per time point.
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Figure 6.5: Creatine breakdown in AGAT-/ brain after 35 days of supplementation. tCr concentrations 
were determined by 1H MRS using water as a reference signal. Day 0 indicates the last day of the Cr 
administration. n = 3 or 4 per time point. WT reference values are given on the left side of the dotted line. 
Brain spectra were obtained from a 8.8 jxh volume in the thalamus/hippocampus region. Values are 
expressed as mean ± SD.
Middle cerebral artery occlusion— Focal cerebral ischemia was induced for 30 minutes by the 
insertion of an intraluminal filament in the middle cerebral artery. Neurological scores were 
determined one hour after the occlusion and showed comparable deficits in controls (1.9 ± 0.8, n 
= 7) and AGAT-/- mice (2.0 ± 0.3, n = 6), see fig. 6.6C. After 24 hrs of reperfusion, however, wild 
type mice showed an improvement in neurological score (1.3 ± 0.3, n = 7), whereas neurological 
deficits in AGAT-/- mice further deteriorated (2.7 ± 0.4, n = 6).
In order to investigate whether there was a correlation between the disturbed behavior score 
and the size of non-recovered brain tissue, brains were collected after 24 hr reperfusion. Slices 
were stained to show the infarct areas; typical examples for a knockout and a wild type are 
shown in fig. 6.6A. Analysis of the infarct areas of all mice showed that the ischemic area in 
AGAT-/- mice (56.5 ± 6.4 % of the hemisphere) was significantly larger than the average infarct 
volumes in the control group (23.1 ± 6.8 %, P < 0.01), see fig. 6.6B.
In order to evaluate whether AGAT-/- mice could be rescued from the enhanced susceptibility to 
stroke, we performed similar measurements on AGAT-/- that were treated with Cr from birth. 
Body weights of AGAT-/- mice normalized under 0.5 % Cr supplementation (WT 27.5 ± 0.7 g, 
AGAT-/- 26.5 ± 0.8 g), indicating proper Cr supplementation (see chapter 4). However, both 
neurological score and infarct sizes (48.3 ± 10.7 %; P > 0.05) did not differ significantly from 
untreated AGAT-/- mice. Hence, oral Cr treatment did not directly ameliorate stroke recovery in 
the AGAT-/- mice.
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Figure 6.6: MCAO induced injury and neurological scores in AGAT-- and WT control mice. (A)
Representative coronal sections stained with 2,3,5-triphenyltetrazolium chloride from an AGATL-' (right) and 
WT (right) brain. For color figure, see Appendix. Both brains were removed 1 day after the 30 min MCAO. 
Note the large infarct volume (white areas) in the AGAT-' sections. (B) Infarct volume of AGAT-' (n = 6), 
AGAT--- on a Cr enriched diet (CRD) (n = 6) and control (n = 7) mice determined from the stained slices that 
were taken out after 1 day of MCAO. (C) Neurological scores determined one hour and one day after MCAO. 
Values in mean ± SD. *P < 0.05 and ** P < 0.01 statistically different when compared with controls.
6.4 DISCUSSION
In vivo and in vitro MR spectroscopy measurements on brain of mice deficient in the enzyme 
AGAT showed a complete absence of cerebral Cr and PCr after a period with a creatine-free diet. 
Other differences in MR-visible metabolites were limited. Most importantly, the lack of Cr 
resulted in a markedly reduced capability to recover from stroke, which was shown by severely 
increased infarct volumes upon ischemia-reperfusion experiments. While cerebral Cr levels 
were successfully replenished in 20 days by oral Cr administration, recovery from stroke did not 
improve in AGAT-/- mice that had received Cr substitution before undergoing 
ischemia/reperfusion experiments.
Metabolic consequences of Cr deficiency in brain— Targeted disruption of the AGAT genomic 
locus results in AGAT deficiency, disabling the biosynthesis of Cr as shown by the depleted levels 
of circulating Cr in mutant mice that were fed with a Cr-free diet (see Chapter 4). Here we show 
that systemic Cr deficiency eventually leads to a complete lack of Cr in AGAT-/- brain, while this
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organ normally contains large tissue concentrations of 8-11 mM creatine in the mouse (33). 
With respect to the low levels or absence of cerebral Cr the AGAT-/- mice are a proper model for 
patients with inborn errors in the genomic locus for AGAT (23, 46).
In contrast to the accumulation of GAA in GAMT-/- mice (27), the lack of Cr in the AGAT-/- mice 
did not result in an accumulation of a Cr precursor or an alternative HEP compound at levels 
detectable by MR spectroscopy. This means that AGAT-/- knockout mice are an attractive model 
to study the pure effects of cerebral deficiency and supplementation of Cr; i.e. without potential 
interference of comparable substances.
At normal conditions a large part of the Cr in the CNS is present in its phosphorylated form as 
PCr; ~4 mM (1, 47). It is clear that as a result of the total absence of Cr, the AGAT-/- mice are not 
capable of using the CK system for ATP synthesis when the circumstances require so. Extensive 
investigation of mutant mice with deletions in the brain specific isoforms of CK (i.e. B-CK and/or 
UbCKmit) have already shown that the CK system plays an important role in maintaining ATP 
levels in cerebral tissue at circumstances of high energy demand. This was for example shown 
by their decreased susceptibility to chemically induced epileptic seizures, which was in 
accordance with the CK system having an important function in burst mode firing of action 
potentials (2, 6). Similar to AGAT-/- mice, double knockout models for both brain CK isoforms 
(BubCK=/= mice) demonstrate a total absence of cerebral PCr levels, which had no further 
consequences on the phosphor-metabolite profile: i.e. pH, Pi and ATP levels appeared normal in 
BubCK=/= brain. Cr was still present in BubCK=/= mice, although decreased by 20-30 %, which is 
in contrast to the virtually complete absence of Cr in the CNS of AGAT-/- mice. Thus in adult 
BubCK=/= mice it is still possible that Cr plays a metabolic role, that is lost in AGAT-/- mice. In the 
brain of AGAT-/- mouse PME levels appeared to be increased, but not in BubCK=/= mice (1). This 
elevation might reflect an adaptation in glucose metabolism, i.e. an accumulation of glucose-6- 
phosphate. As several PME compounds stimulate Mg2+-ATPase mediated glutamate uptake (11), 
it is of interest to investigate glucose metabolism, for instance with 13C labeling studies (see 
Chapter 7), which might also provide more information on the origin of the elevated glutamine 
concentrations. Glutamine is predominantly found in astrocytes, where it is synthesized from 
glutamate that is taken up from the synaptic cleft after neuronal release. Hence, further research 
could elucidate whether the absence of Cr affect normal neurotransmitter cycling.
A comparison of 31P spectra of AGAT-/- brain with those measured of skeletal muscle of AGAT-/- 
mice (Chapter 5), demonstrates a four-fold increase in Pi/ATP levels of skeletal muscle, whereas 
brain was capable of maintaining Pi/ATP ratios at a near-normal range. Apparently, systemic Cr 
deficiency has a lower impact on phosphate homeostasis in the CNS. In muscle this increase is
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partly due to a ~50% reduction in [ATP]; at this moment we cannot rule out a reduction in 
cerebral ATP levels.
Cr supplementation— In this study we observed a gradual increase of Cr taking about 20 days 
to reach normal WT values in the CNS. However, a previous study in skeletal muscle tissue of 
AGAT-/- mice showed that Cr and PCr levels were already normalized after one day of oral Cr 
supplementation (Chapter 5). The relatively inefficient uptake of Cr by the CNS compared to 
muscle has also been observed in a GAMT-deficient patient (48) and in GAMT-/- mice (34). 
Previous in vivo labeling studies on rats and mice showed that the CNS is able to take up Cr from 
the blood, even against a large concentration gradient (49-50), which is accomplished by the Na+ 
and Cl- dependent Cr transporter protein SLC6A8 (21, 51). This transporter is expressed in the 
micro capillary endothelial cells that form the BBB (17, 50, 52-53). However, SLC6A8 is not found 
in the astrocytes that surround the capillaries, which might be the main reason for the relatively 
inefficient uptake of Cr in brain tissue (17,19, 50).
Cr administration studies in humans, rats and mice have shown no (54-55) or a limited elevation 
of Cr in brain (35, 56-58) with respect to basal concentrations in healthy subjects. Our results 
show a saturation in Cr uptake in the CNS that levels off at normal Cr concentrations of WT 
controls. This is most likely due to down-regulation of transporter proteins at high Cr 
concentrations (59-60).
The virtually complete replenishment of cerebral Cr levels in the knockout mouse model for 
AGAT-/- is in accordance with previous reports on AGAT deficient patients, in which oral intake 
not only increased its levels in brain, but also improved neurologic condition (22, 46, 61). On the 
other hand, a comparative study in a few patients with either AGAT or GAMT deficiency 
suggested an enhanced uptake of Cr in the CNS in AGAT-/- patients (61-62). The less effective 
treatment response in the GAMT-/- patients was ascribed to a potential competition between the 
elevated GAA levels in blood and the administered Cr (63) or a neurotoxic effect of GAA 
accumulation. The similar uptake responses of Cr by the CNS of mouse models with AGAT and 
GAMT deficiencies in the present study (34), however, did not confirm the observations seen in 
patients. Furthermore, GAA is not taken up into brains of AGAT/GAMT double knockout mice 
that were on a 0.5 % GAA-containing diet (data not shown) indicating that GAA cannot pass the 
BBB and thus might not compete with Cr at the Cr transporter.
Creatine breakdown— This mouse model for cerebral Cr deficiency syndrome enabled the 
determination of tissue specific turnover/degradation of Cr in brain. The results of the present
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study are in accordance with the non-enzymatic conversion of Cr into Crn with a rate of ~1.7 % 
per day (8, 64). Although the depletion of Cr from normal to a complete absence takes several 
months, the results of the present study show that AGAT-/- mice have the attractive property to 
be switchable between states of complete Cr depletion and normal Cr levels by simply 
withholding them or feeding them with Cr. This does not only apply to systemic Cr levels, but is 
also observed in brain. In this way, any pre and postnatal adaptation that takes place in mice 
lacking the various isoforms of brain CK can be avoided.
Prophylactic effect of Cr in the recovery from cerebral ischemia— Oral supplementation of Cr 
has been demonstrated to be neuroprotective in a variety of experimental neurological disease 
models, including anoxia (65-67), trauma (68) and chronic diseases, e.g. amyotrophic lateral 
sclerosis (69-70), Huntington’s disease (57, 71-72), Parkinson’s disease and Alzheimer’s disease, 
for review see (16). The precise mechanisms for these neuroprotective effects are as yet unclear, 
although it is thought that the neuroprotective effect of Cr in these diseases might at least partly 
be due to the inhibition of neurotoxin-mediated cell death (73).
To investigate the importance of Cr in a situation in which it is thought to have a prophylactic 
effect, we performed acute injury induced cerebral ischemia-reperfusion experiments on AGAT-/- 
and control mice and compared infarct volumes and neurological deficits between the two 
groups. Our results show that after 30 minutes of MCAO followed by a 24hr reperfusion, both 
neurological deficits and infarct volumes are significantly larger in the knockout mice. Hence, Cr 
deficiency inhibits normal recovery from acute brain injury. As such, the increased infarct 
volumes of the AGAT-/- mice demonstrate major consequences of depleted Cr (and PCr) during 
ischemia and/or its recovery period, which is understandable as the latter is an energy 
demanding process.
Previous studies involving ischemia-reperfusion experiment in mice or rats that were treated 
with Cr for at least 3 weeks (74-75) demonstrated decreased infarct sizes compared to 
unsupplemented controls, however, both cerebral Cr and ATP levels did not show significant 
increases. This essentially ruled out an enhanced phosphorylation capacity -by increased PCr 
levels- as the predominant mechanism that ameliorates the capability to recover from ischemia. 
Other experiments have seen an inverse relation between (P)Cr levels and infarct site, e.g. in rat 
hippocampal slices preincubated with Cr (66), pre-supplemented neonatal rats (76), indicating 
a beneficial effect of Cr supplementation in some experimental models of ischemia/hypoxia. 
Indeed, this seems in agreement with the results on AGAT-/- mice a Cr-free diet. In contrast, our
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experiments on Cr-administered AGAT-/- mice indicate that the reduced capability to cope with 
anoxic situations cannot simply be solved by increasing (P)Cr levels in brain: both stroke sizes 
and neurological scores were still significantly elevated. Thus Cr might stimulate the recovery 
from cerebral ischemia by a mechanism independent of its energetic status or an adaptation to 
chronic Cr deficiency which takes a long time to restore after a period of Cr deficiency. Although 
restoration of energy balance during ischemia is essential for cellular survival; relatively little is 
known concerning the regulation of cerebral metabolic pathways in response to cerebral 
ischemia.
At this moment we cannot rule out that AGAT expression itself is involved in pathways involving 
regulation of mitochondrial function or processes such as apoptosis. An example of such a 
regulatory role is GAMT expression, which appears to be involved in p53-dependent apoptosis 
induced by glucose deprivation. It is argued that increased GAMT expression supports increased 
PCr levels in cells undergoing apoptosis or needing survival under conditions of nutrient stress 
(77-78). Another explanation might be given by the systemic decrease in GAA levels in the AGAT- 
/- mice. Even after supplementation this compound maintains absent as a consequence of the 
lack of AGAT-/- activity. GAA could be crucial for processes that determine cellular survival after 
stroke.
An important regulator of energy balance at various levels is AMP-activated protein kinase 
(AMPK) (79). This energy sensor is activated when the cellular energy balance is suboptimal, 
which is the case in the PCr deficient AGAT-/- brain. Studies on knockout mice with null-deletions 
for AMPK and rats in which AMPK was pharmacologically inhibited demonstrated that a 
decrease or total lack of AMPK results in significantly smaller infarct sizes compared with WT 
littermates (80-81). A relation between nitric oxide (NO) production and AMPK activation has 
been proposed to play a role in this mechanism. Further research is required to elucidate if a 
possible chronic upregulation of AMPK, mediating NO levels, is responsible for the decreased 
recovery from stroke in the AGAT-/- mice.
The Cr supplementation experiments of Prass et al., described above (74) already indicated an 
important role for Cr apart from being a substrate in the CK reaction; Cr supplementation 
improved vasodilatory responses in isolated middle cerebral arteries and reduced infarct 
volumes. Our experiments do not rule out this explanation, but raise the question if cerebral 
blood flow in AGAT-/- on 0.5% Cr supplementation is not ameliorated, which thus is of interest to 
be investigated in detail.
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We conclude that brain tissue of AGAT-/- mice can be switched from a Cr saturated to a Cr 
depleted state, by simply changing Cr intake. This provides us with a unique opportunity to 
study Cr uptake and metabolic effects of cerebral Cr deficiency without long term adaptations or 
interfering effects of accumulating compounds such GAA. The absence of Cr in brain shows only 
mild metabolic effects at common ambient conditions. However, chronic Cr depletion inhibits 
the ability to recover from cerebral ischemia, although our data suggest that it is not directly 
related to the presence of Cr. Hence, the precise mechanism that causes this effect remains to be 
elucidated.
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Chapter 7
Localized sensitivity enhanced in vivo 
13C MRS to detect glucose metabolism 
in the mouse brain
This chapter is based on:
Nabuurs CI, Klomp DW, Veltien A, Kan HE, Heerschap A. Localized sensitivity enhanced in vivo 
13C MRS to detect glucose metabolism in the mouse brain. Magn Reson Med. 2008 
Mar;59(1):626-30.
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The application of in vivo 13C MR spectroscopy to mouse brain models is potentially 
valuable for improving the understanding of cerebral carbohydrate metabolism and 
glutamatergic neurotransmission in various neuropathologies. However, the low 
sensitivity of 13C nuclei and contaminating signals of lipids in the relatively small mouse 
brain make this application rather challenging.
To meet these technical challenges, localized semi-adiabatic distortionless enhanced 
polarization transfer (DEPT) MR spectroscopy in combination with a continuous i.v. [1,6- 
13C2] glucose infusion was implemented to detect glucose metabolism in isoflurane- 
anesthetized mice at 7T.
The signal enhancement and high spectral resolution obtained in these experiments, 
enabled the separate determination of 13C label incorporation into as much as 13 
metabolites from a 175 .^L volume. Signal increases of glucose (C6), glutamine (C3, C4) 
and glutamate (C3, C4) were determined with a time resolution of 8.6 min. This study 
demonstrates an optimized MR method for the application of in vivo 13C MRS in mouse 
brain.
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7.1 INTRODUCTION
Energy metabolism in the brain and other organs has been frequently studied by in vivo 13C MR 
spectroscopy (MRS). With this method the conversion of 13C labeled compounds in metabolic 
pathways can be monitored after the infusion of 13C labeled substrates such as glucose. From 
this dynamic information the quantitative determination of substrate uptake and metabolic 
fluxes is possible with the help of metabolic models (2-5).
Most in vivo 13C MRS experiments on brain have been performed on relatively large volumes in 
humans and animals like primates or rats. Detailed in vivo 13C MRS studies of pathologies in 
humans may be cumbersome for various reasons such as high cost and demand on patient 
compliance. The application of dynamic in vivo 13C MRS to murine transgenic models, especially 
for transporter deficiencies, mitochondrial dysfunction, and energy related modifications in 
brain, would provide excellent opportunities to study metabolism in brain pathologies. 
However, until now 13C MRS of mouse brain has mainly been limited to experiments on tissue 
extracts (6). The first in vivo 13C MRS of transgenic mouse brain used surface coil localization to 
determine glucose clearance after a [1-13C] glucose bolus (7). The contamination of signals from 
naturally abundant 13C in lipids, originating from subcutaneous fat tissue, hampered the 
detection of other compounds, such as glutamate (Glu) and glutamine (Gln), in this study. 
Recently, we demonstrated the elimination of lipid signals by subtraction methods to monitor 
the time courses of label incorporation in Glu and Gln C4 and C3 in mouse brain at 7T (8). These 
studies were performed after a bolus injection of 13C labeled glucose, whereas fluxes are 
commonly calculated using a glucose infusion protocol that aims at achieving a step function in 
the 13C isotopic enrichment of plasma glucose.
In vivo 13C MRS of the small mouse brain is especially challenged by a relative low sensitivity. In 
the past several methods were introduced to increase sensitivity of in vivo 13C MRS. A first 
approach is infusing double labeled [1,6-13C2] instead of single labeled [1-13C] glucose, yielding a 
twofold signal increase for carbons in metabolites downstream of fructose 1,6-biphosphate (9). 
Secondly, SNR losses and potential errors due to subtraction can be avoided when making 
optimal use of localization techniques. Finally, the relatively low sensitivity of 13C nuclear spin 
systems can be improved by spin manipulating techniques like polarization transfer which yield 
a higher sensitivity than techniques based on the nuclear Overhauser effect (NOE) (7). While 
indirect Proton Observed Carbon Edited (POCE) spectroscopy generates the highest sensitivity,
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the direct 13C acquisition by cross polarization (10) or Distortionless Enhanced Polarization 
Transfer (DEPT) yields a larger chemical shift dispersion, which allows distinction of Glu and Gln 
at both the C2 and C3 position (11-13).
Another challenge of dynamic 13C MRS of the mouse is the difficulty to monitor blood glucose 
levels during the measurements due to its small blood volume. In studies of larger animals, 
blood samples are taken during the entire MRS experiment, enabling small adjustments in 
infusion rates to keep glucose at a steady state level. Parallel benchtop assessment outside the 
MR magnet can be a reasonable alternative to determine plasma glucose concentrations.
With this study we aim to show the feasibility of in vivo localized sensitivity enhanced 13C MRS of 
mouse brain. For this purpose an image selective in vivo spectroscopy (ISIS) localized DEPT 
sequence was combined with the infusion of double-labeled [1,6-13C2] glucose for time resolved 
monitoring of glucose metabolism.
7.2 METHODS
Animal preparation— All experiments started in the morning and were performed on male 
C57Black6/J mice (n=5, 33.4 ± 0.8 g, fed ad libitum), which were anesthetized with 1.5-1.8% 
isoflurane in a gas mixture of 25/75% O2/air. The mice were either artificially ventilated (n=3, 
Harvard Apparatus, Massachusetts, USA) with 150 strokes/min and 8 mL/kg, or they were 
breathing freely (n=2, breathing frequency = 80 - 120 per minute). Body temperature was kept 
at 37 ± 1°C using a warm water blanket and monitored with a rectal temperature sensor 
(Luxtron 712, California, USA). MR compatible electrocardiographs enabled heart rate 
monitoring. Glucose ([1,6-13C2] 99% enriched, 1.075M, Campro Scientific, Veenendaal, NL) was 
administered through the tail vein. A bolus of 130 mg/kg infused in 20 seconds was followed by 
a continuous infusion rate of 0.97 g/h/kg over 4 hrs. The total infusion volume during the 4h 
experiment was approximately 620^L.
In benchtop experiments under identical experimental conditions with artificial ventilation, 
blood glucose (orbital samples) was monitored before and every 10-30 minutes during 
unlabeled glucose infusion (n=5, 29.5 @± 3.9 g). This was performed to validate that steady state 
glucose concentration was above euglycemic levels (>5mM), as glucose uptake is a rate-limiting 
factor for brain metabolism at hypoglycemic conditions (14). Arterial blood gasses (pO2, pCO2,
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pH) were determined at the end of the experiment. All procedures were approved by the local 
animal ethics committee.
MR instrumentation— All experiments were performed on a 7T/200 mm horizontal-bore 
magnet interfaced to a broadband MR spectrometer (MR Solutions, Surrey, UK). The head of the 
mouse was positioned in the centre of a XH volume coil (birdcage, diameter=50 mm, length=55 
mm) to maximize B1 field homogeneity. An elliptical 13C surface coil (diameters: 14 and 12 mm) 
was positioned over the head of the mouse, covering nearly the entire brain for an optimal field 
of view. The surface coil fitted closely around the head of the mouse, which prevented vertical 
movements. In the ventilated mice, jaw movements were also prevented by the tube. A high­
pass filter (insertion loss at XH frequency: -0.4 dB, rejection at 13C frequency: -100 dB) was used 
in the XH RF channel to suppress noise from the RF amplifier in the frequency range of 13C. To 
prevent the preamplifier from saturation by the large RF power during XH decoupling, a low- 
pass filter (insertion loss at 13C frequency: -0.1 dB, rejection at XH frequency: -90 dB) was used 
at the 13C receiver channel.
In vivo 13C MR spectroscopy— Scouts and coronal multislice Gradient Echo images (FOV= 
25x25 mm2, matrix=256x256, 8-12 slices, TR=3500 ms, TE=7 ms, 1 mm slice thickness) were 
used for voxel positioning. Care was taken to avoid subcutaneous fat and cranial muscles in the 
region of interest. Manual localized shimming was performed with a STEAM sequence resulting 
in a full width at half height for the H2O signal of 27-30 Hz.
Localized in vivo 13C MR spectra were acquired using an ISIS localized semi-adiabatic DEPT 
sequence (12), which was adapted from a previous non-adiabatic DEPT sequence (11, 13). In 
short, localization was performed on the XH magnetization using 3D ISIS (15). The bandwidth of 
XH ISIS was 6.5 kHz leading to a chemical shift error of ± 5% in all three directions. A 
homogeneous XH transmit birdcage coil for maximal field homogeneity in the mouse brain was 
used for optimal 90° and 180° RF pulses in the XH part of the DEPT sequence even with hard 
pulses (16). This homogeneous XH coil also made spoil gradients less crucial for eliminating 
unwanted, offset-dependent amplitude oscillations.
1H magnetization was then transferred to 13C by a semi-adiabatic DEPT sequence using a 
segmented 0° adiabatic BIR4 pulse with 500 ^s elements on the 13C channel to compensate for 
B1 field inhomogeneities of the surface coil (13). The 3.4 ms inter pulse delay was optimized for 
Jch average = 145 Hz. A flip angle of 45° was used for the last XH pulse to enable simultaneous
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detection of signals from CH, CH2 and CH3 groups. Pulse durations at XH were 100 ^s, 200 ^s and 
100 ^s for the 90°, 180° and 45° pulses, respectively.
The theoretical sensitivity enhancement by polarization transfer of XH to 13C nuclear spins by the 
DEPT sequence in this experimental setup was tested on a [1-13C] glucose phantom using 3.3 ms 
interpulse delays for the 150 Hz Jch coupling and a 90° flip angle on the last XH pulse for optimal 
detection of the glucose CH bond. We used direct 13C detection with an adiabatic 90° pulse as a 
reference.
During 0.1 s of 13C acquisition, WALTZ-16 XH decoupling (17) with 900 elements of 300^s (i.e 
bandwidth = 100 ppm, yB1 = 833 Hz) was applied for 58 ms and centered at 2.6 ppm at a 
bandwidth of 5 ppm to cover all XH resonances of interest. Other parameters were: voxel size = 
5x5x7 mm3 , TR = 1000 ms and 256 averages resulting in a measurement time of 4.3 min per 
spectrum. A small phantom filled with 0.2 M alanine (13C labeled at C3) was fixed to the coil to 
check 13C acquisition and XH decoupling prior to infusion of 13C labeled glucose.
Data processing— Besides Fourier transformation and phase-correction, line-broadening was 
applied (-10 Hz Lorentzian and 10 Hz Gaussian), but no zerofilling or baseline correction. 
Glucose (Glc C6), glutamate (Glu C2, C3, C4), glutamine (Gln C2, C3, C4), GABA (C2), aspartate 
(Asp C2, C3), lactate (Lac C3) and the overlapping signal of GABA C4 and N-acetyl aspartate 
(NAA C3) were determined from two summed subsequent 13C MR spectra (8.6 min) using jMRUI 
software [version 3.0, http://www.mrui.uab.es/mrui/]. Lineshapes were fitted to Lorentzian 
curves, line widths of all metabolite signals were constrained to that of Glu C4 as determined 
from the last four spectra of each time course. Frequencies were fixed relative to the Glu C4 
resonance. Zero and first order phases for the total time course were fixed to values that were 
obtained from the last spectra of the experiment.
7.3 RESULTS
The XH polarization transfer to 13C nuclear spins lead to a signal enhancement factor of 3.5 for 
DEPT on the [1-13C] glucose signal as compared to the direct detection method, which is close to 
the maximal theoretical signal enhancement of four. Although broadband XH decoupling was 
realized using a volume coil, no additional noise was detected in the 13C MRS data, indicating 
proper functioning of the RF filters.
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The in vivo 13C MR spectra obtained during [1,6-13C2] glucose infusion demonstrated that the ISIS 
DEPT sequence ensured excellent localization in all mice as shown by the complete absence of 
lipid signals around 30 ppm (fig. 7.1). The high SNR provided by both the polarization transfer 
signal enhancement and the use of double labeled [1,6-13C2] glucose allowed simultaneous 
detection of signals from labeled brain glucose (Glc C6) and the carbons in metabolized products 
of glucose, i.e. Glu (C4, C3, C2), Gln (C4, C3, C2), Asp (C3, C2), GABA (C2) and NAA C3 + GABA C4. 
Lac C3/Glu C4 and Ala C3/ Glu C4 ratios at the end of the experiment were elevated in the 
artificially ventilated mice (1.08 ± 0.19 and 0.32 ± 0.06) as compared to freely breathing mice 
(0.14 ± 0.05 and 0.05 ± 0.01) (fig. 7.1).
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Figure 7.1: Localized in vivo 13C MR spectra of the brain in individual mice after infusion of [1,6-13C2] 
glucose using isoflurane anaesthetics. (A): This spectrum was acquired while artificially ventilating the 
mouse. It was obtained by adding spectra over the last hour (180-240 min) of the 4 hr glucose infusion in a 
175^1 volume at 7T. -10 Hz Lorentzian and 10 Hz Gaussian apodization, but no zerofilling was applied.
(B): A similar spectrum obtained from a mouse without artificial ventilation: the gas mixture with isoflurane 
was freely inhaled. The spectrum was also obtained during one hour (162-222 min) and shown with the same 
data processing. Note the much decreased Lac C3 signals. Abbreviations: Ala alanine, Asp aspartate, GABA 
gamma aminobutyric acid, Glc glucose, Gln glutamine, Glu glutamate, Lac lactate, NAA N-aspartyl aspartate.
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Signal intensities were sufficiently high to permit determination of label incorporation into 
carbons of multiple metabolites over time (fig. 7.2). The time courses of signal increase (time 
resolution of 8.6 min) clearly demonstrate that Glc C6 reaches a steady state plateau after 2 hrs, 
subsequently followed by Glu C4 and Glu C3 and Glu C2 (fig. 7.3).
The high spectral resolution at 7T enabled the distinction of Glu and Gln signals at C2 and C3 
positions. However, spectral resolution was not sufficient for detecting homonuclear 13C-13C J- 
coupling doublets of adjacent C3 and C4 glutamate or glutamine signals.
Initial blood glucose levels (8.6 ± 2.1 mmol/L) were similar to those of conscious mice (18). 
Benchtop experiments indicated that blood glucose levels stayed well above euglycemic levels 
(7.9 ± 2.1 mmol/L). At the end of these experiment pO2 values (26 ± 2 kPa) showed sufficient 
oxygenation, however pCO2 (4.8 ± 0.7kPa) and pH (7.26 ± 0.06) were rather low.
ppm
Figure 7.2: Typical time courses of 13C-iabeiing of cerebral compounds obtained from a 175pL volume 
in mouse brain a t 7T acquired using semi-adiabatic ISIS-DEPT. The 17.1 minute spectra were obtained 
during 4hrs of [1,6-13C2]glucose infusion while the mouse was ventilated with isoflurane.
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Figure 7.3: Temporal evolution of the 13C label in Glc C6 (a), Glu C4 and Gin C4 (b) and Glu C3 and Gin 
C3 (c) in mouse brain during [1,6-13C2]  glucose infusion. Signal intensities represent peak amplitudes 
obtained from 8.6 min spectra that were fitted with AMARES.The dotted lines represent Boltzmann sigmoidal 
fits for visualization purposes. Note that the label incorporation of brain glucose is preceding that of the 
neurotransmitters. As expected according to metabolic models and other studies, Glu C4 is followed by the 
label incorporation of Glu C3.
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7.4 DISCUSSION
In this study we showed the feasibility of dynamic localized detection of glucose metabolism in 
mouse brain by in vivo sensitivity enhanced 13C MRS during continuous [1,6-13C2] labeled glucose 
infusion. The technical challenges in the realization of these measurements in mouse brain, i.e. 
having to avoid lipid contamination and to deal with low sensitivity, were adequately met.
An important advantage of the 1H to 13C polarization transfer in the DEPT sequence is the 
possibility to combine sensitivity enhancement of 13C acquisition with 1H localization. While 
direct 13C localization suffers from large chemical shift displacement errors especially at higher 
fields, 1H localization takes advantage of a much smaller chemical shift dispersion of all relevant 
metabolite signals, thereby minimizing the chemical shift displacement errors to 5% when using 
a bandwidth of 6.5 kHz for the 1H ISIS localization (12,19). The accurate localization on protons 
in this study also provided an excellent method for completely eliminating lipid contamination 
from subcutaneous fat tissue, without the need for subtraction techniques and which may suffer 
from deterioration in signal-to-noise ratios and potential subtraction artifacts. The complete 
lack of lipid signals in the region of interest enabled accurate detection of Glu and Gln signals 
around 30 ppm.
The signal enhancement by DEPT and the use of double labeled [1,6-13C2] glucose yielded 
sufficient SNR within a 175 ^L volume to detect 13C label incorporation due to glucose 
conversions in the small mouse brain. Although polarization transfer techniques such as fully 
and semi-adiabatic INEPT have also been used in rat (9, 20), monkey (21) and human (22) brain, 
the SNR of our spectra is best evaluated by comparison with those from a study of Henry et al. 
(12), which also used a semi-adiabatic DEPT. These authors acquired a spectrum from rat brain 
using a voxel size of 400 ^L, achieved 18-23 Hz water line widths at 9.4T and summed spectra 
obtained over 1.8 hr, while we used a 175 ^L voxel that included ventricles, achieved 27-30 Hz 
line widths at 7T and summed spectra obtained over only 1 hr (fig. 7.1). Taking these factors 
into account, the signals in our spectra reflect the expected SNR.
Because of the high resolution of 13C MR spectra at 7T, the signals from Glu and Gln at C4, C3 and 
C2 could be separately detected. This allows the analysis of many time courses during 13C 
labeling which is an advantage compared to POCE techniques where Glu and Gln signals at C2 
and C3 may be difficult to resolve in mouse brain at this field strength (5). However, the spectral 
resolution in this study was not sufficient to detect 13C-13C J-coupling doublets of adjacent C3 and 
C4 glutamate signals. When compared to the line widths that were achieved in a more
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homogeneous voxel in rat brain (12, 23), the larger line widths in our study mainly resulted from 
the larger susceptibility differences in the volume that included almost the total mouse brain. 
The spectral resolution might be improved using recently reported alternative shimming 
approaches (24).
The limited number of mice included in this study allows us to draw only preliminary 
conclusions on differences seen between ventilated and freely breathing animals: i.e. the 
increased lactate production and the blood gas values that could indicate metabolic acidosis in 
the artificially ventilated mice might be caused by a particular physiological condition in our 
setup e.g. hyperventilation (25).
The sequential incorporation of 13C label into Glc C6, Glu C4 and followed by Glu C3 corresponds 
with previous results from rat and human studies (5), thereby confirming that common brain 
metabolism is assessed. The determination of metabolic fluxes in further studies would require a 
normalization of the 13C MRS signal integrals to the final isotopic enrichment and absolute 
concentrations of the metabolites, which can both be obtained from brain extracts. In addition 
an known input function of label into the brain as a time dependent function of isotopic 
enrichment is required (5). Unfortunately, the need for the collection of blood through long 
tubes and the relatively large blood samples hampered frequent sampling during the MR 
experiments. In the benchtop study we validated that blood glucose stayed above hypoglycemic 
levels and thus that cerebral metabolic rate of glucose was not limited by glucose uptake; 
instead alternative methods for determining both blood glucose and isotope enrichment in mice 
during MR experiments are needed.
We conclude that dynamic in vivo 13C MRS on mouse brain is feasible using [1,6-13C2] glucose 
and localized DEPT. This approach provides ways to explore fluxes through energy related 
metabolic pathways in various mouse models of human brain disease.
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Adenosine triphosphate (ATP) is the most essential energy-carrying molecule in living 
organisms. Hydrolysis of ATP into adenosine diphosphate (ADP) and inorganic phosphate (Pi) 
releases free energy, which becomes directly available for numerous energy-demanding 
processes. It is therefore essential for eukaryotic cells to maintain ATP concentrations. This is 
achieved by a complex system of metabolic processes, which ensure that ATP production and 
consumption are balanced in different tissues and under varying circumstances. ATP production 
is predominantly accomplished by aerobic or anaerobic combustion of carbohydrates and/or 
lipids. In tissues with high fluctuations in energy demand, such as skeletal muscle, the 
phosphocreatine-creatine kinase (PCr-CK) system plays an important role as a rapidly available 
phosphate buffer for ATP replenishment.
In vivo magnetic resonance spectroscopy (MRS) is a very suitable and non-invasive method for 
metabolic profiling or studying metabolic pathways by dynamic measurements. In this thesis, 
various MRS methods were used on muscle and brain tissue of different mouse models to study 
energy metabolism or characteristics of high energy phosphate compounds.
A unique feature of nuclear magnetic resonance (NMR) is the possibility to label a spin system 
magnetically by applying frequency selective pulses that introduce a non-equilibrium 
magnetization to this system. Subsequently, the transfer of this non-equilibrium magnetization 
to one or multiple other spin systems may be observed, the so-called magnetization transfer 
(MT) effect. Phosphate-exchange rates for metabolic reactions that produce or consume ATP 
have been successfully studied by observing MT effects in 31P MRS. Rates of ATP-producing 
exchange reactions are obtained from decreases in PCr and Pi signals upon selective saturation 
of the y-ATP resonance.
The motivation for the study described in Chapter 2 and 3, is the lack of unambiguous 
explanation for the origin of an additional and frequently observed MT effect on the ß-ATP 
resonance in those experiments. Two potential causes have been suggested in literature: (i) ß- 
phosphate exchange between ADP and ATP and (ii) MT effects due to relaxation processes. 
However, both options have never been properly investigated. The unclear origin of the MT 
effect was the reason for examining the MT effects involving the phosphate groups of ATP, using 
specific knockout mice to eliminate some of the exchange reactions that might play a role in this 
MT effect.
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First, Chapter 2 gives a model-based description concerning the time-dependent transfer of 
magnetization between two spin systems caused by the application of frequency selective 
saturation pulses. More specifically, a model is described which includes possible MT effects 
occurring in saturation transfer experiments on the phosphate resonances of ATP. All known 
possible transfers of magnetization due to phosphoryl exchange reactions between ATP, PCr, 
ADP and Pi were considered. Although free ADP concentrations in resting muscle are so small 
(<0.1 mM) that their MR signals are below the detection level of in vivo MRS, the resonances of y- 
ATP and ß-ADP are so close together that it is almost impossible to saturate either of them 
separately. For this reason, ß-phosphoryl exchange between ATP and ADP could give rise to the 
MT-effect on the ß-ATP resonance in saturation transfer experiments where the y-ATP signal 
was saturated. Assuming equal forward and reverse fluxes through solely the CK reaction, it was 
calculated that co-saturation of the ß-ADP should lead to a ~60% decrease in the ß-ATP MR 
signal.
In addition, the relaxation processes that can cause transfer of magnetization in a 31P-31P two- 
spin system were modeled: in a molecule that contains several spin systems, transfer of 
magnetization between the individual spins may occur without any involvement of chemical 
exchange reactions. This form of MT effect by relaxation is called nuclear Overhauser 
enhancement (NOE). The size of this MT effect depends on the type of nuclear spin, the mobility 
of the molecules, the distance between the spins and the strength of the magnetic field. Based on 
the values of these parameters for ATP free in solution, it was investigated whether it is 
theoretically possible to measure NOE effects caused by relaxation processes between the spins 
of 31P ATP at different field strengths. The result was that for ATP free in solution, the 
contribution of the chemical shift anisotropy (CSA) to the spin-lattice relaxation is so large that 
for magnetic field strengths >2 Tesla, NOE effects are below the detection level. However, NOE 
effects of free ATP could be observed, when this free pool is in exchange with a bound ATP pool. 
This indirect form of MT effect is referred to as transferred NOE (trNOE). Assuming a relatively 
small fraction of bound ATP (< 10%), this pool of molecules should have a very limited mobility 
compared to free ATP; this is possible when ATP forms complexes with receptor molecules that 
are larger than most ATP binding-enzymes.
Chapter 3 describes in vivo saturation transfer 31P MRS measurements on hind limb muscles of 
wild type and double-mutant mice lacking cytosolic muscle creatine kinase (CK) and adenylate 
kinase 1 (AK1) activity. The choice for these knockout mice eliminated the phosphoryl exchange 
reactions between ß-ADP and ß-ATP mediated by CK and AK, in order to simplify the potential
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causes for the MT effect seen on ß-ATP when saturating the y-ATP/ß-ADP resonances. These 
experiments showed, as expected, severely decreased CK fluxes in mutant muscle, while equal 
decreases of the ß-ATP signal occurred in wild type and mutant mice. Hence, neither CK nor AK 
significantly contribute to the MT effect on the ß-ATP resonance.
Interestingly, we found identical MT effects between the nearest-neighbor phosphates (a-ß and 
ß-y) of ATP in both wild type and knockout mice, and a decreasing PCr signal upon saturation of 
the ß-ATP spins in only the wild type muscle. These effects can only be explained by NOE effects 
between ATP phosphates. However, from the calculations in Chapter 2 it was already concluded 
that direct NOE effects in ATP are not detectable due to the large contribution of the CSA to the 
spin-lattice relaxation of the 31P spins. The conclusion was that these effects may only occur if 
ATP forms short-living complexes with slowly tumbling macromolecules exceeding the size of 
most ATP binding enzymes.
An additional but just as important finding in the experiments of Chapter 3: the inability to 
detect phosphoryl exchange between ß-ADP and ß-ATP provides evidence for a non-saturable 
free ADP pool. Based on the calculations in Chapter 2, a ~60% decrease in the ß-ATP MR signal 
was expected. However, we demonstrated that even if the saturation pulse is applied exactly at 
the resonance of the ß-ADP spins system, the MT effect on the ß-ATP is not larger than 25-30%, 
which was completely attributed to trNOE effects. Hence, the free ADP pool was non-saturable. It 
is generally assumed that the bulk of the ADP (> 90%) in bound state is not participating in the 
exchange between free ADP and ATP, and free ADP concentrations are below the detection level 
of in vivo MRS measurements. Therefore, instead of measuring it, the free cytosolic ADP 
concentration is commonly calculated from the CK equilibrium. However, the evidence for a 
non-saturable free ADP pool challenges the validity of these calculations, as was demonstrated 
by proposing a model in which ADP is presented as a transient reaction intermediate between 
free ATP and bound ADP.
Chapter 4 studies the consequences of a defect in the biosynthesis of creatine (Cr) in knockout 
mice with a null mutation in the gene coding for arginine: glycine amidino transferase (AGAT). 
This enzyme catalyses the first and rate-limiting step in the Cr biosynthesis. Cr is a substrate for 
the CK-PCr system, which plays an important role as energy buffer system in tissues where 
energy demand may increase rapidly.
The mutant mice, in this thesis referred to as AGAT-/- mice, showed negligible levels of guanidino 
acetic acid (GAA), creatine (Cr) and creatinine (Crn) in plasma and urine, when the mice were
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kept on a Cr-free diet. The absence of those three guanidine compounds confirmed a defect in 
the first step of the endogenous Cr production.
The phenotype of the AGATV- mice demonstrated that Cr deficiency has a significant impact on 
whole body energy metabolism: The mice had a much lower body weight and an abnormal fat 
distribution; most prominent was the decrease in subcutaneous white adipose tissue. Together 
with the two-fold increased food intake per body weight and normal locomotor activity, the low 
fat mass suggests an enhanced energy expenditure in the depleted AGATV- mice. This was in 
agreement with in vitro 2H NMR measurements on liver extracts from mice administered with 
3% deuterated water (2H2O), which demonstrated that a relative small fraction of the ingested 
fatty acids ends up in the AGATV- liver. Thus, it is plausible that in Cr-depleted mice free fatty 
acids from the diet are directly taken up by energy-demanding and (P)Cr depending tissues like 
muscle.
Another interesting finding was the significantly enhanced glucose tolerance of the AGATV - mice 
compared with wild type mice. Since insulin levels during glucose tolerance test were lower, it 
was concluded that this is due to increased insulin sensitivity, and not to an increased insulin 
production.
A high fat diet had no effect on the increased glucose tolerance and the abnormal low fat mass in 
the knockout mice, whereas in the wild type mice this diet induced a decrease in glucose 
tolerance and a large increase in subcutaneous fat tissue.
Oral administration of Cr, however, abolished all abnormalities that were seen in the AGATV - 
mice on a Cr-free diet and therefore these appeared to be a direct consequence of Cr deficiency. 
The results in this study confirmed that AGATV - mice are a valuable model to study the effects of 
Cr deficiency on whole body level. The effects of Cr deficiency on food intake, weight, body fat 
and insulin stimulated glucose uptake suggest an important role of Cr in energy homeostasis on 
the whole body level.
In Chapter 5 the effects of Cr deficiency were further investigated, but now specifically in 
skeletal muscle tissue. 1H and 31P in vivo MRS measurements showed that Cr and PCr are indeed 
completely absent in AGATV - muscles when the mice were kept on a Cr-free diet. The absence of 
Cr was associated with severe muscle atrophy and decreasing grip strength. Also morphological 
changes were seen in some muscle fibers, in particular an increase in intramyocellular lipid 
droplets and crystal formation in the mitochondria. Metabolic effects were observed by an 
approximately two-fold decrease in ATP levels and a substantial increase in Pi. The absence of Cr 
also affected the activity of enzymes involved in mitochondrial ATP production. Together with
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increased glucose tolerance and low amounts of white adipose tissue seen in Chapter 4, these 
changes indicate a shift towards a more oxidative ATP production of carbohydrates and fats in 
the muscle fibers. Enhanced energy expenditure in muscle may explain why all dietary fatty 
acids and glucose appear to be almost immediately transported into depleted muscle tissue.
The uptake of Cr in muscle observed during a longitudinal 1H MRS study, over a period of oral Cr 
administration, was remarkably rapid: already after 1 day of treatment, Cr concentrations in 
muscles reached normal wild type levels. The same was true for the PCr levels, while 
normalization of the elevated Pi concentrations was much slower. Hence, the phosphorylation of 
Cr did not deplete immediately the readily available and increased Pi pool. The slow decrease in 
Pi points towards adaptations on the transcriptional level. Abnormalities in morphology, muscle 
volume and strength all normalized upon oral Cr supplementation.
Some of the effects in the depleted AGATV - muscles have also been observed in transgenic mice 
with deficiencies in specific muscle enzymes CK, although generally in a milder form. In contrast 
to AGATV -, CK deficient muscles still contain Cr (and especially at a young age also PCr), even 
though they cannot rely on the CK system when energy demand is rapidly increasing. Depleted 
AGATV - muscle also shows some similarities with muscle of knockout mice with a null mutation 
in the gene for the second enzyme that is involved in the biosynthesis of Cr (guanidiono 
amidiono methyltransferase, GAMT), and also with rats and mice that were fed with ß-GPA (a 
Cr analogue) to reduce Cr levels. The phenotype of AGATV- muscle, however, appears more 
severe; this can be explained because the AGAT mice are the only model for Cr depletion that 
have no alternative substrate for the CK reaction.
Chapter 6 describes a study of the pathological effects of AGAT deficiency on brain metabolism. 
Like in muscle, 31P and 1H MRS measurements showed a complete absence of Cr and PCr, while 
alterations for the other MRS visible phosphate metabolites in brain appeared to be less 
pronounced. A longitudinal 1H MRS study showed that the uptake of Cr in the brain is much 
slower than in skeletal muscles: only after about 20 days normal Cr concentrations were 
reached. This delay is probably a result of limited transport across the blood-brain barrier. 
Degradation of Cr in brain showed a rate of 1.7%, confirming non-enzymatic breakdown, thus 
cerebral Cr was not lost in a different way.
Ischemia-reperfusion experiments were performed to investigate the recovery from a metabolic 
challenge. Infarct volumes in the brains of the AGATV - mice were significantly increased 
compared to those measured in wild type control littermates. Interesting were the still 
significantly increased infarct volumes in the AGATV- mice that were treated with Cr. This means
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that not only the Cr concentration determines the capability to recover from a temporary 
hypoxic challenge. Possible alternative causes may be changes in perfusion, or decreased GAA 
and homo-arginine levels that were detected in both treated and untreated AGATV- mice. 
Further research is warranted to elucidate the actual underlying causes of an inhibitory effect on 
the recovery after an ischemic period in the brains of these mice.
In all creatine kinase or creatine deficient mice glucose metabolism has been affected. To study 
the dynamics of glucose metabolism in various organs, 13C MR spectroscopy, after the 
administration of 13C labeled glucose, is a very useful approach. The application of in vivo 13C 
MRS to mouse brain models is valuable to understand both carbohydrate metabolism and 
glutamatergic neurotransmission in various neuropathologies. However, this application is 
hampered by the low sensitivity of 13C nuclei and contaminating signals of lipids in the relatively 
small mouse brain make this application rather challenging. In Chapter 7 the technical 
challenges of 13C MR spectroscopy are met by optimizing RF coil design for the mouse brain and 
by implementing a localized semi-adiabatic polarization transfer enhancement method: i.e. 
distortionless enhanced polarization transfer (DEPT) on a 7 T MR system. The method was 
evaluated in vivo by performing measurements on the brain of isoflurane anesthetized mice that 
received a continuous intravenous [1,6-13C2]-glucose infusion. The signal enhancement and high 
spectral resolution obtained in these experiments enabled the separate determination of 13C 
label incorporation into as much as 13 metabolites from a 175 [jL volume. Signal increases of 
glucose (C6), glutamine (C3, C4) and glutamate (C3, C4) were determined with a time resolution 
of 8.6 min. This study demonstrates an optimized MR method for the application of in vivo 13C 
MRS in mouse brain and offers new perspectives to study fluxes through the tricarboxylic acid 
and neurotransmitter cycle.
In conclusion, the work in this thesis shows that in vivo MRS measurements in mouse models are 
a valuable contribution to the understanding of energy metabolism in various organs, in both 
health and disease.
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Adenosinetrifosfaat (ATP) speelt een centrale rol in de energiehuishouding van levende 
organismen. Bij hydrolyse van ATP in adenosinedifosfaat (ADP) en inorganisch fosfaat (Pi) komt 
energie vrij. Deze kan direct gebruikt worden voor de vele energievragende processen die nodig 
zijn voor een cel om normaal te functioneren. De energievoorraad in eukaryotische cellen wordt 
op peil gehouden door de ATP productie aan te passen op het verbruik, wat afhankelijk is van 
het type cel en de omstandigheden. Er zijn grofweg twee dominante ATP genererende 
stofwisselingsprocessen: de aerobe en anaerobe verbranding van voornamelijk koolhydraten en 
vetten. In een aantal weefsels, zoals de skeletspieren, het hart en de hersenen, vervult daarnaast 
fosfocreatine (PCr) een belangrijke rol als een fosfaatbuffer, die ingezet kan worden als snelle 
aanvulling van ATP.
Magnetische resonantie spectroscopie (MRS) is een uitermate geschikte methode om de energie 
stofwisseling in vivo te bestuderen, omdat zowel stationaire concentraties van belangrijke 
fosfaathoudende stoffen (ATP, PCr en Pi), als ook dynamische parameters (bijv. chemische 
omzettingen of uitwisselings reacties) op een non-invasieve manier gemeten kunnen worden in 
het weefsel van interesse.
De MRS experimenten in dit proefschrift zijn op verschillende manieren ingezet voor het 
bestuderen van stofwisselingsprocessen in gezonde muizen en in muizen waarin een bepaald 
gen zodanig is gemuteerd dat het corresponderende enzym niet werkzaam is (knock-out muis).
Een unieke eigenschap van nucleaire magnetische resonantie (NMR) technieken is de 
mogelijkheid om een spinsysteem magnetisch te labelen, bijvoorbeeld door het te verzadigen, en 
vervolgens te kijken aan welk spinsysteem dit label wordt overgedragen (MT : magnetisatie 
transfer). Chemische uitwisseling van bijvoorbeeld fosfaatgroepen tussen twee verschillende 
moleculen kan er zo voor zorgen dat, na verzadiging van een 31P spinsysteem, ook het andere 
spinsysteem in enige mate en na enige tijd gelabeld wordt. Deze overdracht van magnetisatie 
wordt vaak bestudeerd met zogenaamde saturatie transfer MRS experimenten, hierbij wordt 
een van twee uitwisselende spinsystemen verzadigd. Deze techniek wordt veelvuldig toegepast 
in vivo voor het meten van fluxen door reacties waarbij fosfaten worden uitgewisseld tussen 
ATP, PCr en Pi. In deze saturatie transfer 31P MRS experimenten wordt een frequentie specifieke 
verzadigingspuls meestal aangebracht op de resonantie van de eindstandige fosfaat van ATP ( y-
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ATP). De gemeten daling in de signaal intensiteiten van PCr en Pi, geeft vervolgens informatie 
over de flux van PCr of Pi naar ATP.
De aanleiding voor het onderzoek dat beschreven is in hoofdstuk 2 en 3, is een extra, nog 
onverklaard MT effect op het spinsysteem van de middelste 31P kern van ATP (de ß-ATP) in deze 
experimenten waarbij de selectieve verzadigingspuls aangebracht wordt op de resonantie y- 
ATP. Dit MT effect is door meerdere onderzoekers waargenomen in de zogenaamde saturatie 
transfer experimenten. Hoewel er tot op heden geen eenduidig bewijs is aangevoerd voor de 
herkomst van dit effect, zijn er wel twee mogelijke oorzaken geopperd voor dit MT effect: (i) 
chemische uitwisseling van fosfaatgroepen tussen ß-ADP en ß-ATP en (ii) relaxatie processen. 
Het is van groot belang dit te weten, daar het informatie kan geven over de hoedanigheid van 
ATP en ADP in de cel.
In hoofdstuk 2 een model opgesteld dat de tijdsafhankelijke veranderingen in magnetisatie in 
31P saturation transfer MRS metingen beschrijft, met als doel de individuele bijdragen van de 
twee mogelijke oorzaken theoretisch in kaart te brengen. In het model is niet alleen de 
overdracht van magnetisatie van y-ATP naar PCr en Pi, maar tevens uitwisseling tussen ß-ATP 
en ß-ADP in rekening gebracht, omdat juist deze uitwisseling het effect op de ß-ATP zou kunnen 
verklaren in de experimenten waarbij ingestraald wordt op de y-ATP. De resonanties van ß-ADP 
en y-ATP liggen namelijk zo dicht bij elkaar, dat ze moeilijk onafhankelijk van elkaar te 
verzadigen zijn. Op grond van gelijke fluxen in heen en teruggaande richting door de CK reactie 
verwachten we vervolgens een MT effect van ongeveer 60% op de ß-ATP bij steady state 
verzadiging van het ß-ADP spinsysteem.
Ook relaxatie processen kunnen zorgen voor de overdracht van magnetisatie. Meer specifiek: 
wanneer een molecuul meerdere spinsystemen bevat, zoals het ATP, dan kan overdracht van 
magnetisatie tussen de twee spinsystemen ook plaats vinden zonder dat daar chemische 
reacties bij betrokken zijn. Deze vorm van MT door relaxatieprocessen wordt ook wel het 
nuclear Overhauser effect (NOE) genoemd. De grootte hiervan wordt bepaald door het type 
kernspin, de beweeglijkheid van de moleculen, de afstand tussen de spins en de sterkte van het 
magnetische veld.
Op basis van de beweeglijkheid van ATP vrij in oplossing en de afstand tussen twee 
dichtstbijzijnde 31P spins in ATP, hebben we onderzocht of het theoretisch mogelijk moet zijn om 
NOE effecten in ATP in vivo te meten. Dit bleek niet het geval, omdat de bijdrage van de relaxatie 
door chemical shift anisotropie (CSA) voor vrij ATP zo groot is, dat in velden hoger dan 2 Tesla 
de NOE effecten beneden de detectielimiet liggen. Het is echter toch mogelijk om NOE effecten te 
meten wanneer een deel van het vrije ATP in uitwisseling is met een gebonden fractie. Deze
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indirecte overdracht van magnetisatie wordt ook wel aangeduid met de term transferred NOE 
(trNOE). Uitgaande van een relatief kleine fractie (< 10%) gebonden ATP, moet deze wel vele 
malen minder beweeglijk zijn dan de vrije ATP fractie. Dit is mogelijk bij complexvorming met 
een groot receptormolecuul. Uit de afschatting van de grootte van zo’n molecuul bleek dat het 
ATP-complex groter moet zijn dan de meeste enzymen waaraan het ATP bindt.
In hoofdstuk 3 is de overdracht van magnetisatie tussen 31P spins bij verzadiging van de y- 
ATP/ß-ADP resonantie experimenteel gemeten op achterpoot spieren van wildtype muizen en 
knock-out muizen waarbij het gen voor spierspecifieke creatine kinase (M-CK) en adenylaat 
kinase (AK1) gemuteerd is. De bijdrage van CK en AK gekatalyseerde uitwisseling tussen ß-ATP 
en ß-ADP en het daarmee mogelijke aandeel in het MT effect op de ß-ATP resonantie is daarmee 
uitgeschakeld in deze muizen. Het MT-effect op de ß-ATP na saturatie van de y-ATP/ß-ADP 
resonantie bleek vergelijkbaar in knock-out en wild type muizen. Daarmee is bewezen dat 
chemische uitwisselingsreacties gekatalyseerd door CK en AK niet de oorzaak kunnen zijn voor 
het MT effect gemeten op de ß-ATP resonantie.
Opmerkelijk waren de identieke MT effecten tussen twee naaste 31P spinsystemen van ATP (a-ß 
en ß-y), en een daling in het PCr signaal na selectieve verzadiging van de ß-ATP resonantie. Deze 
MT effecten wezen duidelijk in de richting van NOE effecten, echter was in hoofdstuk 2 al 
uitgerekend dat directe NOE effecten in ATP niet detecteerbaar kunnen zijn door de grote 
bijdrage van de CSA relaxatie in de 31P spinssystemen van ATP. De identieke MT effecten tussen 
twee dichtstbijzijnde 31P spins van ATP kunnen alleen verklaard worden door het optreden van 
trNOE effecten.
Bij deze experimenten hebben we nog een ander, maar zeker zo belangrijke bevinding gedaan: 
de ß-ADP resonantie bleken we niet te kunnen verzadigen. In hoofdstuk 2 was reeds berekend 
dat het verwachtte MT effect op de ß-ATP veroorzaakt door alleen de ß-fosfaat uitwisseling via 
de CK reactie 60% zou moeten zijn. Echter, zelfs wanneer de verzadigingspuls exact op de ß-ADP 
resonantie instraalt is het MT effect op de ß-ATP niet groter dan 25-30%. In dit hoofdstuk wordt 
een model voorgesteld waarin het vrije ADP slechts een transiente vorm is tussen het gebonden 
ADP en de ATP. Er wordt algemeen aangenomen dat het overgrote deel van het ADP (>90%) 
zich in gebonden toestand bevindt en niet meedoet aan de uitwisseling tussen het vrije ADP en 
de ATP. Daarom wordt de vrije ADP concentratie doorgaans berekend uit het CK evenwicht. De 
juistheid van deze berekening valt echter te betwijfelen op grond van de bevinding dat het ADP 
spinsysteem niet te verzadigen is en er dus geen vrije ADP kan zijn.
I 211
Samenvatting
Hoofdstuk 4 beschrijft een studie naar de consequenties van een defect in de biosynthese van 
creatine in knockout muizen met een null-mutatie in het gen dat codeert voor arginine: glycine 
amidino transferase (AGAT). Dit enzym catalyseerd de eerste en snelheidsbepalende stap in de 
biosynthese van Cr. Creatine is een substraat voor het PCr-CK systeem, wat een belangrijke 
functie heeft als energie buffer (fosfaatbuffer) in weefsels waarin de vraag naar energie snel kan 
toenemen.
Urine en bloed van de mutant muizen (AGAT-/-) die op een Cr-vrij dieet gehouden werden, 
vertoonden slechts verwaarloosbare concentraties guanidinoacetaat (GAA), creatine (Cr) en 
creatinine (Crn). Dit kenmerkt een totaal gebrek aan Cr in het hele lichaam en bevestigt het 
defect in de eerste stap van de biosynthese van Cr. De afwezigheid van Cr bleek een grote impact 
te hebben op de vet en koolhydraat stofwisseling in het hele lichaam. De AGATV- muizen hadden 
een veel lager lichaamsgewicht en een abnormale verdeling van vetweefsel over het lichaam, 
met name het onderhuids vet weefsel was duidelijk verminderd. Samen met een verhoogde 
inname van voedsel per gram lichaamsgewicht en normale locomotor activiteit, lijkt de 
verlaging in subcutaan vetweefsel een gevolg te zijn van een verhoging in gebruik van energie. 
Veranderde voedselinname en/of beweging zijn dus uitgesloten als verklaring voor de lagere 
relatieve vetfractie in de AGATV- muizen. In vitro 2H NMR metingen op lever extracten van 
muizen die met 3% gedeutereerd water (2H2O) verzadigd werden, toonden aan dat slechts een 
kleine fractie van de vetzuren uit het dieet uiteindelijk terecht komen in de lever. Aannemelijk is 
dus dat ingenomen vetzuren direct worden opgenomen door andere energiebehoevende 
organen (bijv. spieren).
Een andere interessante bevinding was de significant hogere glucose tolerantie van de AGATV- 
muizen vergeleken met wildtype muizen. Aangezien insuline waarden tijdens de glucose 
tolerantie test lager waren, konden we concluderen dat dit niet veroorzaakt wordt door een 
hogere insuline productie, maar door een hogere insuline gevoeligheid.
Een dieet met een hoog vetgehalte had geen invloed op de verhoogde glucose tolerantie of 
abnormale vetverdeling over het lichaam: de onderhuidse vetmassa nam niet of nauwelijks toe 
in de knockout muizen. Dit in tegenstelling tot de wildtype muizen die, zoals verwacht, bij een 
hoog vetdieet een daling in de glucose tolerantie en een grote toename in de onderhuidse 
vetmassa lieten zien.
Na orale toediening van Cr, normaliseerden alle abnormaliteiten die we eerder gezien hadden in 
de AGATV- muizen op een Cr-vrij dieet. De effecten lijken dus een direct gevolg te zijn van Cr 
deficiëntie.
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De resultaten in dit onderzoek laten zien dat AGAT-/- muizen een waardevol model zijn om de 
effecten op Cr deficiëntie te bestuderen. De afwezigheid van Cr heeft effecten op voedselinname, 
gewicht, vetverdeling over het lichaam en insuline gestimuleerde glucose opname. Dus vervult 
Cr een belangrijke rol in de energiehuishouding van het gehele dier.
In hoofdstuk 5 zijn de effecten van Cr deficiëntie verder onderzocht, maar nu specifiek op 
spierniveau. In vivo 1H en 31P MRS metingen toonden aan dat Cr en PCr volledig afwezig waren in 
AGATV- spieren, wanneer de muizen op een Cr-vrij dieet gehouden werden. De afwezigheid van 
Cr ging gepaard met een ernstige mate van spier atrofie en afname in spierkracht. Ook op 
morfologisch niveau waren veranderingen te zien; toename in intramyocellulaire vetdruppels en 
kristalvorming in de mitochondria. Metabole effecten vertaalden zich in een halvering van de 
ATP concentratie en een substantiële verhoging van Pi. De afwezigheid van Cr had ook duidelijke 
effecten op de activiteit van enzymen betrokken bij ATP productie in de mitochondria. Samen 
met de verhoogde glucose tolerantie en lage vetstapeling in adipose tissue wijzen deze 
veranderingen op een aanpassing van de spiercellen naar een meer oxidatieve ATP productie 
van koolhydraten en vetten. Een hogere energieverbranding zou mogelijk ook kunnen verklaren 
waarom alle ingenomen vetten en glucose vrijwel direct door de spieren worden opgenomen en 
verbrandt.
De opname van Cr in spierweefsel, onderzocht in een longitudinale 1H MRS studie tijdens een 
periode van orale toediening, bleek opmerkelijk snel: al na 1 dag waren de Cr concentraties in 
spieren genormaliseerd. Hetzelfde gold voor de PCr niveaus. De normalisatie van de verhoogde 
Pi concentraties was echter veel trager, wat kan worden toegeschreven aan adaptaties op 
transcriptioneel niveau. Ook morfologie, spiervolume en kracht normaliseerden na behandeling 
met Cr.
Een aantal van de gevolgen in de gedepleteerde AGATV- spieren zijn ook eerder geconstateerd in 
transgene muizen met deficiënties in spierspecifieke CK enzymen, hoewel over het algemeen in 
een mildere vorm. In tegenstelling tot AGATV-, bevatten CK deficiënte spieren nog wel Cr (en op 
jonge leeftijd ook PCr), maar het PCr-CK systeem kan niet gebruikt worden als fosfaat buffer 
wanneer de vraag naar energie snel toeneemt. Nog meer lijken de gevolgen van de afwezigheid 
van Cr in de AGATV- muizen op die van de GAMTV- muizen (knock-out muizen met een null- 
mutatie in het gen voor het tweede enzym betrokken in de biosynthese van Cr) en ratten waarbij 
een Cr analoog is toegediend om Cr concentraties te reduceren. Er is echter een belangrijk 
verschil tussen deze modellen voor Cr deficiëntie en de knockout muizen beschreven in dit 
proefschrift: de AGAT muizen zijn het enige model met een volledige Cr depletie waarbij er geen
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alternatief substraat voor de CK reactie aanwezig is. De ernstigere gevolgen van Cr deficiëntie in 
de skeletspieren van de AGAT-/- muizen kunnen dus een direct gevolg zijn van de afwezigheid 
van Cr, maar ook van de afwezigheid van enig fosfaathoudend substraat voor de CK reactie.
Hoofdstuk 6 beschrijft een onderzoek naar de pathologische effecten van AGAT deficiëntie in de 
hersenen. Ook hier toonden 1H en 31 MRS metingen een volledige afwezigheid van Cr en PCr aan. 
De metabole veranderingen in brein bleken lang niet zo drastisch als in de spieren. Een 
longitudinale 1H MRS studie liet zien dat de opname van Cr in het brein veel trager is dan in de 
spieren: pas na ongeveer 20 dagen worden normale Cr concentraties bereikt. Deze vertraging is 
naar alle waarschijnlijkheid een gevolg van een gelimiteerd transport over de bloed-brein 
barrière. De afbraaksnelheid van Cr in brein (trouwens ook in spier) bleek 1.7% per dag te zijn, 
wat overeenkomt met de non-enzymatische afbraak snelheid van Cr. Er gaat dus geen Cr 
verloren op een andere manier.
Ischemie-reperfusie experimenten werden ingezet om te onderzoeken of het Cr deficiënte AGAT- 
/- brein zich goed weet te herstellen van een metabole verstoring. Dit bleek niet het geval 
aangezien de infarct volumes in de hersenen van de AGATV- muizen aanzienlijk groter waren 
dan de infarct volumes gemeten in de wildtype controle muizen. Pas echt interessant was dat de 
infarct volumes in de AGAT muizen na een aantal weken behandeling met Cr nog steeds 
significant groter waren. Dit betekent dat naast de Cr concentratie ook andere factoren bepalend 
zijn voor een goed herstel op een tijdelijke hypoxische verstoring. Mogelijke oorzaken zouden 
kunnen liggen in veranderingen in perfusie of een rol voor de lage GAA en homo-arginine 
concentraties. Verder onderzoek op dit gebied is nodig om te achterhalen wat dan wel de 
precieze onderliggende oorzaken zijn van een remmend effect op het herstel na een ischemische 
periode in de hersenen van deze muizen.
Alle onderzoek aan creatine kinase en creatine deficiëntie wijst op een duidelijke aanpassing van 
het glucose metabolisme. In vivo 13C MRS is een MR methode om direct de dynamiek van glucose 
stofwisselingsprocessen te bestuderen. Na infusie van 13C gelabeld glucose kan met deze 
methode de inbouw van het 13C label in andere metabolieten gevolgd worden. Dit geeft 
informatie over bijvoorbeeld de snelheid van glucoseverbranding in organen, maar ook 
neurotransmitter activiteit in de hersenen. Het toepassen van deze techniek op transgene 
muismodellen voor neuropathologische aandoeningen, kan een belangrijke bijdrage leveren aan 
een beter begrip van stofwisselingsprocessen en bepaalde verstoringen daarvan in de hersenen. 
Echter de lage gevoeligheid van deze methode in combinatie met het kleine muizenbrein, maken
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zulke metingen nogal moeilijk. In hoofdstuk 7 zijn we er in geslaagd om de technische 
problemen van deze metingen op muizen op te lossen. Dit hebben we gedaan met behulp van 
een geoptimaliseerde 1H-13C MR opstelling en een MRS sequentie, die de signaal ruis verhouding 
in 13C spectra verhoogt door magnetisatie over te dragen van 1H naar naastgelegen 13C kernen 
(gelokaliseerde semi-adibatische distortionless enhanced polarization transfer sequentie). Deze 
sequentie hebben we geïmplementeerd op een 7T MR systeem. Zo waren we in staat om tijdens 
infusie van [1,6-13C2] glucose in een muizen brein (onder isofluraan anesthesie) , de inbouw van 
13C label in maar liefst 13 downstream metabolieten te meten met een tijdsresolutie van 8,6 
minuten, Dit biedt perspectieven voor het berekenen van fluxen door de citroenzuurcyclus en 
neurtransmittercyclus, maar vereist nog wel een methode om ook de fractie van gelabeld 
glucose in het bloed te monitoren tijdens de MRS meting.
Het werk in dit proefschrift laat zien dat in vivo MRS metingen in muismodellen een zeer 
waardevolle bijdrage leveren aan het begrip van de energiehuishouding in verschillende 
organen in zowel gezonde als pathologische condities.
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Eindelijk ben ik aanbeland bij het schrijven van dit nawoord. Eindelijk, want dit betekent dat de 
rest klaar is. Dat geeft een fijn, maar ook een dubbel gevoel. Immers voor het submitten van een 
aantal van de hoofstukken wordt mijn geduld helaas nog even op de proef gesteld. Maar toch het 
is al een hele opluchting dit werk geheel uitgeprint in de vorm van een boekje te zien, een heel 
mooi concreet, ja zelfs vast te pakken, resultaat van hetgeen waarmee ik me afgelopen jaren in 
Nijmegen heb bezighouden. Daarnaast zijn er natuurlijk ook een aantal abstracte resultaten en 
dingen die ik geleerd heb, die niet terug te vinden zijn in dit boekje maar waarvoor ik hier toch 
een klein beetje ruimte wil innemen. Deze hebben te maken met de weg naar het doel toe. In de 
afgelopen vijf jaar heb ik heel wat over mezelf bijgeleerd. Zo ben ik toch niet zo doelgericht 
gebleken als ik dacht dat ik was. Maar gaandeweg ben ik er achter gekomen dat voor mij de weg 
naar iets toe eigenlijk belangrijker is dan het uiteindelijke resultaat. Een doel is vaak niet meer 
dan een aanleiding om ergens heen te gaan of om aan iets te beginnen. Op weg naar mijn 
promotie heb ik heel wat interessante zijpaadjes kunnen verkennen. Soms was het een 
doodlopende weg (mangaan-project), soms bleek de weg niet begaanbaar (31P saturation 
transfer in muizenbrein), soms moest ik tussen twee wegen kiezen (13C of fMRI in muizen 
brein), maar soms leidde een interssant zijpaade tot een prachtig project (hst 2 en 3). Sommige 
paden heb ik met veel plezier bewandeld, andere soms met wat moeite, maar het was een mooie 
reis.
Op weg naar de eindbestemming zijn het juist vaak de ingeslagen zijpaadjes die de reis de 
moeite waard maken. (Foto genomen door B. Poser, Heumens bos)
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Het doen van een promotie onderzoek was een bijzonder gebeuren. Het leek misschien vaak of 
ik dit veelal in mijn eentje in de kelder achter de scanner of tikkend aan je bureau doet, maar in 
feite zijn er heel wat mensen geweest, die op een of andere manier een echt belangrijke bijdrage 
hebben geleverd aan de tot standkoming van dit proefschrift. Op de reis naar deze 
eindbestemming waren er mensen me de weg hebben gewezen, me hebben geholpen bij pech, 
me hebben geduid op beter begaanbare wegen of interessante plekken om even bij stil te staan. 
Arend, ik heb een fijne tijd gehad in de Nijmeegse spec-groep, bedankt voor de kans die je me 
gegeven hebt om in Nijmegen lekker mijn eigen paadjes in te slaan hier en daar. Ik heb het heel 
fijn gevonden dat ik altijd binnen kon lopen voor een brainstorm of met vragen of updates. Fijn 
ook dat je zo open stond voor samenwerking met verschillende andere collega’s!
Prof. Isbrandt, Dirk, I truly enjoyed our discussions in Nijmegen and in Hamburg. Your 
persistency to aim for papers with a complete story rather than publishing fast and open-ended 
short stories makes you in my view a truly dedicated scientist. Although this way of working has 
resulted in a long test of my patience, I share the view that thorough investigation is the best 
way in which science should be practiced.
Prof. Hilbers, u wil ik enorm bedanken voor alle tijd en geduld die u heeft opgebracht om mij een 
aantal NMR principes tot in de kleinste details bij te brengen. Ik heb echt ongelooflijk veel 
geleerd en enorm genoten van de middagen dat we samen aan het stoeien waren met formules, 
teksten of gedachtenspinsels. Vaak kwamen we er niet meteen uit, maar zelfs dan ging ik op die 
middagen fluitend naar huis en voelde me een echte wetenschapper, een geweldig gevoel!
Prof. Wieringa, Bé, ik heb je biologische kijk op mijn resultaten heel waardevol gevonden, ook 
die persoonlijke vraag of tip zo nu en dan.
De Specgroep waarin ik terecht kwam toen ik in april 2005 begon als kersverse AIO was echt 
heel bijzonder. Het enthousiasme en hulpvaardigheid van iedereen op de afdeling nodigde uit tot 
een energieke start van mijn onderzoek. In het bijzonder wil ik een aantal collega’s bedanken. 
Hermien, jij hebt me vooral in de eerste jaren van mijn promotie regelmatig de weg gewezen 
wanneer ik door de bomen het bos niet meer zag. Als bewegingswetenschapper had je een 
andere, maar zeker heel waardevolle kijk op de op de experimenten en hun uitkomsten. Ik ben 
blij dat je me af en toe even door jou bril naar de experimenten en resultaten hebt laten kijken! 
Andor (alias Andorias), natuurlijk super bedankt voor je hulp bij de ontelbare technische 
problemen op de SMIS die steeds maar weer opgelost moesten worden of gewoon een dom
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foutje van mijn kant bleken. Zonder alle kopjes koffie met opgewekte Andor-verhalen of weetjes 
had ik al die uren achter de scanner in de kelder van het CDL nooit volgehouden!
Dennis of Mister D, je onuitputtelijke enthousiasme, interesse in alles wat met MR te maken 
heeft stralen uit op iedereen die ook maar een beetje bij jou in de buurt komt. Ik zal nooit meer 
vergeten dat je een onneembare berg ook altijd als een mooie uitdaging kan zien!
Tom, fijn dat je je kennis ook meerdere malen met mij hebt gedeeld. Helaas heb ik je humor en 
soms wat ongezouten mening deels al wat heb moeten missen na de verhuizing ;-)
Kim, Mark, Edwin en Cindy, mijn allerliefste kamergenootjes in de kelder van het ziekenhuis! Het 
was erg gezellig, maar ook fijn werken met zijn allen in 1 kamer de laatste anderhalf jaar. Het 
was erg leuk om via jullie ook wat meer mee te krijgen van het reilen en zeilen op de radiologie 
afdeling en het klinische MRS onderzoek. Ik hoop dat ik mijn downs ook goed heb kunnen 
maken met wat ups en verstrooide karaktertrekjes!
Sjakie, bedankt voor de fijne uurtjes HRMASSEN en het samen prutsen in TOPSPIN. Maar vooral 
ook bedankt voor je ‘schetenwapperige’ grapjes en je bijzondere kijk op het leven: Ik ken maar 
weinig mensen die zo intens kunnen genieten van alles wat ze beleven!
Jonge honden: Isabell, Hetty, Thiele, Valerio, Edwin en Patricia, bedankt voor het inblazen van 
wat nieuw leven in de SPECgroep. Ook de bijdrage van Allen daarbij niet te vergeten. Patricia, it 
was a pity that you did not join our lab earlier; but as a dedicated biochemist you added a lot of 
knowledge to the interpretation of my results. Although it was only for a short period, I enjoyed 
your smile when working in the lab and our discussions with a bit Mediterranean sauce!
Martijn en Bertolt, wat was ik blij met twee zulk ijverige studenten toen de experimenten van 
hoofstuk 3, 5 en 6 zo ongeveer gelijktijdig uitgevoerd moesten worden! Jullie enthousiasme en 
inzet hebben echt een heel positieve uitwerking gehad op mijn werkplezier.
Zonder de inzet van een heel aantal dierverzorgers en biotechnici in het CDL (centraal 
dierenlab) had dit boekje niet tot stand kunnen komen: Henk, Leo, Bianca, Connie, Iris, Claudia, 
Maikel en Alex in het bijzonder bedankt voor jullie hulpvaardigheid en werkbare oplossingen. 
Jan van Egmond, Francien en Ilona met veel plezier heb ik bij jullie de benchtop experimenten 
gedaan en heel wat geleerd van de anesthesie, beademen en chirugische ingrepen. Bedankt ook 
voor de gezelligheid en alle kopjes cup-a-soup!
Luuk en Joan, bedankt voor de hartelijke ontvangst in Maastricht voor de biochemische 
bepalingen op de spiertjes. Richard, Liesbeth en Berendien bedankt voor de complex I metingen. 
Chi-Un, it was a pleasure to meet you and work with you on the AGAT chapters. It is amazing 
how you manage to combine your work in the clinics with scientific experiments!
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A special thanks to all the FCDC-people. I am so glad to have been able to just have a small share 
of the special Donders atmosphere that brings about the best in every scientist I did not only 
enjoy the multimodal meetings or 'advanced MR lectures’ but also all the organized events 
(movie-nights, stamppot avondjes, estafette race and most of all the Batavieren races!!!).
Ik had mijn promotie onderzoek niet kunnen afronden zonder me regelmatig even samen met 
wat andere fanatiekelingen fysiek uit te leven: even op de reset knop duwen. Ben, David and 
Rene; rain, sun or snow, I enjoyed every Tuesday lunch-run in the forest. Apart from a physical 
workout it was a very good course in “learning English with hurdles”: keeping up your fast paces 
up and down the hills, with virtually all the oxygen going to my muscles and not to my brain, it 
was already difficult to think, let alone speak English in between two breathings! Whoootoch, 
vette sjizzl: Jasper, Gerben, Joa, Thijs, Linda en niet te vergeten de wedrenners (B1 groep), 
bedankt voor de fijne tochten in de omgeving van Nijmegen (of rond het Ijsselmeer): vaak 
helemaal dood na een ritje, maar vol frisse moed om me weer op het werk te storten! Heleen, 
Elien, Anne-lize, Marjolein, Irma, ik heb genoten van de zaterdagochtenden met jullie op het 
idylisch Eindhovens kanaal en de teamspirit op wedstrijden. Bedankt voor al jullie medeleven in 
tijden van hoogte en dieptepunten!
Fem en Meik, super bedankt voor jullie handige tips om mijn chaotische anti-organisatie weer 
wat onder controle te krijgen en voor de objectieve blik: de spiegel die jullie me regelmatig voor 
hielden had ik zo nu en dan wel echt even nodig. Joyce en Wilma, bedankt voor jullie immer 
oprechte interesse!
Ben, talking or just running during our runs in the forest (getting lost, or meeting a deer 
occasionally) or having a couple (or more) beers or wine at our place, these shared moments 
meant very much to me. It’s a big pity you can’t be there at my dissertation, but drink a cocktail 
on me the 6th of October: I wish you, Wiebke and Ida the very best in Hawaii! See you there!
Bob en Jannie, mede-promovendi, paranymfen; na al even samen wat gesnoven te hebben aan 
MR onderzoek in het afstudeerhok bij Klaas Nicolay, zijn we nagenoeg tegelijkertijd begonnen 
bij Arend. Door de synchroniteit en de BMT achtergrond vonden we elkaar in het enthousiasme 
voor bepaalde onderwerpen, maar liepen we ook vaak tegen dezelfde tekortkomingen op. Ik heb 
het fijn gevonden zo veel met jullie te kunnen delen de afgelopen jaren.
Bob, alias Bobbelmans, superman voor MR-onderzoekers in nood! Altijd in om even mee te 
denken hoe een technisch of wetenschappelijk probleem te tackelen (liefst volautomatisch in 
MATLAB). Ik hoop dat je ook gauw als post-doc aan de slag kunt gaan!
Jannie (Wijntjes), niet alleen in Eindhoven, maar ook in Nijmegen heb ik als vriendin, collega en 
huisgenootje mogen genieten van je bijna altijd zonnige opgewektheid en energie. Met enige
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jaloezie heb ik wel eens gekeken naar jou efficiente manier van werken en het organiseren van 
de rest van je leven. Jammer dat we elkaar voorlopig wat minder vaak zien. Maar gelukkig er is 
genoeg overlap in interesses, hobbies en vrienden om elkaar even bij te babbelen over MR en 
andere belangrijke dingen. Veel succes met David in de VS!
Izaak, Regie, Evelien en Niek, bedankt voor jullie vragen die me dwongen het nut van wat ik nu 
eigenlijk aan het doen was te verwoorden en te blijven inzien.
Papa en mama, Bram en Rob bedankt voor jullie eeuwige support en begrip en steeds 
voorzichtigere informeren naar de vorderingen. Rob, ook veel succes met jou laatste loodjes! 
Jaap, ik geloof dat ik hier niet veel hoef te zeggen: zo fijn dat je er voor me was en nog steeds 
bent.
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Christine Ida Harmina Catharina Nabuurs werd geboren op 5 oktober 1978 te Nijmegen. Zij 
groeide op in Noord-Brabantse St-Hubert en behaalde in 1997 haar atheneum diploma aan het 
Elzendaal College te Boxmeer. Daarna begon zij aan de propedeuse psychologie aan de Radboud 
Universiteit Nijmegen, maar brak dit na enkele maanden af om een jaar te gaan werken, toen dit 
geen goede keuze bleek te zijn. Vanaf 1998 studeerde zij Biomedische Technologie aan de 
Technische Universiteit Eindhoven. Gedurende haar studie voltooide zij meerdere stages, 
waaronder een project op de afdeling radiologie in het academisch ziekenhuis in Maastricht (dr. 
E. Kooi) waar ze voor het eerst in aanraking kwam met magnetische resonantie spectroscopie 
(MRS). In hetzelfde ziekenhuis op de KNO afdeling van het academisch ziekenhuis in Maastricht 
(prof. H. Kingma) deed zij buiten het curriculum om een extra stage naar de haalbaarheid en 
ontwikkeling van een implanteerbaar artificieel evenwichtsorgaan. Tijdens haar studie zette zij 
zich ook in om zowel beeldvormende technieken in de geneeskunde al in het middelbaar 
onderwijs te promoten bij docenten van exacte vakken in de bovenbouw. Tevens was zij nauw 
betrokken bij het opzetten van het klinische blok Radiotherapie gegeven aan de MAASTRO 
CLINIC te Heerlen en Maastricht.
De masteropleiding Medical Engineering sloot zij af met een onderzoek naar de relatie tussen de 
aanwezigheid van intramyocellulaire vet in inactieve spieren en insuline sensitiviteit. Dit 
onderzoek werd uitgevoerd in de Biomedical NMR onderzoeksgroep aan de Technische 
Universiteit Eindhoven (prof. K. Nicolay), alwaar zij in april 2005 haar Ingenieurs titel behaalde. 
In April 2005 begon zij aan de afdeling Radiologie van het UMC St. Radboud in Nijmegen aan 
haar promotieonderzoek. In de periode april-november 2005 bleef ze werkzaam op dezelfde 
afdeling als onderzoeksmedewerker aan een klinische MRI-MRS studie naar 
fascioscapulohumerale dystrofie (FSHD) in samenwerking met de afdeling neurologie. Sinds 
maart 2010 is zij werkzaam als post-doc aan de École Polytechniques fédérale de Lausanne.
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Figure 4.8: AGAT/- and WT mice on a high fa t  diet. (A) Changes in body weights in knockout and control 
mice upon a normal diet (ND) and a high fat diet (HFD) (30-35 week old females, n = 5-6). (B) Histology of 
hepatic biopsies stained with Oil-red-O showing increased numbers and sizes of TG-rich lipid droplets upon 
HFD in only the WT mice. (C) Absolute and relative values of body composition and (D) fat distribution 
determined in AGAT-/- mice and WT littermates on ND and after 12 weeks of HFD, n = 5-6 per group. Relative 
values were normalized to total body weight. Significance levels when compared to WT mice on ND: * P < 
0.05, ** P < 0.01, *** P < 0.001. Two-way ANOVA with Bonferroni post-test.
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ATPase flux
AGAT day 0 AGAT day 2 AGAT day 21
Figure 5.8: Metabolic responses to ischemia and calculated ATPase flux. Changes in PCr (A), Pi (B) and
pH (C) in skeletal muscle before and during an ischemic period. Concentrations and pH levels were 
determined from 31P MR spectra in WT (black), AGATs- on a Cr free diet (day 0, blue), and after 2 (red) and 
21 (grey) days of Cr administration. PCr and Pi signal intensities were normalized to the ß-ATP signal 
intensity before ischemia (ß-ATPß). Data in mean ± SEM, n = 5-7 per group. (D): ATPase rates were 
determined from the decreases in PCr during the first 7 minutes of the ischemic period. Data in mean ± SD, 
n=5-7 per group. * significantly different from WT muscle (P < 0.05).
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Figure 6.6: MCAO induced injury and neurological scores in r u r i / ana w i control mice. (A)
Representative coronal sections stained with 2,3,5-triphenyltetrazolium chloride from an AGATs- (right) and 
WT (right) brain. Both brains were removed 1 day after the 30 min MCAO. Note the large infarct volume 
(white areas) in the AGAT-/- sections. (B) Infarct volume of AGAT-- (n = 6), AGATs- on a Cr enriched diet 
(CRD) (n = 6) and control (n = 7) mice determined from the stained slices that were taken out after 1 day of 
MCAO. (C) Neurological scores determined one hour and one day after MCAO. Values in mean ± SD. *P < 0.05 
and ** P < 0.01 statistically different when compared with controls.
224 I
